University of Kentucky

UKnowledge
Theses and Dissertations--Chemistry

Chemistry

2014

Addressing Public Health Risks of Persistent Pollutants Through
Nutritional Modulation and Biomimetic Nanocomposite
Remediation Platforms
Bradley J. Newsome
University of Kentucky, bradnewsome@gmail.com

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Newsome, Bradley J., "Addressing Public Health Risks of Persistent Pollutants Through Nutritional
Modulation and Biomimetic Nanocomposite Remediation Platforms" (2014). Theses and Dissertations-Chemistry. 38.
https://uknowledge.uky.edu/chemistry_etds/38

This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been
accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For
more information, please contact UKnowledge@lsv.uky.edu.

STUDENT AGREEMENT:
I represent that my thesis or dissertation and abstract are my original work. Proper attribution
has been given to all outside sources. I understand that I am solely responsible for obtaining
any needed copyright permissions. I have obtained needed written permission statement(s)
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing
electronic distribution (if such use is not permitted by the fair use doctrine) which will be
submitted to UKnowledge as Additional File.
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and
royalty-free license to archive and make accessible my work in whole or in part in all forms of
media, now or hereafter known. I agree that the document mentioned above may be made
available immediately for worldwide access unless an embargo applies.
I retain all other ownership rights to the copyright of my work. I also retain the right to use in
future works (such as articles or books) all or part of my work. I understand that I am free to
register the copyright to my work.
REVIEW, APPROVAL AND ACCEPTANCE
The document mentioned above has been reviewed and accepted by the student’s advisor, on
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of
the program; we verify that this is the final, approved version of the student’s thesis including all
changes required by the advisory committee. The undersigned agree to abide by the statements
above.
Bradley J. Newsome, Student
Dr. Bernhard Hennig, Major Professor
Dr. Dong-Sheng Yang, Director of Graduate Studies

ADDRESSING PUBLIC HEALTH RISKS OF PERSISTENT POLLUTANTS
THROUGH NUTRITIONAL MODULATION AND BIOMIMETIC
NANOCOMPOSITE REMEDIATION PLATFORMS

DISSERTATION
A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy in the
College of Arts and Sciences
at the University of Kentucky
By
Bradley J. Newsome
Lexington, Kentucky
Co-Directors: Dr. Bernhard Hennig, Professor of Toxicology
and
Dr. Leonidas Bachas, Professor of Chemistry
Lexington, Kentucky
2014
Copyright © Bradley J. Newsome 2014

	
  

ABSTRACT OF DISSERTATION

ADDRESSING PUBLIC HEALTH RISKS OF PERSISTENT POLLUTANTS
THROUGH NUTRITIONAL MODULATION AND BIOMIMETIC
NANOCOMPOSITE REMEDIATION PLATFORMS
Due to their relative chemical stability and ubiquity in the environment,
chlorinated organic contaminants such as polychlorinated biphenyls (PCBs) pose
significant health risks and enduring remediation challenges. Engineered nanoparticles
(NPs) provide a novel platform for sensing/remediation of these toxicants, in addition to
the growing use of NPs in many industrial and biomedical applications, but there
remains concern for their potential long-term health effects. Research highlighted herein
also represents a transdisciplinary approach to address human health challenges
associated with exposure to PCBs and NPs. The objectives of this dissertation research
are two-fold, 1) to develop effective methods for capture/sensing and remediation of
environmental toxicants, and 2) to better understand associated risks and to elucidate
relevant protective mechanisms, such as lifestyle-related modulators of environmental
disease.
Prevalent engineered nanoparticles, including aluminum oxide and titanium
dioxide, have been studied to better understand effective nanoparticle dispersion
methods for in vitro nanotoxicology studies. This work has served both to effectively
stabilize these nanoparticles under physiological conditions and to better understand the
associated mechanisms of toxicity, which links these metal nanoparticles to endothelial
oxidative stress and inflammation through phosphorylation of key cellular signaling
molecules and increased DNA binding of pro-inflammatory NFκB. Surface
functionalization, though, is being found to limit potential toxicity and has been utilized in
subsequent research.
A novel polyphenol-functionalized, NP-based system has been developed which
combines the biomimetic binding capabilities of nutrient polyphenols with the separation
and heating capabilities of superparamagnetic iron oxide NPs for the capture/sensing of
organic contaminants in polluted water sources. Magnetic nanocomposite microparticles
(MNMs) incorporating the fluorescent polyphenols quercetin and curcumin exhibit high
affinity for model organic pollutants followed by rapid magnetic separation, addressing
the need for sustainable pollutant remediation.

	
  

Further work has been performed to both better understand health concerns
associated with environmental toxicants such as PCBs and to determine effective
methods for modulating their toxicity. This research has shown that PCB remediation
through dechlorination is a viable technique for decreasing endothelial inflammation,
although complete dechlorination to biphenyl is necessary to effectively eliminate
superoxide production, NFκB activation, and induction of inflammatory markers.
Additionally, the nutrient polyphenol EGCG, found in green tea, has been shown to
serve as a biomedical modulator of in vivo PCB toxicity by up-regulating a battery of
antioxidant enzymes transcriptionally controlled by AhR and Nrf2 proteins.
KEYWORDS: POP toxicity; polyphenol; oxidative stress; antioxidant response;
sustainable remediation
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Chapter 1. Introduction
1.1 Background
1.1.1 Combining environmental science and biomedical strategies to better
protect against pollutant toxicity
Contaminant remediation and biological modulation of environmentally persistent
pollutants are two crucial means of reducing the human health risks of Superfund
chemicals/toxicants and related hazardous materials. The Superfund program, designed
to clean up sites contaminated with a variety of hazardous substances, was formed as
the United States’ response to this growing environmental and public health concern1,
but these pollutants are of worldwide concern. Although complete remediation of a
hazardous site may continue to be an ultimate goal of human exposure risk reduction, it
is important to design and implement other biologically relevant means of buffering
against toxicant exposure before, during, and after remediation activities. Of additional
emerging concern, nanotechnology products, such as metal oxide nanoparticles (NPs),
show much potential both for drastically improving biomedical and consumer products
and as the basis for effective pollutant remediation strategies, but they also present
potential physiological and toxicological concerns associated with their ability to pass
through cell membranes and into the cytosol of cells2. There is a clear need to develop
the potential uses of NPs in biomedical treatments and remediation platforms while
concomitantly understanding potential public health concerns that may arise from their
increased use.
Additionally, new data now implicate the importance of an individual’s nutritional
status and the use of protective bioactive food components to decrease the overall
toxicity of environmental pollutants to biological systems3. Nutrition is being
substantiated as an important modulator of inflammatory and antioxidant pathways,
especially with regard to environmental insults. Interestingly, novel research now shows
that bioactive food components that are environmentally friendly can also be integrated
into remediation technologies, which in turn allow for more sustainable, inexpensive, and
effective pollutant removal and detoxification4. Implementing bioactive molecules in both
biomedical and environmental science settings, together, will allow for decreased overall
body burden and human toxicity of a multitude of pollutants (see Figure 1.1 for
overview). Herein, the relevant literature concerning this novel paradigm is discussed,
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which points to the possible future uses of bioactive food components in healthful
nutrition as well as their emerging uses in environmentally friendly remediation strategies
for ultimately reducing human risks to persistent environmental pollutants.

1.1.2 Exposure to POPs, risks for non-communicable diseases, and mechanisms
of toxicity
Persistent organic pollutants (POPs) consist of a long list of toxic chemicals
designated as persistent due to their high chemical stability. POPs have been widely
banned due to their unforeseen adverse health effects5. Of special interest herein,
polychlorinated biphenyls (PCBs) are a diverse class of manmade POPs that have been
outlawed in the United States since the 1970s, but still pose toxicological risks due to
their persistence to environmental degradation6. Marketed for their effective thermal and
electrical properties, PCBs became commonplace in capacitors, caulking, and hydraulic
fluids but have become notorious for their correlation to multiple human toxicities ranging
from endocrine disruption to vascular inflammation7. Although PCBs are detrimental to
multiple target organ systems and tissue types8, special focus of this research has been
placed on their role in vascular related toxicity. Of the 209 individual congeners that
were manufactured, dioxin-like coplanar PCBs such as PCB 77 and PCB 126, which
lack chlorine substitutions on ortho positions of both phenyl rings, are most toxic to the
endothelium and associated vasculature9.
Halogenated POPs, including polychlorinated biphenyls (PCBs) and
trichloroethylene, are highly prevalent in the environment in soil, air, and water3. For
example, a major source of human exposure to PCBs is through dietary intake of
contaminated foods and through inhalation of airborne pollutants8. Because most
halogenated POPs, including PCBs, are lipid soluble, they easily accumulate in human
tissues, leading to a perpetually increasing disease risk throughout a life span, especially
in overweight populations10. Historically, epidemiological studies have been focused on
occupational exposures such as those that occurred with Swedish capacitor workers in
the mid 20th century, but it is becoming clearer that chronic low-dose exposure may pose
the most risk for the general public11; 12. For example, populations most at risk for
chronic exposure are those that ingest high levels of fatty fish due to the fact that PCBs
preferentially bioaccumulate in adipose tissue and thus can be transported vertically
through the food chain13; 14. Although Inuit populations have been observed to have 3.4-
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fold higher plasma PCB levels than Caucasians, low ppb concentrations in plasma are
common for the general United States population15. Importantly, according to the
National Health and Nutrition Examination Survey (NHANES) there appears to be an
association with plasma levels of PCBs and cardiovascular disease in women in the
United States16. Although these association studies are far from causative and can only
correlate levels of PCBs with disease outcome, there are human studies that show PCB
exposure can alter blood lipid profiles and increase total blood cholesterol and
triglycerides, lending merit to the paradigm that environmental toxicants can promote or
exacerbate vascular pathologies in humans13.
Mechanistically, an increase in cellular oxidative stress often precedes an
inflammatory response17. PCBs, and in particular coplanar PCBs, have been shown to
cause oxidative stress primarily through a cytochrome P450 (CYP1A1)-mediated
uncoupling mechanism18. CYP1A1 induction allows for the detoxification of multiple
xenobiotics, but when in the presence of PCB, can become inefficient and leaky (i.e.,
uncoupled) and produce detrimental reactive oxygen species18. A hallmark of the
pathology of vascular diseases, including atherosclerosis, includes a change in the
cellular redox status and a resultant increase in oxidative stress, which favors chronic
and low level inflammation19. Such changes in redox status and oxidative stress levels
can be driven in part by pro-oxidative and pro-inflammatory environmental pollutants that
are persistent and which can be easily stored in adipose tissue. Thus, an increased
body burden of such persistent environmental pollutants is a particular risk factor during
obesity, a disease characterized by excessive adipose tissue10. There is sufficient
evidence that several POPs contribute to inflammation by activating oxidative stresssensitive transcription factors such as nuclear factor kappa-light-chain-enhancer of
activated B cells (NFκB)20. For example, our studies suggest that PCBs, and in
particular coplanar PCBs, can increase cellular oxidative stress and induce inflammatory
parameters such as inflammatory cytokines, chemokines, and adhesion molecules in the
vascular endothelium, which are metabolic events that foster an inflammatory response
and atherosclerosis20-23. Through these pro-inflammatory mechanisms, PCBs and
related environmental toxicants have been correlated with increased risk of multiple
human chronic disease phenotypes including diabetes and heart disease13; 24-27. The
pathology of many inflammatory diseases, especially of non-communicable or chronic
diseases, develops over a long period of time and thus can be easily modulated by
environmental exposures, specifically to persistent organic pollutants. Since many
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populations susceptible to toxicant-induced disease are often also afflicted by dietinduced diseases, future human studies and integrated risk assessments are needed to
better investigate the interaction between nutrition and toxicology28.

1.1.3 Potential opportunities and risks associated with nanotechnology
Nanotechnology and the production of nano-sized particles have emerged as
promising areas of study due to their many applications in industry and medicine29; 30. In
fact, it is conservatively estimated that $10 billion of industrial and governmental funding
is directed toward nanotechnology research each year, and that the global production of
metal oxide NPs alone, without considering engineered nanoparticles, will increase
600% over the next 5 years to 1.6 million tons31. Nanoscale materials have several
properties that cause them to behave differently than their bulk counterparts upon
interacting with chemical and biological compounds, such as their size, shape, surface
chemistry, presence of surface lattice defects, curvature of the NP surface, and the
atomic arrangement of the crystalline facets32. Additionally, nanomaterials have
increased surface-to-volume ratios, which favor adsorptive phenomena. As crystalline
particles become smaller, their surfaces become strained; consequently they have more
facets and surface atom steps. This results in atoms in under-coordinated states (i.e.,
"hot spots") on the surface of NPs to a greater extent than those found in mesoscale
materials33. These edge effects lead to differences in chemical reactivity and electronic
properties. Although these differences at the nanoscale provide the basis for much
opportunity for the development of new industrial and therapeutic products, it is
conceivable that materials considered generally bioinert could behave differently at the
nanoscale. This behavior may not only be a result of different NP surface properties, but
also due to increased ability to be internalized by cell systems through receptormediated endocytosis34. Given the commercial promise of nanotechnology, it is
necessary to establish whether exposure to manufactured nanoparticles poses
significant health risks.
Nanoscale metal oxides such as TiO2, ZnO, Fe3O4, SiO2, Al2O3, and CrO3 all
have been found to have some effect on cellular viability, plasma membrane
permeability, cell morphology, lactate dehydrogenase (LDH) membrane leakage,
mitochondrial function, and/or increased cell apoptosis35; 36. Some have also been
shown to increase inflammatory markers of the endothelium, such as VCAM-1, ICAM-1,
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and ELAM-1 and initiate the secretion of proinflammatory cytokines37. In previous tests,
Al2O3 and TiO2 have shown relatively low cytotoxicity as compared to ZnO and CrO3,
although decreased mitochondrial function and increased LDH leakage occurred at
higher NP concentrations36; 38. Our laboratory’s recent work with TiO2, however, has
further highlighted the ability of these NPs to induce oxidative stress and inflammation
through increased DNA binding of NFκB and phosphorylation of multiple intracellular
signaling pathways; physicochemical similarities between TiO2 and Al2O3 indicate the
potential for similar health concerns39.
Although there are potential negative health concerns associated with
nanomaterials, much has been done to limit these potential concerns while building upon
the many uses for industrial and biomedical applications. For instance, magnetic
nanoparticles (MNPs) have found widespread applications in bioseparation, catalysis,
environmental remediation, and magnetic resonance imaging, as well as in emerging
medical areas for targeted drug delivery and hyperthermia40-43. Their nanoscale size is
critical for their superparamagnetism, and thus their end applications, and much
progress has been made in colloidal synthesis for tailoring nanoparticle size and surface
characteristics for a wide range of applications. Nanoparticle surface functionalization,
and specifically magnetic nanoparticle surface functionalization, with polymer systems is
of great emerging interest for combining the beneficial characteristics found at the
nanoscale with biomimetic functionalities imparted through polymer science41; 42.
1.2 Nutrition as a modulator of environmental chemical insults
1.2.1 Sub-optimal or unhealthy nutrition modulates the toxicity of environmental
pollutants
There is a large collection of evidence pointing to the role that a person’s dietary
makeup and eating habits can play in the promotion of chronic inflammation, metabolic
disorders and vascular diseases44-46. Additionally, emerging data show that exposure to
POPs such as PCBs may work in concert with unhealthy diets to promote cumulative or
synergistic negative effects47. POPs and subprime nutritional status share mechanisms
of disease development including the induction of pro-inflammatory pathways.
Interestingly, a growing body of evidence implicates an exacerbated toxic effect of PCBs
and other environmental pollutants when combined with an additive pro-inflammatory
dietary environment3. For example, our group has shown that, when combined, pro-
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inflammatory PCBs and omega-6 fatty acids create an exacerbated toxicological
response that is not simply the sum of their individual inflammatory responses48.
Importantly, animal fats such as those found in beef and chicken are significant sources
of pro-inflammatory medium and long-chain omega-6 fatty acids as well as PCBs and
other related POPs49. Also, other groups have investigated a linkage between high
saturated fat diets and increased toxicity of POPs such as polycyclic aromatic
hydrocarbons and have shown an increased risk for adenomas and cancer50. In
addition, other environmental contaminants such as heavy metals and nanoparticles
may work in concert with sub-optimal nutrition to promote chronic inflammation and
disease, but studies that investigate the impacts of mixing multiple types of exposures,
(e.g. chlorinated pollutants and heavy metals) in combination with the added variable of
an unhealthy diet are severely lacking51; 52. These types of comprehensive integrated
toxicity studies will better mirror real world exposure conditions especially for people
residing in close proximity to Superfund and other hazardous waste sites. Newly coined
“obesogen research,” which deals with the study of toxicants that can promote obesity
and related syndromes, is a compound-driven area of study that is an important addition
to the toxicological sciences, but we suggest that it does not focus enough on the
interactions between diet and pollutant53. Although obesogen research is becoming a
more developed area of study, work is still needed to elucidate interactions between
nutrients, nutritional status, environmental toxicants and human health.
1.2.2 Healthful nutrition decreases the toxicity of pro-inflammatory pollutants
Polychlorinated biphenyls and related Superfund POPs induce chronic oxidative
stress and disregulated inflammatory responses, but anti-inflammatory nutritional
antioxidants may buffer and protect against toxicant-induced disease through multiple
cell signaling mechanisms3. Diets rich in bioactive food components such as
polyphenols and omega-3 polyunsaturated fatty acids have been correlated with
decreased toxicant-induced maladies including liver diseases, tumor formation and
growth, and endothelial cell activation3; 54-57. Polyphenols, for example, are an abundant
and diverse class of bioactive compounds found in many fruits and vegetables and have
been linked to decreased toxicity from dioxin and dioxin-like PCBs58. These reactive
oxygen species (ROS) scavenging compounds can also increase PCB excretion rates59,
prevent AhR-induced inflammation60, limit body wasting61 and decrease cellular
dysfunction62. Resveratrol, a well-studied polyphenol, has been shown to interact with
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the primary receptor of coplanar PCBs, AhR, and to limit its activation and subsequent
proinflammatory signaling cascade63; 64. Diets rich in antioxidant and anti-inflammatory
agents are well known as a part of French and Mediterranean diets65. It should not be a
surprise then that heart disease and related pathologies are significantly lower in these
areas when compared to similarly industrialized western regions66. Although it is
extremely difficult to determine a unique causative protective agent, bioactive nutrients
such as resveratrol, quercetin, tea catechins, and docosahexaenoic acid (DHA) may all
work independently or synergistically to decrease oxidative stress, inflammation, and
vascular diseases67-69. Since the hallmark of coplanar PCB vascular toxicity is also
increased oxidative stress and inflammation, polyphenols (e.g., flavonoids) and omega-3
polyunsaturated fatty acids are prime nutritional candidates as biomodulators of PCBmediated cytotoxicity. Our work has shown that plant-derived flavonoids such as
epigallocatechin-3-gallate (EGCG), and long-chain omega-3 fatty acids such as
docosahexaenoic acid (DHA) can protect cellular systems by decreasing proinflammatory lipid raft signaling domains called caveolae and by simultaneously upregulating antioxidant defenses through increased nuclear factor (erythroid-derived 2)like 2 (Nrf2) activation70; 71. Most recently we have elucidated novel cross-talk
mechanisms between caveolae and Nrf2 pathways and have shown that nutrients
and/or bioactive food compounds may protect against vascular dysfunction, oxidative
stress and inflammation by down-regualting caveolae and simultaneously up-regulating
Nrf2 target antioxidant genes3. Other groups have shown that bioactive food
compounds such as those found in broccoli (sulphoraphane) and red wine (resveratrol)
can activate Nrf2 through multiple mechanisms and decrease oxidative stress levels in
cells and in animals64; 65; 72-75. Polyunsaturated fatty acids, and especially omega-3 fatty
acids, as well as their anti-inflammatory breakdown metabolites can protect against
PCB-induced disease by activating Nrf2 but interestingly also by disrupting functional
caveolae70. Although caveolae and Nrf2 pathways appear to be prime candidates for
bioactive food components to work through, more research is necessary to better
elucidate other novel pathways that can be targeted both in vitro and in vivo.
1.2.3 Protective cellular signaling pathways
Multiple signaling pathways have been attributed to nutritional modulation of
environmental toxicants, but we have shown that caveolae and the antioxidant master
controller Nrf2 play integral protective roles. There is increasing evidence that lipid raft
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membrane microdomains, i.e., caveolae, may play an important role in atherosclerosis,
the toxicity of coplanar PCBs, and nutritional protection76-78. Caveolae are flask shaped
membrane invaginations that are important in cholesterol transport, nutrient and
xenobiotic import into cells and cellular signaling79. Due to the lipophilicity of PCBs, they
may enter the cell through lipid raft mediated events or come into contact with caveolaerelated signaling proteins. Interestingly, caveolae-mediated endocytosis is a leading
mechanism for nanoparticle entry into cells as well and a focal point of nanotoxicology
studies (see Figure 1.2)80. Caveolae are abundant in vascular endothelial cells and the
cardiovascular system in general, which points to a highly probable role for caveolae in
inflammation and atherosclerosis81. Our laboratory has previously reported that coplanar
PCBs promote the up-regulation of genes related to the activation of endothelial cells
and the initial stages of atherosclerosis, and that the loss of functional caveolae
ameliorates these detrimental effects82. Caveolin-1 (Cav-1), the major structural protein
of caveolae, contains the “Cav-1 binding domain” that is known to bind multiple proteins
including endothelial nitric oxide-synthase (eNOS), v-src sarcoma (SRC), protein kinase
C (PKC), extracellular-signal-regulated kinase (ERk) and protein kinase B (Akt); many of
which are involved in inflammatory pathways76. For example, down-regulation of Cav-1
can lead to eNOS activation and subsequent increases in diffusible nitric oxide, which
has been shown to play a major role in healthy blood pressure and vessel tone22. Many
publications from our laboratory and others show down-regulation and elimination of
Cav-1 to be anti-atherosclerotic23; 83. Importantly, eliminating Cav-1 prevents PCBinduced cellular dysfunction82. Our data point to Cav-1 as a possible anti-atherosclerotic
therapeutic target, and we hypothesize that nutritional intervention can down-regulate
Cav-1 and, in turn, protect against PCB-induced inflammation.
Nrf2 is a transcription factor that can up-regulate cytoprotective genes in
response to oxidative stress, xenobiotics, and bioactive food molecules84-86. Many
nutrients, including resveratrol, sulforaphane, and epigallocatechin gallate (EGCG), have
been shown to activate Nrf274; 87; 88. There are multiple mechanisms of Nrf2 activation,
including direct phosphorylation of Nrf2 by PKC delta and loss of contact between Nrf2
and inhibitory kelch-like ECH-associated protein 1 (Keap-1)89. Upon activation, Nrf2 is
able to evade ubiquitination, enter the nucleus, and bind cis-acting antioxidant response
elements (ARE) in target genes such as heme-oxygenase 1 (HO-1) and
NAD(P)H:quinoneoxidoreductase 1(NQO1)90. Importantly, Nrf2 activation leads to
decreased inflammation, which is a hallmark of PCB toxicity86. Activation of Nrf2 may
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lead to vascular protection from PCB-induced toxicity, and we hypothesize that a diet
rich in bioactive food components can activate Nrf2 and prevent PCB-induced
inflammation. Nrf2 has been shown to cross-talk with multiple signaling partners,
especially with the major player in PCB toxicity, AhR91. Although it has been known for
decades that dioxin and dioxin-like compounds activate both AhR- and Nrf2-related
genes, it was shown only recently that Nrf2 is required for induction of AhR genes such
as CYP1A192. This observed cross-talk can be explained mechanistically at the genetic
level by the fact that the promoter region for Nrf2 contains AhR binding regions and the
gene promoter for AhR contains multiple Nrf2 binding elements91. Our laboratory
previously determined that AhR is a binding partner of Cav-1, so it is plausible that
cross-talk between caveolae and Nrf2 signaling pathways also exists83.
Little is known about the cross-talk between Nrf2 and caveolae signaling and
how bioactive compounds such as omega-3 lipids, flavonoids and other polyphenols
interact to protect against environmental insults. We have shown that decreasing
cellular Cav-1 levels results in a more intense antioxidant response. Mechanistically, we
attribute this to decreased AhR activity as well as increased Nrf2 activity60. Recently, an
intimate example of cross-talk between Cav-1 and Nrf2 was illustrated93, and our
published and unpublished data supports this phenomenon. We have shown that
decreasing Cav-1 via siRNA technology or utilizing Cav-1 KO mice can result in
decreased expression of inhibitory Keap1, which allows for increased Nrf2 activation.
Importantly, we have shown in vitro that pretreatment with the polyphenol EGCG can
cause decreased expression of Cav-1 and up-regulation of the Nrf2 target cytoprotective
genes glutathione S-transferase (GST) and NQO1 (unpublished data). We believe that
an efficient nutritional biomodulator will work through the observed cross-talk between
caveolae and Nrf2 and result in broad and diverse cellular protection. These data
support the paradigm that utilizing bioactive food components can be an effective
strategy to combat PCB-induced vascular toxicity. Using bioactive food components
such as flavonoids and omega-3 polyunsaturated fatty acids (PUFAs) may be an
economically and logistically beneficial method to counteract PCB-induced vascular
inflammation. Although it does appear that both caveolae and Nrf2 signaling pathways
play an important role in nutritional modulation of vascular inflammation, other signaling
cascades may also prove to be involved.
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Phytochemicals may work through mechanisms that up-regulate protective
genes, down-regulate pro-inflammatory genes and/or decrease overall oxidative stress
(Figure 1.3). For example, the green tea polyphenol EGCG has been shown to protect
against inflammation via many of the previously discussed signaling mechanisms, but
interesting new data also points to a role of the laminin receptor. The laminin receptor is
a cell surface receptor that has been shown to play a role in inflammation and cancer
metastasis, and multiple groups have shown EGCG to directly bind the receptor and
subsequently decrease basophil activation, induce apoptosis in cancer cells, inhibit
TLR4 and down-regulate pro-inflammatory cytokines and chemokines94; 95. Studying the
interactions between laminin receptor, nutrients and environmental toxicants may help to
elucidate more effective nutritional modulation strategies to prevent vascular
inflammation and disease.
1.2.4 Healthful nutrition can decrease body burden of environmental toxicants
An emerging paradigm implicates healthful nutrition as an effective protective
modulator of environmental toxicant-induced inflammation and human disease. Multiple
laboratories have investigated the decreased toxicities of environmental pollutants due
to bioactive nutrients such as flavonoids and omega-3 polyunsaturated fatty acids, but
many of these studies rely on in vitro assays that lack the complexity of a whole body
organismal approach. Importantly, emerging classes of bioactive food components such
as polyphenols also have been shown to modulate the pro-inflammatory effects of
environmental toxicants. Our laboratory and others have shown that a wide array of
phenolic compounds such as EGCG, curcumin and quercetin can decrease toxicantinduced oxidative stress and inflammation in multiple cell types, tissues and animal
species54; 59; 67; 71; 96; 97. Although human studies are lacking, strong evidence in animal
models implicates a protective role for flavonoids and other polyphenols perhaps through
the induction of antioxidant enzyme pathways and increased fecal excretion rates59; 98.
Along with the protective effects of healthful nutrition against biological insults induced
by exposure to POPs (summarized in section 1.2.3)3, healthful nutrition, and specifically
antioxidant polyphenols, is also being found to decrease body burden of PCBs and other
POPs. In other words, plant-derived polyphenols are being found to not only protect
against POP-mediated oxidative stress, inflammation, and toxicity but also to bind to
POPs and thus contribute to a decrease in body burden. In fact, if has been proposed
that green tea, containing high levels of polyphenols including EGCG, can inhibit the
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intestinal absorption of lipids and highly lipophilic organic compounds and accelerate
excretion of PCBs59; 99; 100.
Certain foods and polluted air can be major sources of toxicant exposures8.
Thus, altering nutritional choices may prove to effectively modulate risks associated with
exposure to POPs. Making informed dietary decisions such as substituting lower fat
versions of protein sources (e.g., legumes, nuts, or lean meats and dairies) may have
multiple health benefits including decreased exposure to detrimental pollutants such as
dioxins and PCBs101. For many populations it may be difficult or cost-prohibitive to
change major dietary protein sources; thus, increasing dietary intake of other bioactive
nutrients may buffer already exposed individuals against the negative ramifications of
pollutant exposures. For example, several laboratories have shown that diets high in
fiber can alter the absorption and excretion rates of pollutants such as PCBs102-104.
Mechanistically, multiple dietary fibers have been shown to effectively bind pollutants
such as dioxins, which may help to explain increased fecal excretion rates, decrease in
body burden, and observed protection102. Increasing excretion of lipophilic toxicants
through other nutritional compounds such as fat substitutes may also effectively
decrease risk. For example, much emphasis including human clinical trials has been
placed on the interactions between the non-absorbable fat substitute olestra and
environmental toxicants105-109. Researchers determined that low levels of olestra
supplementation (25 grams/day) increased the excretion of multiple PCBs and related
contaminants upwards of 11-fold compared to normal diet109. Interestingly, in a human
case study, an olestra-supplemented diet completely eliminated excessive POP
concentrations in adipose tissue and reversed POP-mediated clinical conditions such as
diabetes and hyperlipidemia110. Diet-derived bioactive compounds such as EGCG are
attractive modulators of toxic exposure because they may both help to prime the
physiological system prior to a toxic insult by up-regulating protective detoxifying
enzymes as well as protect therapeutically after exposure by increasing the rate of
excretion and lowering overall body burden98. Altering diets to increase fiber and
bioactive nutrients from fruits and vegetables is an effective and cost-efficient means of
modulating POP toxicity, but interestingly an emerging and growing body of knowledge
also implicates the use of bioactive nutrients such as quercetin and curcumin as
effective components of novel environmentally friendly remediation technologies.
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Environmental remediation not only relies on efficient pollutant degradation but
initially on effective pollutant sensing and capture/removal from contaminated settings.
Emerging research suggests that the utilization of polyphenols for capture and sensing
of POPs may provide a technologically efficient and cost effective remediation platform
that results in minimal environmental and health impacts. This work adds to the
paradigm that nutrients or diet-derived bioactive compounds can broadly impact health
concerns associated with POP exposure (see Figure 1.1).
1.3 Utilizing polyphenols for pollutant sensing, binding, and remediation efforts
1.3.1 Current methods and difficulties for POP sensing and remediation
Persistent organics, and especially PCBs, have proven difficult to remove from
contaminated sources and subsequently remediate due to their poor aqueous solubility
and low volatility, which makes extraction from soil and water especially challenging111.
Further, sensing of these pollutants is both difficult and cost prohibitive, relying heavily
on GC-MS methods and complicated extraction techniques112-114. POP remediation to
date often involves dredging and subsequent deposition in landfills or further pollutant
degradation through incineration or various chemical dehalogenation techniques115.
Studies have shown, though, that dredging and deposition results in substantial leaching
into the surrounding environment, incineration can produce even more harmful
byproducts if insufficient temperatures are reached, and organic solvents used for
chemical dehalogenation are often as toxic as the pollutants being remediated116; 117.
There is a clear need for more effective pollutant remediation involving inexpensive,
environmentally friendly, stable systems for the capture/sensing of PCBs and other
POPs, as well as environmentally-conscious pollutant degradation. In fact, as of 2011,
the Ecologic Institute of the European Union’s Screening methods for the Water
Framework Directive (SWIFT-WFD) has continued to focus on this need for discovery
and translation of low-cost screening tools for environmental contaminants118.
As a result, much research has been performed to determine novel technologies
and methods to capture, sense, and remediate POPs. One such example includes
engineered antibodies that contain binding domains that can specifically associate with
PCBs and other POPs, which can be utilized for specific binding and sensing
applications119. Due to inherent cost barriers and stability issues of these antibodies,
though, other low-cost, stable engineered materials have been sought as an alternative
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platform to mimic this specific binding interaction; growing data are implicating the use of
nutrient polyphenols as effective components of engineered POP capture/sensing
platforms both due to their fluorescent detection characteristics and affinity for
chlorinated organics120. It has been reported that the binding domains of PCB-specific
antibodies (e.g., the monoclonal antibody S2B1) form sterically constrained, highly
aromatic pockets, which allow for pi-pi bond stacking interactions119. Researchers have
successfully mimicked these interactions in the development of synthetic materials,
including those composed of polyphenolic moieties, for capture and sensing
applications121-124. For instance, by exploiting their biomimetic binding properties,
researchers have developed porphyrin-containing compounds (highly aromatic
compounds with similar molecular geometries to polymeric polyphenols) for the
detection of environmental contaminants113; 125.

1.3.2 Emerging methods for POP sensing and remediation utilizing polyphenolbased nanomaterials
There is emerging evidence that biomimetic PCB binding domains can be
synthesized by incorporating phenolic and related moieties into polymeric coatings,
which will greatly enhance the ability to detect and remove/remediate PCB
contamination120. Polyphenols such as quercetin and curcumin are of special interest
not only because of their beneficial health effects and environmentally benign nature but
also because of their highly aromatic structures, which may enable effective and/or
specific binding and sensing of aromatic pollutants126. Recently, we developed a novel
strategy to synthesize polymeric networks that incorporate these polyphenols as both
stable coating materials and biodegradable hydrogels for use as a pollutant binding
platform and an antioxidant release platform to combat localized cellular oxidative stress,
respectively127-129. These materials can have enhanced biocompatibility over their free
compound form130 and in preliminary studies, we have shown that PCB binding is
increased through the incorporation of phenolic moieties in a polymeric matrix4.
Additionally, the characteristic fluorescence peaks associated with these flavonoids
effectively have been used preliminarily to sense PCB congeners in a concentrationdependent fashion4.
Although, biomimetic polymeric networks have been utilized for rapid binding of
relevant pollutants131, these pollutant-bound materials must be easily removed from
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contaminated environments in order to be effective remediation systems. Combining
polyphenolic polymers with magnetic nanoparticles in nanocomposite microparticle
systems, then, allows for rapid binding of aromatic pollutants followed by highthroughput magnetic separation from contaminated samples. Magnetic nanoparticles
(MNPs) have found widespread applications in magnetic fluids, catalysis, and
bioseparation, and are being utilized increasingly in environmental remediation, either as
uncoated particles or polymer-functionalized particles for increased pollutant adsorption,
sensing and degradation131-134. Although nanoparticles in general have been studied for
some time to elucidate their potential toxicity, magnetic iron oxide nanoparticles have
shown minimal cytotoxicity and additionally have been used successfully in biomedical
applications for many years in areas such as magnetic resonance imaging, targeted
drug delivery, and hyperthermia40-43; 135. Further, recent studies in our group have shown
that polyphenolic polymers can enhance the biocompatibility of metal nanoparticles like
iron oxide136, thus forming the basis for a safe, environmentally-sound remediation
platform. MNPs have found great utility in biomedical applications due to their
superparamagnetic properties (conferred by their nanoscale size), which allow for easy
manipulation with a magnetic field (e.g., for effective magnetic separation of captured
molecules or for transport and immobilization at target sites) and heat generation in
response to an alternating magnetic field (AMF) for local heating to modify properties
(e.g., reaction rates, binding properties, thermal treatment)137. By utilizing diet-derived
polymeric polyphenol coatings of defined thickness and matrix structure, our work has
shown that pollutants can be very quickly removed from contaminated water samples4.
Further, heating of the material can result in thermal destabilization of the polymer matrix
and subsequent release of bound pollutants for potential reuse. This combined system,
incorporating the binding potential of nutrient polyphenols with the separation and
remote heating potential of magnetic nanoparticles potentially could be used for rapid
removal of pollutants from environmental samples. The addition and implementation of
bioactive nutrients into engineered polymers and nanoparticles allows for efficient
remediation of contaminated sites and is worthy of increased investigation due to the
high efficiency and specificity potential as well as the environmentally responsible
makeup of the technology.
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1.4 Overall research goals
Nutrition is being further substantiated as an important modulator of inflammatory
and antioxidant pathways, especially associated with environmental insult, and is also
emerging as a tool to address exposure toxicity of persistent organic pollutants as both a
sensing and remediation platform (Figure 1.1). Evidence now shows that a person’s
nutritional status can play a key role in determining the severity of environmental
toxicant-induced pathologies such as diabetes and cardiovascular diseases. People
with subprime nutrition may be more susceptible to the toxicity of environmentally
persistent pollutants whereas individuals that make healthy nutritional decisions and
emphasize the importance of foods high in bioactive nutrients such as flavonoids may be
less vulnerable to environmental insults by being able to buffer against the toxicity of
pro-inflammatory pollutants. Although augmenting the nutritional profiles of at-risk
populations may prove to be an effective modulator of toxicant-induced disease in the
long term, it is critical to discover and design novel sensing and remediation
technologies that are effective, sustainable and environmentally friendly to address
immediate needs. Therefore, the novel and emerging evidence that bioactive nutrients
may be incorporated into sensing and remediation components may lead to viable
technologies that circumvent many of the issues concerning current-day
decontamination platforms. Ultimately, further research into nutrient polyphenols, such
as EGCG, quercetin, and curcumin, will highlight their potential as sustainable,
inexpensive components both that can decrease health concerns associated with
environmental pollutants in the short term and remediate these concerns in the long
term.
The following studies highlight a systematic approach to addressing concerns
associated with POP toxicity through both environmental remediation efforts and
biomedical intervention strategies. PCBs 77 and 126 were selected as examples of
coplanar persistent environmental pollutants that exhibit dioxin-like toxicity. PCB
degradation product in vitro toxicity was evaluated following pollutant dechlorination
using iron/palladium nanoparticles, as was in vitro toxicity attributed to other metal oxide
nanoparticles, specifically titanium dioxide nanoparticles. Improved methods for
nanoparticle suspension for subsequent industrial application and toxicity evaluation
were also studied. Biomedical intervention strategies were developed using nutrient
polyphenols to mitigate in vivo PCB toxicity and polyphenol-functionalized nanoparticles
were developed as a biologically-inspired remediation platform for removing PCBs from
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contaminated water sources. Overall, this research has sought to address the
significant public health risks and enduring remediation challenges posed by PCBs as
model toxicants, as well as to further understand potential concerns and opportunities
associated with nanomaterial usage. (The information in Chapter 1 represents a
compilation of information from published review articles3; 138.)

Copyright © Bradley J. Newsome 2014
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Figure 1.1. Illustration of nutrition as 1) a modulator of health risks associated with
environmental exposure and toxicity of persistent organic pollutants (POPs) and as 2) an
environmentally sustainable tool to capture, sense and remediate POPs. We propose
that nutrition, and in particular diet-derived bioactive compounds such as polyphenols,
can protect against POP toxicity through their antioxidant and anti-inflammatory
properties. Polyphenols also can participate in a remediation platform that includes their
roles in POP capture and sensing technologies, thus allowing for environmentally
friendly and sustainable remediation of POPs.
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Figure 1.2. Three mechanisms of endocytosis: clathrin-mediated endocytosis (CME),
caveolae-mediated uptake (CAV), and clathrin-and caveolae-independent internalization
(CCIE).
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Figure 1.3. Caveolae play a critical role in PCB-induced vascular toxicity. Protective
bioactive nutrients such as omega-3 PUFAs and flavonoids can utilize caveolae Nrf2
cross-talk to decrease reactive oxygen species, limit inflammatory responses and
ultimately prevent PCB-induced vascular toxicity.
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Chapter 2. Optimization of alumina nanoparticle dispersion for environmental and
toxicological studies
2.1 Synopsis
Current dispersion techniques of nanoparticles (NPs) rely on organic solvents,
pH extremes, or stabilizing agents, but these methods are not conducive to
environmental and toxicological studies. The aim of this study was to determine optimal
dispersion characteristics for nano-sized aluminum oxide (alumina) particles in aqueous
solutions that mimic biological systems. Alumina NP dispersion was tested in six
biologically relevant buffers, as well as cell culture media, and artificial pulmonary
surfactant. Suspension media, concentration, and pH were optimized for preparation of
alumina NPs at or below 100 nm in size. These NPs were suspended most stably and
reproducibly in citrate buffer using high-sheer probe sonication (forming particle sizes of
~68 nm), and exhibited high charge stabilization, which produced highly stable
suspensions. Acetate buffer also served to suspend alumina at approximately 95 nm in
size, although higher polydispersity and decreased long-term suspension stability
hampered its use. Alumina particles initially prepared using citrate buffer also remained
well suspended with size near 70 nm following addition to cell culture media, indicating
that this may be a valuable nanoparticle preparation mechanism for further toxicological
studies examining nano-sized effects, instead of the more typical studies associated with
micron-sized particle agglomerates. This research highlights mechanisms to stably and
reliably disperse alumina NPs in the nano-size regime for environmental and
toxicological studies.
2.2 Introduction
Nanotechnology has become commonplace not only in the scientific community,
but also in industry and the consumer market139. Nanoscale aluminum oxide (alumina)
has become important for its wide range of uses: water- and wear-resistant coatings,
propellants, personal care products, pharmaceuticals, air and water purification, and
structural ceramics, to name a few140; 141. There are approximately 50 million tons of
alumina produced each year, which are increasingly being used in nanoparticle (NP)
form142. This increased use of nanoscale alumina has in turn led to increased concern
over its safety. Although much is known about alumina on a macroscopic level, little is
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known about the toxicological properties of its NP form. Most metal oxides, including
alumina, are benign at the macroscale, and even at the microscale, but, because of
quantum size effects and larger surface area, as the nanoscale is approached materials
can exhibit drastically different properties143; 144.
Nanoparticles involve a size range between 1 and 100 nm. Nanopowders, on
the other hand, consist of agglomerates of these NPs that can begin to exhibit properties
of the bulk material. Although the manufactured size of NPs is often 10-50 nm, the
agglomerates formed from these particles can easily reach to micron sizes, limiting the
material’s benefits found at the nanoscale145-148. Effective stabilization of alumina NPs,
especially in aqueous environments, allows for their further utilization in biomedical
applications but has proven difficult because most industrial NPs have not been
developed to be compatible with physiological or environmental conditions149. Instead,
they rely on organic solvents, pH extremes, or stabilizing agents to remain in
suspension147; 150-160. In order to maintain efficient particle dispersion, the steric or
charge barriers that cause particle-particle repulsions must be sufficient to overcome the
attractive van der Waals forces that lead to particle adherence161; 162. As particles
agglomerate, these larger particles gain an increased affinity for smaller particles,
eventually resulting in bulk material formation that sediments out of suspension163; 164.
Dispersant layers (adlayers) surrounding the NPs of interest are often used to provide a
steric barrier when using NPs in biologically relevant environments and are effective at
maintaining stable NP suspensions159; 165. In order to study the actual environmental and
physiological effects of NPs instead of that simply attributed to their adlayers, it is
necessary to obtain effectively stabilized NP suspensions both under near-neutral pH
conditions in biologically relevant buffers and without surface passivation by materials
not found in nature or in the body166; 167.
Analysis of NPs in suspension provides another obstacle. Transmission electron
microscopy (TEM) is often used to provide highly accurate particle size determination,
but cannot be used to determine overall aggregation characteristics or gather
information about how particles behave in solution. Dynamic light scattering (DLS), on
the other hand, can be used to determine average hydrodynamic diameters of NPs
interacting in solution168; 169. Laser Doppler electrophoresis (LDE) also can provide an
indication of the stability of a suspension by measuring its zeta potential and
electrophoretic mobility169. At high zeta potentials, either positive or negative, charge
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stabilization occurs between the bulk solution and the nearby particles causing the
suspension to resist aggregation. By tailoring the suspension medium with regard to
concentration and the types of ions in solution, it is possible to obtain a stable
suspension of NPs that could resist aggregation170.
Although there is much potential for NPs to drastically improve biomedical and
consumer products, they also present potential physiological and toxicological concerns
because, for one, they are capable of passing through cell membranes and into the
cytosol of cells2. Principally, their very small size, but also their shape, chemical
composition, and surface charge, facilitates entry into the body and into cells. It is
thought that NPs enter cells through active transport mechanisms such as receptormediated endocytosis, but are also capable of passing into cells passively via
pinocytosis171-175. Nanoscale metal oxides such as TiO2, ZnO, Fe3O4, SiO2, Al2O3, and
CrO3 all have been found to have some effect on cellular viability, plasma membrane
permeability, cell morphology, lactate dehydrogenase (LDH) membrane leakage,
mitochondrial function, and/or increased cell apoptosis35; 36. Some have also been
shown to increase inflammatory markers of the endothelium, such as VCAM-1, ICAM-1,
and ELAM-1 and initiate the secretion of proinflammatory cytokines37. In previous tests,
Al2O3 and TiO2 have shown relatively low cytotoxicity as compared to ZnO and CrO3,
although decreased mitochondrial function and increased LDH leakage occurred at
higher NP concentrations36; 38. Our laboratory’s recent work with TiO2, however, has
further highlighted the ability of these NPs to induce oxidative stress and inflammation
through increased DNA binding of NFκB and phosphorylation of multiple intracellular
signaling pathways; physicochemical similarities between TiO2 and Al2O3 indicate the
potential for similar health concerns39.
Recent tests performed with alumina use NPs with manufactured diameters of
approximately 20-50 nm. However, it is broadly known that in aqueous solutions
manufactured NPs exist as aggregates with size of 200-500 nm and above37; 140.
Sonication is commonly used to disperse nanopowders as smaller and smaller
aggregates, but proper charge stabilization following dispersion is key for maintaining
effectively dispersed NP suspensions176. Stabilization of NPs nearer to their
manufactured size could result in greater effectiveness in pharmaceutical/consumer
applications, but also potentially increased toxicity and additional ability of inhaled
nanoparticulates to progress further down the respiratory tract 177-179. Tests with soot
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samples have shown that particles ranging from approximately 100 nm to 20 µm can
deposit in nasopharyngeal/laryngeal tissue, while particles less than 100 nm are able to
reach alveolar tissue. At the alveoli, NPs are not only able to interact with type I and II
alveolar cells, but there is some concern that they may be able to translocate from the
respiratory system via the alveoli to the capillaries and bloodstream180. It is therefore
important to investigate the physiological impact of particles stabilized at or below 100
nm. These tests in biologically relevant systems are meant to shed light on improved
methods of alumina NP dispersion not only for potential use in biomedical and consumer
applications, but also for continued risk assessment regarding cellular interactions with
NPs, and the nanotoxicological effects thereof.
2.3 Methods and Materials
2.3.1 Materials
Commercial grade uncoated Al2O3 NPs were obtained from Alfa Aesar (0.01-0.02
µm, Lot # B24Q09, Ward Hill, MA) and initially characterized, as seen in Table 2.1.
Sodium acetate, acetic acid, sodium chloride, potassium chloride, sodium phosphate
dibasic, potassium phosphate, tris(hydroxymethyl)aminomethane carbonate (Trizma
base), 2-(N-morpholino)ethanesulfonic acid (MES), 4-(2-hydroxyethyl)piperazine-1ethanesulfonic acid (HEPES), citric acid, sodium citrate, dipalmitoylphosphatidylcholine
(DPPC), phosphatidylglycerol (PG), and bovine serum albumin (BSA) were purchased
from Sigma-Aldrich (St. Louis, MO). All chemicals were reagent grade or better, and all
aqueous solutions were prepared using 16 MΩ deionized water from a Milli-Q water
purification system (Millipore, Bedford, MA). Dulbecco’s Modified Eagle Medium
(DMEM)/High Glucose and fetal bovine serum (FBS) were purchased from
ThermoFisher Scientific (Waltham, MA) and F-12K, 1X media were obtained from
Mediatech (Manassas, VA). Copper Lacey Carbon TEM grids (200 mesh) were
obtained from Electron Microscopy Services (Hatfield, PA).
2.3.2 Experimental conditions and measurement techniques
Alumina (Al2O3) nanoparticle size, surface area, and purity were initially
evaluated in comparison to vendor specifications. Elemental analysis of Al2O3 samples
(prepared at 100 ppm in deionized H2O and evaporated to dryness on carbon tape) was
performed using a Hitachi S-4300 scanning electron microscope (Houston, TX) with a
Princeton Gamma-Tech energy dispersive X-ray spectroscopy (EDS) Microanalysis
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System (Princeton, NJ), primary and aggregate particle sizes were determined using
scanning electron microscopy (SEM), and surface area was determined through the
Brunauer-Emmett-Teller (BET) method using a Micromeritics TriStar 3000 surface area
and pore size analyzer (Norcross, GA), following overnight degassing at 120 °C. Initial
Al2O3 nanoparticle dispersion and size characteristics (suspended in deionized water at
100 ppm) were analyzed using a Malvern ZetaSizer Nano DLS/Zeta potential system
with DTS Nano 5.1 Dispersion Technology software (Worcestershire, United Kingdom).
Characterization results can be found in Table 2.1 as compared to vendor supplied
values.
Herein, alumina nanoparticles were initially suspended at 100 ppm in
suspension medium of interest (n≥6). Samples were vortexed to initially suspend
particles prior to ultrasonicating in an ultrasonic bath (model #: B3500A-MTH, rated
output: 135W, 42 KHz, VWR, Radnor, PA) or with a sonic dismembrator probe sonicator
(model #: XL2015, rated output: 475W, 20KHz, 1” probe immersion depth, pulsed at
15% duty, power input: 50W, Qsonica, Newtown, CT). Samples were sonicated in
ice/water baths to maintain temperature and limit adverse affects from sample heating.
Nanoparticle suspensions were filtered through 0.2 µm Anodisc 47 membrane filters
(Whatman, Maidstone, United Kingdom) or centrifuged using a Beckman Coulter Avanti
J-251 Ultracentrifuge (Fullerton, CA), depending on suspension mechanism, to separate
any remaining large aggregates and sedimented particles. Sample NP final
concentrations were confirmed using a Thermo iCAP 6500 Duo inductively coupled
plasma optical emission spectrometer (ICP-OES) with iTeva ICP software (Waltham,
MA). Sample size and NP physicochemical characteristics were analyzed using a Jeol
2010F transmission electron microscope with an Oxford EDS detector (Tokyo, Japan).
Nanoparticle hydrodynamic diameters and suspension zeta potentials were analyzed via
DLS analysis.
2.3.3 Suspension of nanoparticles in buffers
Various buffers and preparation conditions were tested to determine alumina NP
dispersion conditions. Alumina was suspended in buffers with pKa values covering a
wide pH range from pH 4 to 9. Acetate buffer was prepared in deionized water at 0.1,
0.01, and 0.0001 M concentrations, pH 4, using sodium acetate and acetic acid. Acetate
buffer was selected due to previous success suspending metal oxide NPs. Citrate buffer
was prepared at 0.1, 0.01, and 0.0001 M concentrations, pH 4 and 6, using sodium

24

citrate and citric acid. Buffer solutions of 0.5 M MES and 1 M HEPES were tested at pH
5.5 and 7.5, respectively. PBS 1X was tested due to its wide use and physiological pH,
which is conducive for cell culture studies. One molar Tris buffers (using Trizma base)
were prepared at pH 7.5, 8.6, and 9 in order to analyze solution stabilization
characteristics at, above, and below the pKa of alumina’s surface hydroxyls (pKa 8.6 in
water) 181; 182. Alumina samples were bath sonicated for 6-, 12- or 24-h increments or
probe sonicated for 10 min. Following ultrasonication, samples were allowed to sit
undisturbed for 30 min in order to determine buffer suspension capabilities. In the case
of rapid visible sedimentation, the buffer was eliminated from further studies.
Subsequently, filtered samples were compared to unprocessed samples to determine
the effects of vortexing and filtration on resultant concentration (determined by ICPOES), overall particle size (determined by DLS and TEM), and suspension stability
(inferred visually and by zeta potential). The following suspension conditions were
compared among the various buffers: buffer concentration, pH, dispersion method and
duration, and suspension stability (see Table 2.2 for alumina suspension conditions).
2.3.4 Suspension of nanoparticles in artificial pulmonary surfactant
Lung surfactant was simulated using 10 mg/mL DPPC in deionized water in order
to compare suspension characteristics between buffered systems and a more
physiological environment. Although this phospholipid can be solubilized in chloroform
or 90% propanol (v/v), these dispersants can act as cell fixatives and are not appropriate
further for cell culture studies. A previously reported DPPC dispersion medium was also
used as another means of forming stable alumina NP dispersions in the nano-sized
regime183; 184. This dispersion medium was prepared in deionized water with 0.6 mg/mL
BSA and 0.01 mg/mL DPPC and adjusted to pH 7.4. Deionized water was used as an
alternative to PBS, which was used in previous studies, to address potential issues with
phosphate-induced alumina aggregation. Alumina was suspended with vortexing for 4 h
at room temperature followed by bath sonication for 3 min. DPPC contains two 16carbon chains that can be cleaved by prolonged sonication; limited sonication serves to
solubilize the phospholipid more effectively while limiting breakdown of the molecule.
Alumina suspensions were centrifuged at 4000 rpm for 30 min at room temperature to
remove any remaining large agglomerates.
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2.3.5 Suspension of nanoparticles in media
DMEM/High Glucose media and F-12K media were tested as alumina stabilizing
agents due to their applicability for a variety of cell types, especially alveolar cells.
Alumina nanoparticles were initially prepared as above in biologically relevant buffer and
subsequently added to media at approximately 30 ppm final alumina concentration, in
line with previously published alumina toxicology study concentrations35.
2.4 Results and Discussion
2.4.1 Determination of optimal particle dispersant
Alumina NPs, with a manufactured size of 20 nm, were suspended in six buffers
at an initial concentration of 100 ppm (See Table 2.2). Particle size analysis is
contingent on Brownian motion; therefore, extensive sedimentation leads to decreased
reliability of sizing results. Optimal buffer dispersant was then chosen based on its
ability to both effectively suspend alumina NPs and limit particle aggregation. Optimal
preparation conditions were chosen based on resultant NP size. The stability of
effectively dispersed samples was monitored for 2 weeks by analyzing the change in
particle size and zeta potential. Number distribution was primarily used in our DLS
studies in order to obtain a more reliable analysis of multimodal systems made up of a
mixture of individual particles and small aggregates as well as larger particle
agglomerates. One must take into account, though, that because the number
distribution is an estimation – as this system is not an actual particle counter – it is not
completely reliable on its own to give information about the system. Consequently,
although number distribution was primarily used for analysis, data were also compared
to intensity distribution DLS measurements and electron microscopy results.
Four buffers, including 0.1 M citrate (pH 6.0), 0.1 M citrate (pH 4.0), 0.1 M
acetate (pH 4.0), and 1 M HEPES (pH 7.5), were capable of suspending alumina to
varying extents, while 1X PBS (pH 7.4), 0.5 M MES (pH 6.0), and 1M Tris (pH 7.5, 8.6,
and 9) buffers were unable to stabilize alumina enough to obtain reliable size
measurements. Initial measurements were performed following 6 h sonication in an
ultrasonic bath at 25 °C. Although 0.1 M citrate, pH 4, was capable of dispersing
alumina NPs, the presence of high particle polydispersity indicated poor particle
stabilization. HEPES buffer stabilized particle aggregates outside the target size range
with aggregate size being approximately 1.8 µm. Number distribution was used to look
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more specifically at smaller particle peaks. Peak alumina NP sizes (hydrodynamic
particle diameter) in citrate and acetate buffers were 90±1 nm and 101±7 nm,
respectively. Although acetate buffer, pH 4, produced particle aggregates in the target
size range (~70-100 nm), it also exhibited much increased size variability between
samples because of poor particle charge stabilization. Use of citrate buffer, pH 6, as an
alumina suspension medium provided small agglomerates, highly reproducible results,
and very little formation of large aggregates.
Inductively coupled plasma optical emission spectrometry (ICP-OES) was used
to determine the effect of filtration on sample concentration following initial sample
preparation. Alumina dispersed in citrate buffer, pH 6.0, with 10 min probe sonication
showed average alumina NP recoveries (filtered/unfiltered %) of 27%, indicating final
sample concentrations of approximately 27 ppm alumina NPs dispersed in buffer, which
is in line with recent concentrations used for toxicology studies35. Contaminants due to
the citrate buffer were assumed to be minimal in comparison to alumina NPs for the
purpose of sample analyses.
Although not reported, deionized water was also tested as an alumina
suspension medium control (see initial particle characterization in Table 2.1). A bimodal
particle size distribution was exhibited, with both particles approximately 140 nm in size
as well as large, micron-sized aggregates, although large aggregates heavily
predominated. PBS does not stabilize alumina because phosphate groups bind rapidly
and strongly to the surfaces of particle aggregates, thus limiting particle disaggregation
during sonication185. It is presumed that Tris buffer (pH 7.5, 8.6, and 9) is unable to
stabilize alumina NPs because pH proximity to the pKa of alumina produces a very small
electric potential difference between the buffer and the particles, resulting in very small
zeta potential and diminished charge stabilization.
2.4.2 Buffer concentration effects on particle dispersion
Acetate and citrate buffers (pH 4.0 and 6.0, respectively) were tested at
concentrations of 0.1, 0.01, and 0.0001 M after 6 h sonication durations using both
number and intensity distribution DLS analysis. It was found that higher concentrations
yielded overall lower particle sizes. Nanoparticle suspension in acetate buffer produced
higher sample variability as compared to citrate buffer, and, although a small proportion
of agglomerated particles were stabilized at approximately 100 nm size, large particle
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formation occurred below 0.1 M resulting in a majority of aggregates being
approximately 1 µm in size.
With alumina NPs suspended in citrate buffer, though, there is a correlation
between concentration and particle size (see Figure 2.1). Higher buffer concentrations
led to both a decrease in NP aggregate size (hydrodynamic diameter) and
polydispersity; alumina NPs suspended in 0.1 M citrate had the lowest polydispersity
and smallest overall particle size of 109±4 nm following 6 h sonication in an ultrasonic
bath at 25 °C. Polydispersity increased, with a decrease in suspension stability, at lower
buffer concentrations. The citrate anion, with its high overall charge at pH 6, presumably
forms a highly stable electric double layer around suspended alumina NPs that limits
particle-particle interactions, resulting in a highly stable dispersion.
2.4.3 Ultrasonication effects on particle dispersion
It is well known that sonication conditions help to disperse nanoparticles more
effectively, but this process can be reversed if the surface charge of newly fractured
nanoagglomerates is not maintained to prevent reaggregation. As such, inefficient
suspension media were removed from further optimization studies. A concentration of
0.1 M citrate buffer, pH 6.0, subsequently was tested under various ultrasonication
conditions in order to further optimize particle size and dispersion stability. Alumina NPs
were ultrasonicated in buffer for 6, 12 and 24 h at 25 °C in an ultrasonic bath, and for 10
min on ice with a sonic dismembrator probe sonicator. A trend toward smaller particles
was seen when ultrasonication duration was increased, while probe sonication yielded
the smallest peak aggregate diameters (see Figure 2.2). Mean particle sizes ranged
from 109±4 nm for 6-h sonication to 68±9 nm for 10-min probe sonication. The intensity
distribution showed the presence of aggregates, approximately 1 µm in size, which
decreased from 9.8% of the total sample after 6 h of sonication to 0.6% after 24 h.
Increased sonication time allows for increased disaggregation; smaller particles
disaggregate to a lesser extent because of increased particle-particle adhesive forces
found at small overall particle diameters186. The sonic dismembrator instead relies on
higher power output and proximity of the probe to the sample to produce smaller particle
aggregates with drastically reduced ultrasonication durations.
Samples were compared to unprocessed samples to determine the role that
ultrasonication plays in forming stable alumina suspensions in the target size regime.
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Data confirm findings of Oesterling et al. 2008 that unprocessed samples form
aggregates of approximately 200-500 nm or above in aqueous systems, and our studies
of unprocessed samples in citrate buffer, pH 6.0, exhibit approximate aggregate sizes of
200-300 nm, which drastically decrease with limited sonication37.
2.4.4 Particle suspension stability
As seen in Figure 2.3, citrate buffer produces substantial alumina stability at
various particle sizes. Alumina NP stability in 0.1 M citrate buffer, pH 6.0, was tested
over 2 weeks following sample preparation with 10 min (probe sonicator) and 6 and 24 h
(ultrasonic bath) ultrasonication periods. In each case, alumina aggregate size
remained essentially constant (at least within 6.1% of the initially measured aggregate
size), indicating that 0.1 M citrate buffer is capable of maintaining well-dispersed
suspensions of various-sized alumina NPs based on the extent of initial ultrasonication.
Figure 2.3 represents data analyzed as a number distribution in order to more closely
analyze data in the target size regime. Although the overall suspension remained stable
during the testing period, intensity distribution results showed a small concentration of
larger aggregates, approximately 500-1000 nm in size that increased over time from
0.5% of the initial suspension to at most 24% of the suspension after 2 weeks. As with
the initial sonication duration testing, samples remained stable with specific NP sizes
based on the extent of sonication.
Zeta potential measurements were also used to infer particle stability, based on
surface charge determination, in various suspension media (see Table 2.3 for results).
Zeta potential represents the charge stabilization between the electric double layers of
ions surrounding the suspended particles with the bulk solution, and therefore is
indicative of the overall charge stability of the dispersion. As zeta potential increases, in
either the positive or negative direction, the charge repulsion between particles and the
bulk solution also increases; thus, higher zeta potential values represent more stable
overall suspensions. Particles suspended in citrate buffer had the highest zeta potential
values, and thus the highest stability based on charge, which corresponds well with NP
stability as seen in DLS measurements. All DLS results dealing with particle stability
were confirmed with zeta potential analysis, indicating citrate buffer as the most stable
suspension medium.
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2.4.5 Transmission electron microscopy analysis
Transmission electron microscopy (TEM) analysis of samples showed alumina
particle aggregate sizes that correspond to aggregate diameters found using DLS
analysis. Alumina dispersed in citrate buffer, pH 6.0, with 10 min probe sonication
showed average aggregate size of ~72 nm, while alumina suspended via bath
sonication with 24 h sonication and 6 h sonication resulted in aggregate diameters of
~84 nm and 113 nm, respectively. High dilution samples were analyzed to minimize
potential drying effects that result in larger aggregate formation. Because TEM
confirmed the sizes obtained through DLS, additional aggregation due to drying is likely
minimal (See Supplementary Figure 2.1).
2.4.6 Particle suspension in artificial pulmonary surfactant
Alumina NP suspension characteristics were also tested in systems simulating
physiological environments to facilitate toxicological studies. In the case of inhalation of
alumina NPs into the lungs, alumina will first come into contact with pulmonary
surfactant, composed primarily of dipalmitoylphosphatidylcholine (DPPC), as well as
phosphatidylglycerol (PG) and small quantities of surfactant proteins. DPPC suspended
in deionized water at 10 mg/mL was used to simulate pulmonary surfactant found in the
respiratory tract and specifically in the alveoli. Additionally, dispersion medium
consisting of a lower concentration of DPPC (0.01 mg/mL) and BSA was used as an
artificial system to mimic alveolar pulmonary surfactant while limiting adverse affects of
high protein and phospholipid content on cellular viability NP size measurement in DLS.
When larger particles, greater than approximately 10 µm in size, enter the respiratory
tract they are immediately covered in mucus and removed via the mucocilliary escalator.
Smaller particles that are approximately 1-10 µm in size are able to traverse to the lungs
where they most likely interact with pulmonary surfactant and are cleared.
Nanoparticles, though, have the potential to reach the alveoli and interact with alveolar
cells as well as the alveolo-capillary barrier separating the pulmonary and circulatory
systems instead of readily being cleared from the respiratory tract180; 187-189. It is thought
that if NPs aggregate in artificial lung surfactant, they will also tend to aggregate in vivo.
These aggregates are more easily cleared from the lungs, thus limiting the adverse
affects of nanoparticulates. In the case that alumina remains well suspended in lung
surfactant, toxicological concern increases because of the ability of NPs to enter cells
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and cellular organelles. It is possible that lung surfactant can instead serve to coat and
stabilize very small NPs.
At concentrations above the critical micelle concentration (CMC, ~3.4×10−7
mg/mL190), DPPC forms micelle particles in water, which leads to the presence of a
DPPC particle peak when measured by DLS191; 192. In our DLS studies, DPPC exhibited
a particle diameter of 146±31 nm in the absence of alumina NPs. In multiple tests, the
presence of 100 ppm alumina NPs in the DPPC/H2O suspension caused a decrease in
the observed particle diameter from 146±31 nm without alumina to 79±9 nm with
alumina (see Figure 2.4). It is possible that a sufficient amount of the DPPC adsorbs to
the surface of the alumina NPs in the suspension to decrease the DPPC concentration
below its CMC and prevent micelle formation, which would account for the absence of a
DLS peak representing DPPC in the presence of alumina NPs. In this case, it is
probable that the DPPC does indeed stabilize alumina NPs at approximately 80 nm,
although this particle size range represents only one-quarter of the overall suspension
while larger aggregates (assessed through intensity distribution DLS analysis)
predominate. The presence of a high polydispersity index indicates that, although DPPC
may have the ability to stabilize alumina as relatively small aggregates, the overall
stability of the suspension is low.
In contrast to the effectively dispersed titania seen previously using DPPC/BSA
dispersion medium, alumina dispersion stability remained similar to that of DPPC alone
in water at higher phospholipid concentrations (~200 nm alumina aggregate diameters)
183; 184; 193

. Although it would have been beneficial to test NP suspension characteristics in

artificial pulmonary surfactant with higher energy dispersion techniques (i.e., bath or
probe sonication), vortexing was used herein to limit DPPC phospholipid breakdown and
subsequent unreliable sample analysis.
Alumina NP stability was tested in DPPC/water for three weeks (data not shown);
high particle size variability is present within the first week, which increases drastically
after one week of suspension at which point aggregated particles predominate.
Although number analysis indicates that some particles range from 60 to 90 nm in size,
high polydispersity indices indicate that DPPC/water does not suspend particles reliably
or for long-term.
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2.4.7 Particle dispersion in cell culture media
Alumina dispersions in DMEM/High Glucose and F-12K media produce similar
obstacles to DLS analysis because of interference of various proteins and
macromolecules in the target size range of the alumina particles. TEM analysis showed
that, while DMEM/High Glucose and F-12K media do not serve as sufficient initial
particle dispersants, alumina dispersed initially in 0.1 M citrate buffer, pH 6.0, remains in
a target size range following addition to media at 30 ppm. TEM analysis of citratestabilized alumina, which was suspended in DMEM/High Glucose medium, showed
primary particle sizes of approximately 93 nm, although larger aggregates were also
present (~150 nm in size). F-12K medium effectively suspended citrate-stabilized
alumina at particle diameters of approximately 79 nm with limited aggregates of ~120
nm in size. Consequently, F-12K and DMEM/High Glucose media are well suited to
suspension of citrate-stabilized nanoparticulate alumina for subsequent cell culture
toxicology studies.
2.5 Conclusion
This work highlights the optimization of, as well as the many difficulties
associated with, alumina nanoparticle suspension in aqueous systems for toxicological
evaluation of alumina effectively stabilized in the nano-sized regime (particle sizes at or
below 100 nm). Alumina NPs were dispersed in a wide range of physiologically relevant
buffers, cell culture media, and artificial pulmonary surfactant model systems. These
NPs were suspended most stably and reproducibly in citrate buffer using high-sheer
probe sonication (forming particle diameters near 70 nm), and exhibited high charge
stabilization, which produced highly stable suspensions. Alumina particles initially
prepared using citrate buffer also remained well suspended near 70 nm following
addition to cell culture media, indicating that this may be a valuable nanoparticle
preparation mechanism for further toxicological studies examining nano-sized effects,
instead of the more typical studies associated with micron-sized particle agglomerates.
Further toxicological studies of alumina stabilized in the nano-sized regime will be of
ongoing importance as these particles are increasingly used in industrial, environmental,
and personal care settings. (The data presented in Chapter 2 has been submitted for
publication)
Copyright © Bradley J. Newsome 2014
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Vendor
Analyzed SEM
surface
Avg. size 1 (size
2
area (m /g) range) (nm)

Analyzed DLS Avg. Analyzed
surface area
aggregate size 1
(size range) (nm)
(BET) (m2/g)

Alfa Aesar
Gamma,
Stock # 10459
10-20
99.98%
100
820 (320-1400)
410 (140-1550)
88
5-20% alpha
Lot # B24Q09
1
Initial alumina NP SEM and DLS analyses were performed at 100 ppm in deionized H 2O. For SEM, H 2O suspension medium was
evaporated to dryness prior to analysis.

Table 2.1
Al2O 3 nanoparticle preliminary physicochemical properties
Vendor
Vendor crystal
Vendor
Vendor
structure
size (nm) purity

Table 2.2
Al2O 3 nanoparticle dispersion conditions
Suspension agent
Acetate buffer

Concentration 1
0.0001, 0.01, 0.1 M

pH
4

Citrate buffer

0.0001, 0.01, 0.1 M

4, 6

HEPES buffer
PBS buffer
Tris buffer
MES buffer
DPPC

1.0 M
1X 3
1M
0.5 M
10 mg/mL
0.6 mg/mL BSA
0.01 mg/mL DPPC
---

7.5
7.4
7.5, 8.6, 9
5.5
~7.4

Preparation conditions2
6, 12, 24 h bath
6, 12, 24 h bath;
10 min probe
6 h bath
6 h bath
6 h bath
6 h bath
4 h vortex

7.4

4 h vortex

~7.4
~7.4

4 h vortex
4 h vortex

DPPC/BSA dispersion medium
DMEM media + 10% FBS
F-12K media + 10% FBS
1

Increased concentration-related conditions were tested for citrate and acetate buffers
due to higher dispersion efficiencies and to test ionic strength effects
2

Bath and probe ultrasonication techniques (listed as "bath" and "probe"), as well as
vortex mixing, were used to suspend alumina NPs in suspension media
3

1X PBS consisted of 137 mM NaCl, 12 mM phosphate and 2.7 mM KCl
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Table 2.3
Al2O 3 nanoparticle zeta potential measurements in various suspension agents
Suspension agent
Citrate buffer

Acetate buffer
HEPES buffer
DPPC
dI H 2O

Concentration
0.1 M
0.01 M
0.0001 M
0.1 M
0.01 M
0.0001 M
1M
10 mg/mL
--
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pH
6
6
6
4
4
4
7.5
~7.4
~7.4

Zeta potential (mV)
-46.3±10.2
-40.8±3.2
-13.1±3.7
19.5±0.8
22.3±0.6
10.9±1.6
-9.89±3.0
9.15±0.6
-22.7±0.4

0.1 M
0.01 M
0.0001 M
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Figure 2.1. (A) Number and (B) intensity distributions of alumina nanoparticle dispersion
in citrate buffer, pH 6.0, prepared using 6 h bath sonication at 25 °C. Increasing buffer
concentration yields an overall decrease in particle agglomerate diameter. Intensity
distribution and undersize data of alumina NPs suspended in 0.1 M citrate buffer indicate
minimal large aggregate formation and homology with number distribution data.
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Figure 2.2. Number distribution of nanoparticle dispersion in 0.1 M citrate buffer, pH 6.0,
with varying sonication conditions at room temperature. When prepared using an
ultrasonic bath, mean particle size decreases with increasing sonication duration from
109±4 nm for 6 h sonication to 78±3 nm for 24 h sonication. Increasing sheer using
probe sonication produced the smallest overall alumina aggregate diameters at 68±9
nm.
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Figure 2.3. Alumina nanoparticle stability in 0.1 M citrate buffer, pH 6.0, was tested for 2
weeks after sample preparation using bath and probe sonication. Each preparation
condition provides relatively long-term mean sample stability, with a change in sample
diameter of +5±4 nm (6 h bath sonication), -3±5 nm (24 h bath sonication), and +5±2 nm
(10 min probe sonication).
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Figure 2.4. Alumina particle stabilization in dipalmitoylphosphatidylcholine (DPPC). Size
analysis of alumina nanoparticles suspended in 10 mg/mL DPPC. DPPC exhibits its
own peak at approximately 150 nm, in the absence of alumina nanoparticles,
corresponding to micelle formation.
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Chapter 3.A. Titanium dioxide nanoparticles increase inflammatory responses in
vascular endothelial cells
3.A.1 Synopsis
Atherosclerosis is a chronic inflammatory disease that remains the leading cause
of death in the United States. Numerous risk factors for endothelial cell inflammation and
the development of atherosclerosis have been identified, including inhalation of ultrafine
particles. Recently, engineered nanoparticles (NPs) such as titanium (TiO2) NPs have
attracted much attention due to their wide range of applications. However, there are also
great concerns surrounding potential adverse health effects in vascular
systems. Although TiO2 NPs are known to induce oxidative stress and inflammation, the
associated signaling pathways have not been well studied. The focus of this work,
therefore, deals with examination of the cellular signaling pathways responsible for TiO2
NP-induced endothelial oxidative stress and inflammation. In this study, primary vascular
endothelial cells were treated with TiO2 NPs for 2-16 h at concentrations of 0-50 µg/mL.
TiO2 NP exposure increased cellular oxidative stress and DNA binding of NFκB. Further,
phosphorylation of Akt, ERK, JNK and p38 was increased in cells exposed to TiO2 NPs.
TiO2 NPs also significantly increased induction of mRNA and protein levels of vascular
cell adhesion molecule-1 (VCAM-1) and mRNA levels of monocyte chemoattractant
protein-1 (MCP-1). Pretreatment with inhibitors for NFκB (pyrrolidine dithiocarbamate),
oxidative stress (epigallocatechin gallate and apocynin), Akt (LY294002), ERK
(PD98059), JNK (SP600125) and p38 (SB203580) significantly attenuated TiO2 NPinduced MCP-1 and VCAM-1 gene expression, as well as activation of NFκB. These
data indicate that TiO2 NPs can induce endothelial inflammatory responses via redoxsensitive cellular signaling pathways.
3.A.2 Introduction
Nanotechnology and the production of nano-sized particles have emerged as
promising areas of study due to their many applications in industry and medicine29; 30.
Particularly, TiO2 NPs are produced on a large scale and are being employed in a variety
of consumer products, such as sunscreens, cosmetics, pharmaceutical additives and
food colorants194; 195. Although TiO2 is considered to be a safe material, concerns have
been raised about the potential adverse health effects in occupational and environmental
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settings196; 197. Because of its toxic potential, TiO2 has been classified by the International
Agency for Research on Cancer as “possibly carcinogenic to humans” by inhalation198.
Uptake of TiO2 NPs can occur through multiple routes, including inhalation, ingestion
and transdermal. Transdermal exposure of TiO2 NPs is linked to the use of sunscreen
and cosmetics, although there is no evidence demonstrating that TiO2 can penetrate into
normal skin199. Actually, the major route of human exposure to TiO2 NPs is through its
use as a pharmaceutical additive and through food intake, where TiO2 has been widely
used as a coloring agent for the food industry. Additionally, studies dealing with oral
exposure of TiO2 NPs in mice have demonstrated the presence of particles in distant
organs such as the liver, spleen, kidneys and lungs200. These data suggest that TiO2
particles can travel to other tissues and organs following uptake by the gastrointestinal
tract, with blood circulation primarily implicated in its biodistribution. A number of studies
for TiO2 toxicity in animals have focused on inhalation although potential inhalation
exposure to TiO2 NPs occurs mostly in the workplace194; 201. Because of the
physicochemical similarities between ambient, nanoscale particles and NPs, there is a
strong rationale linking exposure to TiO2 NPs with adverse cardiovascular effects. Past
studies have demonstrated that inhaled ambient ultrafine particles can reach deep into
the lungs where they can enter the circulatory system, resulting in cardiovascular
diseases202. Also, multiple studies reporting epidemiological animal data have
established a link between ambient particles and the etiology of cardiovascular
disease203; 204. Other exposure routes include surgical implant-derived wear debris and
intravenously administered contrast agents205; 206. Although intravenous exposure cases
are rare, there is potential concern because a direct injection of TiO2-containing contrast
agents into the circulatory system may confer a greater impact on the vascular
endothelium due to near-100% bioavailability.
Vascular endothelial cells are potential targets for TiO2 NP toxicity in human
exposure. There are several cellular events responsible for the initiation of
atherosclerosis in the vascular endothelium, including oxidative stress, inflammation and
activation of endothelial cells207. Previous studies have evaluated endothelial activation
and dysfunction in endothelial cells but the intracellular signaling pathways are not fully
identified208. The purpose of this study is to determine the intracellular signaling
pathways by which TiO2 NPs induce inflammatory responses in vascular endothelial
cells. Our data demonstrate that TiO2 NPs increase vascular adhesion molecules such
as monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion molecule-1
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(VCAM-1), and that this is mediated by multiple intracellular signaling pathways including
mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3 kinase
(PI3K)/Akt.
3.A.3 Materials and Methods
3.A.3.1 Materials
Commercial grade uncoated TiO2 NPs (anatase, metal basis, stock# 44689,
99.9% purity, 5 nm) were purchased from Alfa Aesar (Ward Hill, MA). DMSO, apocynin,
PD98059, SB203580, SP600125 and LY294002 were purchased from Sigma-Aldrich
(St. Louis, MO). The NFкB inhibitor pyrrolidine dithiocarbamate (PDTC) was obtained
from Calbiochem (Darmstadt, Germany). Epigallocatechin gallate (EGCG) was
purchased from Cayman Chemical (Ann Arbor, MI). VCAM-1, IκBα and p-IκBα
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies
for extracellular signal-regulated kinase-1/2 (ERK1/2), p42/44, p38 MAPK, c-Jun-Nterminal kinase (JNK) and Akt were obtained from Cell Signaling Technology (Danvers,
MA). LC3 antibody was purchased from Novus Biologicals (Littleton, CO).
3.A.3.2 Nanoparticle characterization
TiO2 nanoparticle size, surface area and purity were evaluated in comparison to
vendor specifications. Elemental analysis of dry TiO2 samples was performed using a
Hitachi S-4300 scanning electron microscope (Dallas, TX) and Princeton Gamma-Tech
energy dispersive X-ray spectroscopy (EDS) Microanalysis System (Princeton, NJ),
primary and aggregate particle sizes were determined using scanning electron
microscopy (SEM), and surface area was determined through the Brunauer-EmmettTeller (BET) method using a Micromeritics TriStar 3000 surface area and pore size
analyzer (Norcross, GA), following overnight nitrogen degassing at 120 ºC.
Characterization results can be found in Table 3.A.1 as compared to vendor-supplied
values. Suspensions of TiO2 NPs in cell culture media were prepared at a concentration
of 5 mg/mL. Nanoparticle dispersion and size characteristics were analyzed by dynamic
light scattering (DLS) using a Zetasizer Nano ZS90 particle size analyzer (Malvern
Instruments, Westborough, MA), which measures hydrodynamic diameters of
nanoparticles209. TiO2 NP suspensions (n=3) were suspended in deionized H2O,
sonicated briefly using a probe sonicator (Heat Systems, Inc., Farmingdale, NY) for 15
min to minimize particle aggregates, added to cell culture medium and analyzed via DLS
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with five measurements per sample. The same dispersion procedure was also used prior
to in vitro studies. Sizing data, including mean nanoparticle size (nm) and particle size
ranges, was determined using Malvern DTS Software, v. 6.32 (Table 3.A.1).
3.A.3.3 Primary cell culture and endothelial cell treatments
Primary vascular endothelial cells were isolated from porcine pulmonary arteries
and characterized as described previously77; 210. Cells were cultured in M199 media
(Gibco, Grant Island, NY) supplemented with 10% fetal bovine serum (FBS) (Invitrogen,
Carlsbad). Cells were grown to confluence and serum starved overnight in medium
containing 1% FBS prior to initiation of cell treatments. A stock suspension of 5 mg/mL
TiO2 NPs was prepared and dispersed by probe sonication for 15 min. Based on our
preliminary studies, we chose to treat cells with TiO2 NPs at 10 and 50 µg/mL, which
corresponded to 2 and 10 µg nanoparticles/cm2, respectively. Of particular relevance to
the present study, TiO2 NPs have been suggested for use in intravenous applications as
contrast agents205; 206. Due to near-100% bioavailability, potential intravenous
applications could allow nanoparticles to achieve significantly higher concentrations in
the blood circulation than that from translocation of nanoparticles following occupational
and environmental exposure. These nanoparticle concentrations (10 and 50 µg/mL)
were selected not only to address potential intravenous and environmental exposure
levels but also to correspond with previous studies showing increased expression of
inflammatory genes without cell death208; 211. Equal volumes of water (up to 1% of media;
no hypotonic conditions were produced as shown by autophagy analysis in Figure 3.A.6)
were used in place of NP-suspension volumes to serve as controls in cell culture. The
TiO2 NP concentrations and treatment intervals employed in these studies did not lead to
significant cytotoxicity, as seen by trypan blue exclusion staining (data not shown).
3.A.3.4 Assessment of superoxide (O2●–) levels
Endothelial cells were grown to confluence in 8-chamber culture slides (BD
Biosciences, Bedford, MA). Following treatment, cells were incubated with a final
concentration of 5 µM dihydroethidium (DHE), MitoSOXTM Red mitochondrial superoxide
indicator (MitoSOX) or DMSO (blank) in a 5% CO2 incubator for 15 min. Cells were
washed 3x with PBS, fixed with 4% formaldehyde, and washed again 3x with PBS.
Slides were mounted with ProLong Gold Antifade reagent containing 4’6-diamidino-2phenylindole (DAPI) (Invitrogen, Carlsbad, CA) to visualize the nuclei. Slides were
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evaluated under a Nikon ECLIPSE TE2000-U fluorescence microscope and the images
were captured digitally using a Nikon LH-M100CB-1 camera and NIS-Elements BR
4.00.08 software (Nikon Instruments Inc. Melville, NY).
3.A.3.5 Electrophoretic mobility shift assay (EMSA)
Nuclear extracts of endothelial cells were prepared using NE-PER nuclear
extraction reagents (Thermo, Rockford, IL). The concentration of nuclear extract was
determined using Bradford reagent (Bio-Rad, Richmond, CA). DNA binding activities of
NFκB were determined using a LightShift Chemiluminescent EMSA kit (Pierce,
Rockford, IL) according to the manufacturer’s protocol. DNA-binding reactions were
performed with a final volume of 20 µL buffer containing 5 µg of nuclear extract, 50
ng/µL Poly (dI·dC) and biotin end-labeled oligonucleotides. Synthetic 5’-biotinylated
complementary oligonucleotides were purchased from Integrated DNA Technologies
(Coralville, IA). The oligonucleotides containing the NFκB consensus sequence (5’AGTTGAGGGGACTTTCCCAGGC-3’) were described previously22. EMSA gels were
quantified by Image J software (NIH, Bethesda, MD).
3.A.3.6 Quantitative real-time PCR
Cells were grown in 6-well plates, and total RNA was extracted from the cells
using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's
protocol. Reverse transcription was performed using the AMV reverse transcription
system (Promega, Madison, WI). The levels of mRNA expression were then assessed
by quantitative real-time PCR using a 7300 Real-Time PCR System (Applied
Biosystems, Foster City, CA) and SYBR Green master mix (Applied Biosystems). Data
analysis was performed using the relative quantification method (∆∆Ct), in which relative
mRNA expression for target mRNAs (i.e., VCAM-1 and MCP-1) was compared to a
constitutively expressed gene (i.e., β-actin) in the mRNA samples from untreated and
treated cells. Primer sequences for SYBR Green chemistry were designed using the
Primer Express Software 3.0 for real-time PCR (Applied Biosystems) and synthesized by
Integrated DNA Technologies, Inc. (Coralville, IA). Sequences for porcine VCAM-1,
MCP-1 and β-actin were described in previous articles published by our laboratory60.
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3.A.3.7 Western blot analyses
Protein expression was determined using Western blot. Whole cells were lysed in
RIPA lysis buffer (Cell Signaling Technology, Danvers, MA) containing protease and
phosphatase inhibitor cocktails (Thermo, Waltham, MA). Lysed cells were centrifuged at
12,000 x g for 10 min at 4 ˚C. Protein levels of the supernatants were determined via
BCA assay (Pierce, Rockford, IL). Protein samples (30 µg per treatment) were separated
using 10% SDS-PAGE and subsequently were transferred onto nitrocellulose
membranes. Membranes were blocked with 5% non-fat milk buffer and incubated
overnight at 4 ˚C with primary antibodies. After washing, membranes were incubated
with secondary antibodies conjugated with horseradish peroxidase and visualized using
ECL detection reagents (Thermo, Waltham, MA).
3.A.3.8 Statistical analysis
Data were expressed as mean ± standard error of the mean (SEM). Statistical
significance was determined by one-way or two-way ANOVA followed by StudentNewman-Keuls method using Sigma Stat 3.1 software (Systat Software, San Jose, CA).
A probability value p < 0.05 was considered statistically significant.
3.A.4 Results
3.A.4.1 Characterization of TiO2 nanoparticles
Physicochemical characteristics of TiO2 NPs are described in Table 3.A.1. TiO2
size analysis using SEM showed average NP and aggregate diameters of 79 nm,
ranging from 7 to 232 nm. BET analysis of TiO2 NPs showed a specific surface area of
93.9 m2/g. DLS particle size analysis in cell culture media showed particle aggregates
349 nm in diameter on average, with a range of 250 nm to 396 nm. EDS elemental
analysis showed 99.7% TiO2 NP purity, in keeping with manufacturer product
information.
3.A.4.2 TiO2 NPs increase superoxide production
Oxidative stress is a critical event of endothelial inflammation, activation and
dysfunction. The flourescent dye DHE is sensitive to reactive oxygen species and, in
particular, to the superoxide anion. Once this dye is oxidized by superoxide, it stains
cells a bright flourescent red. Our results showed that TiO2 NPs at concentrations of 1050 µg/mL significantly increased superoxide generation at 1 h post exposure (Figure
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3.A.1). In addition, TiO2 NP-induced superoxide production was confirmed by MitoSOX
Red fluorescent dye which selectively detects mitochondrial superoxide production. Like
DHE staining, 10-50 µg/mL of TiO2 NP exposure markedly increased mitochondrial
superoxide production (Figure 3.A.1). Superoxide production was not detected in cells
treated with TiO2 NPs (10-50 µg/mL) alone (Figure 3.A.1). No detectable fluorescence
was seen in controls with TiO2 NPs and fluorescent dye but without cells (data not
shown).
3.A.4.3 Akt and three MAPK pathways are activated by TiO2 NPs in endothelial
cells
Oxidative stressors are known to activate many intracellular signaling pathways.
In order to identity intracellular signaling pathways associated with oxidative stress and
subsequent gene expression, we observed the phosphorylation of some key signaling
molecules. The PI3K/Akt and MAPK signaling pathways are involved in a wide range of
cellular processes, including NFκB activation, which subsequently can induce cell
inflammation in response to extracellular stimuli212; 213. We examined potential
involvement of the MAPK signaling pathways (i.e., p38, ERK and JNK) in endothelial
cells after treatment with various concentrations of TiO2 NPs. Phosphorylation of
endogenous p38, ERK and JNK was determined by Western blot analysis. Treatment
with both 10 and 50 µg/mL TiO2 NPs markedly increased all three MAPK pathways
(Figure 3.A.2). Similar to activation of MAPKs, Akt was phosphorylated at Ser473 by
TiO2 NPs (Figure 3.A.2). Phosphorylation of Akt, JNK and ERK peaked as early as 30
min post-TiO2 NP treatment. Phosphorylation of p38 reached a maximum at 1 h postTiO2 NP exposure.
3.A.4.4 TiO2 NPs activate NFκB
Activation of three MAPKs and PI3K/Akt can lead to activation of the redoxsensitive transcription factor NFκB that subsequently up-regulates genes including
VCAM-1 and MCP-1. Our EMSA results showed that TiO2 NPs significantly increased
NFκB DNA binding activity in vascular endothelial cells (Figure 3.A.3.A). Competition
assays were conducted to ensure the specificity of NFκB DNA binding (Figure 3.A.3.A).
Activation of NFκB was confirmed by phosphorylation of IκBα (Figure. 3.A.3.B).
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3.A.4.5 TiO2 nanoparticles increase gene and protein expression of MCP-1 and
VCAM-1
Vascular endothelial cells were treated with TiO2 NPs at concentrations of 0, 10,
and 50 µg/mL for 2, 4, 8 and 16 h to determine TiO2 NP-induced expression of
inflammatory molecules such as MCP-1 and VCAM-1. TiO2 NPs significantly induced
expression of MCP-1 mRNA for all exposure times at a concentration of 50 µg/mL,
compared to control (Figure 3.A.4.A). In contrast, MCP-1 mRNA was significantly
increased only after a 2 h exposure at a concentration of 10 µg/mL TiO2 NPs. Similarly,
VCAM-1 mRNA expression was significantly up-regulated after cells were treated with
TiO2 NPs (50 µg/mL) for all exposure time points, while TiO2 NPs (at 10 µg/mL)
significantly increased VCAM-1 mRNA only at 2 h (Figure 3.A.4.B). Further, Western blot
analysis showed that VCAM-1 protein was markedly increased when cells were treated
with TiO2 NPs (10 and 50 µg/mL) for 4 h (Figure 3.A.5). TiO2 NPs at 50 µg/mL
maintained significantly higher VCAM-1 protein level up to 16 h. To ensure that the
observed inflammatory responses were derived from the NPs and not from surface
impurities, PBS-washed TiO2 NPs (using centrifugation, 3000 x g, for 5 min, 3 times)
were compared with unwashed TiO2 NPs for VCAM-1 and MCP-1 gene expression. The
results showed similar proinflammatory effects by PBS-washed NPs compared to
unwashed TiO2 NPs (data not shown).
3.A.4.6 TiO2 nanoparticles increase autophagy in endothelial cells
Protein expression of LC3-I and LC3-II was analyzed in order to determine if TiO2
NPs and/or suspension medium increase autophagy levels in porcine endothelial cells.
Our data showed that the addition of water (up to 1%) as the nanoparticle suspension
medium did not lead to increased endothelial cell autophagy (Figure 2.A.6.A). Autophagy
was markedly increased, though, when cells were treated with TiO2 NPs (50 µg/mL),
where a maximum expression of LC3-II was observed after an 8 h exposure (Figure
3.A.6.A). Due to the large surface area associated with NPs, nutrients can adsorb onto
NPs in high quantities, which can potentially lead to nutritional deprivation and ultimately
to increased autophagy. To address this, we tested if different concentrations of FBS (0,
1 and 5%) in TiO2 suspension media can induce varying levels of autophagy in our cell
culture model. A similar level of autophagy was observed only in cells treated with 50
µg/mL TiO2 NPs while other treatment groups did not display autophagy, suggesting
nutritional deprivation was not great enough to induce autophagy in our cell culture
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model (Figure 3.A.6.B). Comparison of water and PBS as NP-suspension media
revealed no significant difference in the induction of autophagy (Figure 3.A.6.C).
3.A.4.7 Pharmacological inhibition of NFκB, oxidative stress, PI3K/Akt and MAPK
pathways result in the decreased expression of MCP-1 and VCAM-1
In an effort to further identify signaling pathways associated with TiO2 NPinduced endothelial inflammatory responses, we determined expression of adhesion
molecules i.e., MCP-1 and VCAM-1 in cells pretreated with pharmacological inhibitors
for three MAPKs, Akt, NFκB and oxidative stress. Pharmacological inhibitors such as
PD98059, SB203580, SP600125 and LY294002 block phosphorylation of ERK, p38,
JNK and Akt, respectively. Pretreatment of cells with these inhibitors significantly
attenuated TiO2 (10 µg/mL)-induced MCP-1 and VCAM-1 gene expression (Figure
3.A.7.A and 3.A.7.B), suggesting that all of these signaling molecules can mediate TiO2induced inflammatory pathways in vascular endothelial cells. Pretreatment of cells with
the NFκB inhibitor PDTC for 30 min followed by TiO2 treatment for 2 h resulted in a
significant attenuation of MCP-1 and VCAM-1 gene expression, compare to TiO2 NPs
alone (Figure 3.A.7.A and 3.A.7.B), confirming that NFκB signaling is a critical mediator
of these proinflammatory responses. Similarly, the antioxidant polyphenol EGCG and
apocynin significantly down-regulated TiO2 NP-induced expression of these genes
(Figure 3.A.7.A and 3.A.7.B). Treatment with SP600125 (40 µM), LY294002 (40 µM)
and apocynin (1 mM) significantly decreased base line MCP-1 mRNA expression but not
in VCAM-1 expression. Overall, these data demonstrate that TiO2 NP-induced
inflammatory gene expression is mediated by oxidative stress and increased DNA
binding of NFκB.
3.A.5 Discussion
Engineered nanoparticles have been suggested to increase the risk and
incidence of cardiovascular diseases, including atherosclerosis144; 214. Occupational and
environmental exposure of TiO2 NPs may be a risk factor for increased cardiovascular
inflammatory responses in humans. Aerosolized sunscreens may lead to higher
inhalation absorption and subsequent translocation of TiO2 NPs into the circulatory
system. Also, intravenous exposure of TiO2 NPs for biomedical uses is of special
concern due to their higher bioavailability in the human vasculature.
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As seen in the current studies and also observed by others, anatase TiO2 NPs
tended to agglomerate to sizes ranging from 250 nm to 396 nm in diameter in cell culture
media containing 1% fetal bovine serum. In cultured endothelial cells, TiO2 NPs and/or
TiO2 NP agglomerates were internalized by cells within one hour, and visualized using a
relatively simple fluorescent microscopy method using ARS that labels TiO2 NPs215. A
recent study also highlighted the cellular uptake of TiO2 NPs by cells where
nanoparticles were massively internalized into cytoplasmic vacuoles in endothelial
cells216; these findings were confirmed using transmission electron microscopy. These
previous reports suggest that endothelial cells can internalize both agglomerated and
non-agglomerated nanoparticles, although the underlying mechanism associated with
nanoparticle uptake is not fully identified.
In the present study, we tested expression of adhesion molecules, particularly
VCAM-1 in primary vascular endothelial cells, when treated with anatase TiO2 NPs. The
role of endothelial inflammation and expression of adhesion molecules such as MCP-1
and VCAM-1 in early atherosclerotic lesion formation is critical, and studies have found
that by blocking VCAM-1 expression, one can reduce monocyte adhesion by 75%217.
Results from the current study demonstrated that MCP-1 and VCAM-1 gene expression
was significantly higher in cells exposed to TiO2 NPs. Both 10 and 50 µg/mL of TiO2 NPs
exhibited the highest gene expression levels after a 2 h exposure. Both MCP-1 and
VCAM-1 gene expression were diminished for longer times points when cells were
treated with 10 µg/mL of TiO2 NPs, while 50 µg/mL of TiO2 NPs sustained the elevated
gene expression up to 16 h. Many mechanisms may be responsible for the decrease of
gene expression during the extended exposure time. A recent study demonstrated that
TiO2 NPs elicit oxidative damage that can lead to the activation of nuclear factor
erythroid 2 related factor 2 (Nrf2) as a protective mechanism218. Nrf2-regulated genes
include many antioxidant proteins such as NAD(P)H:quinone oxidoreductase 1 (NQO1)
and glutathione S transferase (GST). Enhanced expression of these antioxidant proteins
resulted in the reduction of VCAM-1 and MCP-1 gene expression in endothelial cells60.
In the present study, the cellular defensive system is sufficient to reduce TiO2 NPinduced inflammatory gene expression at a concentration of 10 µg/mL. In contrast, 50
µg/mL of TiO2 NPs was able to overcome the cell’s defensive mechanisms, leading to
extended inflammatory gene expression. VCAM-1 protein expression showed a similar
pattern to that of mRNA but the maximum expression was observed at 4 h. These data
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show a potential trend indicating concentration- and time-dependent inflammatory
effects associated with TiO2 NP exposure.
Autophagy is a cellular process involving the lysosomal degradation of
cytoplasmic components and is essential for cell survival and homeostasis219. Our data
showed that autophagy was increased in cells exposed to 50 µg/mL TiO2 NPs while
treatment with 10 µg/mL TiO2 NPs did not increase autophagy. Multiple forms of cellular
stress can induce this cellular defensive process and TiO2 NPs additionally were found
to increase autophagy in cells220; 221. Autophagy is a complex process which is linked to
other stress responses. Recent studies have demonstrated that autophagy can
negatively regulate NFκB signaling and gene expression such as MCP-1222-224. In our
study, however, MCP-1 and VCAM-1 gene expression was not significantly affected by
autophagy, although limited decrease in expression of these genes was seen 8 h post
TiO2 exposure, which occurs concurrently with maximal induction of autophagy. With our
current data, it is not clear if TiO2 NP-induced autophagy is a significant factor for the
observed gene expression, therefore further studies are needed to elucidate the
underlying mechanism.
We also found that TiO2 NPs can increase cardiovascular inflammation by
activation of NFκB and subsequent up-regulation of endothelial inflammatory
parameters, such as MCP-1 and VCAM-1. Further, mechanisms and signaling pathways
associated with TiO2 NP-induced endothelial cell toxicity were studied. TiO2 NPs
stimulated production of ROS (e.g., superoxide), which activated four key signaling
molecules: three MAPKs (p38, ERK and JNK) and Akt. Activation of such signaling
molecules and expression of endothelial inflammatory parameters were dependent on
the concentration of TiO2 NPs (0-50 µg/mL). As stated previously, induction of adhesion
molecules including VCAM-1 and MCP-1 is the product of NFκB activation225; 226; NFκB
is a critical redox-sensitive transcription factor by which expression of inflammatory
genes is regulated by extracellular stimuli in cells227; 228. In the present study, we found
that TiO2 NPs can activate NFκB, which is demonstrated by increased DNA binding
activity of NFκB and increased phosphorylation of IκBα. These results subsequently
were confirmed in cells pretreated with a specific NFκB inhibitor (i.e., PDTC) where this
inhibitor served to significantly attenuate TiO2 NP-induced VCAM-1 and MCP-1 gene
expression. Three MAPK proteins and Akt signaling protein are known to be associated
with activation of NFκB227. Cellular oxidative stress is closely associated with
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phosphorylation of such signaling molecules and subsequent NFκB activation. Recent
studies have demonstrated that ROS are produced by TiO2 NPs and play an
inflammatory role in cells220. Another recent study also implicated ROS in the activation
of NFκB and subsequent induction of inflammatory genes in human endothelial cells
treated with silica nanoparticles229. Similarly, results in the current study demonstrated
that TiO2 NPs induce ROS production; our data show a significant production of
superoxide anion after cell exposure to TiO2 NPs. Further, in order to confirm these
data, we pretreated cells with antioxidants such as EGCG and apocynin, which resulted
in a significant decrease in VCAM-1 and MCP-1 inflammatory gene expression when
compared to treatment with TiO2 NPs alone. Mechanisms responsible for TiO2 NPinduced ROS production are not well defined but possibly are linked to the activation of
NADPH oxidase (NOX) because apocynin, a specific inhibitor for NOX activation, can
attenuate TiO2 NP-induced gene expression for MCP-1 and VCAM-1230. These results
suggest that TiO2 NPs can induce ROS production and that this is a key mechanism
associated with TiO2 NP-induced MAPKs, Akt and NFκB activation.
The mechanisms associated with TiO2 NP-induced inflammation are not simple
and likely involve activation of many intracellular signaling molecules. In our studies with
endothelial cells, treatment with TiO2 NPs phosphorylated three MAPKs and PI3K/Akt.
Phosphorylation of these key signaling molecules can lead to the activation of redoxsensitive transcription factors, such as NFκB227. Indeed, TiO2 NPs increased
phosphorylation of three MAPKs and PI3K/Akt, and DNA binding of NFκB subsequently
led to induction of MCP-1 and VCAM-1. The roles of these three MAPKs and PI3K/Akt
were confirmed by pretreating cells with specific MAPK and PI3K/Akt inhibitors, which
resulted in a significant decrease in VCAM-1 and MCP-1 gene expression compared to
treatment with TiO2 NPs alone. These data suggest a specific role of intracellular
signaling pathways in endothelial inflammation following TiO2 NP exposure.
Taken together, data suggest that TiO2 NPs used in our study can increase
inflammatory gene expression in vascular endothelial cells via redox-sensitive signaling
pathways. This work highlights the toxic effects of anatase TiO2 NPs in the
cardiovascular system to better understand potential overall public health concerns
associated with metal oxide nanoparticles. (The data presented in Chapter 3.A were
published39.)
Copyright © Bradley J. Newsome 2014
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Table 3.A.1
TiO2 Nanoparticle Physicochemical Properties

99%
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and (Size Range) (nm) Size and (Size Range) (nm)
99.7%

93.9
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(EDS)
Area (BET) (m 2/g)

Figure 3.A.1. TiO2 NPs increase superoxide production in endothelial cells. Endothelial
cells grown on 8-chamber culture slides were treated with TiO2 NPs for 2 h. Cells were
then stained with either DHE or MitoSOX, and the intensity of red fluorescence was
assessed using a fluorescence microscope. The red areas in the cells represent
oxidized DHE and MitoSOX representing the generation of superoxide. The nuclei were
stained with DAPI. The images shown here are representatives of three independent
experiments.
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Figure 3.A.2. TiO2 NP-induced phosphorylation of MAPKs and PI3K/Akt pathways in
endothelial cells. Cells were treated with TiO2 NPs to observe the activation of three
types of MAPK signaling pathways, p38, ERK and JNK, as well as the Akt signaling
pathway. The images shown here are phosphorylated signaling molecules at the time of
maximum induction. The Western blots shown here are representative images of three
independent experiments.
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Figure 3.A.3. TiO2 NPs increase activation of NFκB. (A) NFκB DNA binding determined
by EMSA analysis. (B) Phosphorylation of IκBα analyzed in whole cell lysate by Western
blot. Cells were treated with TiO2 NPs (0-50 µg/mL) for 2 h followed by preparation of
nuclear extracts for EMSA or whole cell lysates for Western blot. In EMSA, unlabeled
competitor sequences were present at a 200-fold molar excess over labeled sequences.
Data represent the mean±SEM, with n=3. Experiments were repeated a minimum of
three times. The EMSA and Western blot shown here is a representative image.
*Significantly different compared to control (p<0.05).
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Figure 3.A.4. TiO2 NPs increase expression of MCP-1 (A) and VCAM-1 (B) genes.
Gene expression levels were measured using quantitative real-time PCR. Primary
endothelial cells were treated with 0-50 µg/mL of TiO2 NPs for the indicated times (2-16
h). Results represent the mean±SEM, with n=3. Experiments were repeated a minimum
of three times. *Significantly different compared to control (p<0.05).
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Figure 3.A.5. TiO2 NPs increase VCAM-1 protein expression in primary endothelial
cells. Primary endothelial cells were treated with 0-50 µg/mL of TiO2 NPs for different
time points (2-16 h). Western blots show a dose-dependent increase of VCAM-1 by TiO2
NPs. Western blots shown here are representative images of three independent blots.
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Figure 3.A.6. Expression of LC3-I/II, an autophagy marker, by endothelial cells. (A)
Endothelial cells were treated with 0-50 µg/mL TiO2 NPs at different time points (2-16 h).
(B) Endothelial cells were treated with 0-50 µg/mL TiO2 NPs for 8 h using three different
NP suspension media: water only, water with 1% FBS and water with 5% FBS. (C)
Endothelial cells were treated with 0-50 µg/mL TiO2 NPs for 8 h using two different NP
suspension media: water and PBS. Western blots shown here are representative images
of three independent blots.
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Figure 3.A.7. Pharmacological inhibition of NFκB, oxidative stress, PI3K/Akt and MAPK
pathways result in the decreased expression of MCP-1 and VCAM-1. Expression of
MCP-1 (A) and VCAM-1 (B) mRNA in endothelial cells. Cells were exposed to TiO2 NPs
(10 µg/mL) for 2 h after a 30 min pretreatment with pharmacological inhibitors, i.e.,
PD98059 (40 µM, ERK inhibitor), SB203580 (40 µM, p38 inhibitor), SP600125 (40 µM,
JNK inhibitor) and LY294002 (40 µM, Akt inhibitor). Also, cells were pretreated with the
NFκB inhibitor (PDTC, 10 µM, for 1 h) and antioxidants (EGCG, 50 µM for 3 h and
apocynin, 1 mM for 1 h) followed by TiO2 NP (10 µg/mL) exposure for 2 h. mRNA
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expression levels were measured using quantitative real-time PCR. Results represent
the mean±SEM, with n=3. Different letters correspond to significant differences (p<0.05)
between treatment groups.
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Chapter 3.B. PCB 77 dechlorination products modulate pro-inflammatory events in
vascular endothelial cells
3.B.1 Synopsis
Persistent organic pollutants such as polychlorinated biphenyls (PCBs) are
associated with detrimental health outcomes including cardiovascular diseases.
Remediation of these compounds is a critical component of environmental policy.
Although remediation efforts aim to completely remove toxicants, little is known about
the effects of potential remediation byproducts. We previously published that Fe/Pd
nanoparticles effectively dechlorinate PCB 77 to biphenyl, thus eliminating PCB-induced
endothelial dysfunction using primary vascular endothelial cells. Herein, we analyzed the
toxic effects of PCB congener mixtures (representative mixtures of commercial PCBs
based on previous dechlorination data) produced at multiple time points during the
dechlorination of PCB 77 to biphenyl. Compared to pure PCB 77, exposing endothelial
cells to lower chlorinated PCB byproducts led to improved cellular viability, decreased
superoxide production, and decreased nuclear factor kappa B (NFкB) activation based
on duration of remediation. Presence of the parent compound, PCB 77, led to significant
increases in mRNA and protein inflammatory marker expression. These data implicate
that PCB dechlorination reduces biological toxicity to vascular endothelial cells.
3.B.2 Introduction
Polychlorinated biphenyls (PCBs) are a class of organic pollutants that were
used heavily as dielectric fluids in industrial and electrical applications until evidence
surfaced linking PCBs to cancer and cardiovascular disease. Remediation efforts for
these highly persistent pollutants have proven difficult, expensive and slow. Our
laboratories have developed new fast, low-cost techniques that employ Pd/Fe
nanoparticles for reductive PCB dechlorination, which systematically dechlorinate higher
congener PCBs to biphenyl, with lower chlorinated congeners produced as byproducts
prior to complete degradation. The goal of this work is to better understand the
toxicological effects of these byproducts and to further validate the importance of PCB
dechlorination for reducing cardiovascular risk factors and for improving overall public
health.
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Even though PCB production has been banned in the US since the late 1970s,
PCBs remain concentrated in many waterways and Superfund sites, as well as in
electrical devices such as transformers and light ballasts. Additionally, recent research
has indicated that a variety of PCB congeners are still being generated as industrial
byproducts from pigment production and certain paper manufacturing231; 232. PCBs
exhibit unique properties, such as high environmental persistence and resistance to
metabolism in organisms, which lead to difficulties for remediation. Additionally, the
costs associated with large-scale clean-up and removal of these and other chemical
pollutants is great, and thus the development of more efficient, cost effective
technologies continues to be important. Current remediation techniques rely on
expensive dredging followed by incineration or bioremediation techniques. Although
PCBs can be degraded through some natural processes such as bacterial
degradation233; 234 and photolysis235; 236, these processes are prohibitively slow for
remediation of larger scale contaminations. Our research group recently developed a
Pd/Fe nanoparticle system that catalyzes the dechlorination of PCBs to form biphenyl in
order to address this need for low cost, high throughput chlorinated aromatic
degradation237; 238. During chlorinated aromatic degradation, hydrogen ions are used to
displace chlorine on biphenyl rings in stages, resulting in the production of lower
chlorinated PCB congeners prior to complete degradation to biphenyl. It is generally
believed that less-chlorinated congeners are more water soluble, more volatile, and
more likely to biodegrade further239. In a previous study, we compared the biological
activity of the parent compound (PCB 77) with the dechlorination end product (biphenyl),
and found that complete dechlorination markedly reduced the pro-inflammatory activity
of PCB 77240.
Many environmental contaminants, and especially persistent organic pollutants,
are risk factors for cardiovascular diseases such as atherosclerosis because they can
initiate or exacerbate the underlying disease by altering gene expression patterns and
subsequent vascular inflammation57; 241. Because the endothelium is in immediate
contact with the blood, endothelial cells are particularly susceptible to the effect of
environmental contaminants. The lining of blood vessels is protected by the
endothelium, and endothelial cells play an active role in physiological processes such as
regulation of vessel tone, blood coagulation, and vascular permeability. In turn,
endothelial cell activation or dysfunction is a critical marker of the pathology of
cardiovascular diseases such as atherosclerosis.
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Activated endothelial cells produce chemokines such as monocyte
chemoattractant protein 1 (MCP-1) and inflammatory cytokines, which attract monocytes
from the blood stream to the site of injury. Part of the resulting inflammatory process
includes the endothelial cell expression of adhesion molecules, like vascular adhesion
molecule-1 (VCAM-1), which allow the monocytes to attach to the endothelial layer and
infiltrate this barrier into the intimal space. We have demonstrated previously that
coplanar PCBs (e.g., PCB 77) can induce DNA-binding activity of the oxidative stresssensitive transcription factor nuclear factor kappa B (NFкB) and expression of VCAM-1,
which is dependent on functional aryl hydrocarbon receptor (AhR) activity20. Recently,
we have reported the mechanisms of PCB 77-mediated up-regulation of MCP-123.
Little is known about vascular toxicity of PCBs, and especially about the toxicity
of dechlorination or remediation products. There is a clear need to evaluate products of
remediation (e.g., dechlorination products) for biological activity in mammalian
systems242. It is important to know to what degree remediation processes of persistent
organic pollutants have to occur before toxicity and any vascular injury becomes
negligible. Thus, the present study was designed to test the effects of PCB 77
dechlorination products on pro-inflammatory parameters in a vascular endothelial cell
model system. Data from this study suggest that the presence of the parent compound
(e.g., PCB 77) is necessary for maximal endothelial cell dysfunction and inflammation.
These data also suggest that dechlorination is a successful method for decreasing
biological toxicity, with overall toxicity linked to the level of degradation of the parent
compound. Herein, dechlorination is demonstrated to be an effective platform for
addressing public health concerns associated with these persistent chlorinated
pollutants.
3.B.3 Materials and Methods
3.B.3.1 Materials
Biphenyl, 3-chlorobiphenyl (PCB 2), 4-chlorobiphenyl (PCB 3), 3,3’dichlorobiphenyl (PCB 11), 3,4-dichlorobiphenyl (PCB 12), 3,4’-dichlorobiphenyl (PCB
13), 4,4’-dichlorobiphenyl (PCB 15), 3, 3’,4-trichlorobiphenyl (PCB 35), 3,4,4’trichlorobiphenyl (PCB 37) and 3, 3’, 4, 4’-tetrachlorobiphenyl (PCB 77) were purchased
from AccuStandard, Inc. (New Haven, CT). Experiments that included hazardous
materials such as PCBs were performed in accordance with institutional and federal
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guidelines243. All cell culture reagents, including ProLong Gold antifade reagent with
4',6-diamidino-2-phenylindole (DAPI), were purchased from Life Technologies (Carlsbad,
CA). All other chemicals were purchased from Sigma-Aldrich Corporation (St. Louis,
MO), unless otherwise specified.
3.B.3.2 Description of PCB 77 dechlorination treatment mixtures
Treatment mixtures were based on the composition of PCB 77 and its
dechlorination products at 0, 10, 24, and 48 hours of remediation as derived from GCMS data comparing the reductive efficiencies of 0.1 mg/mL 400 nm Pd/Fe nanotubes
and 1 mg/mL Pd/Fe nanoparticles237; 240. Dechlorination product compositions were
determined from these data (Table 3.B.1); treatments from each stage of the
dechlorination are described as percent by weight and as molarity. Stocks of individual
PCB commercial congeners were solubilized in fresh dimethyl sulfoxide (DMSO) at a
concentration of 10 mM. Treatment mixtures were developed to delineate between the
effects of the parent compound and dechlorination products including treatments
representing product mixtures without PCB 77, treatments representing only the
concentration of PCB 77 at a particular stage of dechlorination, and a treatment
representing the 24 h dechlorination products with the higher PCB 77 concentration
found following 10 h dechlorination, to emphasize the role of PCB 77 in overall toxicity
(Table 3.B.2). Stock treatment mixtures were prepared in DMSO at a 5 mM total
concentration and diluted 1:1000 in cell culture medium for 5 µM final cell culture
treatments.
3.B.3.3 Cell culture
Primary endothelial cells (ECs) were isolated from porcine pulmonary arteries as
described previously210. Cell culture media consisted of medium 199 (M199) containing
10% fetal bovine serum (FBS). At 70-80% confluence, cells were incubated overnight
with treatment media (M199 with 1% FBS), followed by exposure to PCB 77 or
respective treatment mixtures for 24 h. Treatment mixtures were added to cell culture at
a final concentration of 5 µM, which represented a maximum concentration of 0.1%v/v
DMSO/media (see Tables 3.B.1 and 3.B.2 for PCB treatment concentrations). Cell
viability was tested in the presence of dechlorination products using the Vybrant MTT
Cell Proliferation Assay Kit (Invitrogen, Eugene, OR) according to manufacturer
guidelines.
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3.B.3.4 Assessment of superoxide (O2●–) levels
Superoxide levels were assessed as recently reported70. Cells were grown to
confluence in 4-chamber culture slides (BD Biosciences, Bedford, MA). After 4 h
exposure to PCB treatments (5 µM total concentrations; Table 3.B.1), the cells were
rinsed 2x with Krebs-Ringer buffer (KRB) and incubated with 5 µM dihydroethidium
(DHE) or KRB (blank) at 37oC for 30 min. Cells were rinsed with KRB, fixed with 10%
buffered formalin, and washed with PBS. Slides were mounted with ProLong Gold
antifade reagent with DAPI for nuclei staining. Slides were evaluated with an Olympus
BX61W1 fluorescence microscope. Mean fluorescence intensity was quantified using
ImageJ 1.42q (NIH, Bethesda, MD).
3.B.3.5 Assessment of NFкB activation
Nuclear extracts were prepared from endothelial cells cultured as described
above in 10 cm dishes and treated with PCB 77 or dechlorination mixtures for 4 h. The
nuclear extraction was performed as described previously22. EMSA (electrophoretic
mobility shift assay) of nuclear factor kappa B (NFкB) binding was kindly performed by
Dr. Seong-Su Han of the University of Iowa College of Medicine using the DNA-protein
binding detection kit (Gibco-BRL, Grand Island, NY) with radio-labeled
oligonucleotides60; 77.
3.B.3.6 Measurement of CYP1A1, MCP-1 and VCAM-1 mRNA
CYP1A1, MCP-1 and VCAM-1 mRNA expression was assessed using real-time
PCR (RT-PCR), as described previously23; 77. Briefly, mRNA was isolated using TRIzol
Reagent (Life Technologies, Carlsbad, CA) and quantified using a SmartSpec Plus
Spectrophotometer (BIO-RAD, Philadelphia, PA). cDNA was then generated using
Promega AMV reverse transcriptase (Fisher Scientific, Waltham, MA) and RT-PCR was
performed using Power SYBR Green PCR Master Mix (Life Technologies, Carlsbad, CA)
and the following porcine primer sequences: β-actin sense 5′-TCA TCA CCA TCG GCA
ACG-3′ and antisense, 5′-TTC CTG ATG TCC ACG TCG-3′; CYP1A1 sense 5’- TGG
AGA GGC AAG AGT AGT TGG-3’and anti-sense 5’-GGC ACA ACG GAG TAG CTC
ATA-3’; MCP-1 sense 5′-CGG CTG ATG AGC TAC AGA AGA GT-3′and antisense, 5′GCT TGG GTT CTG CAC AGA TCT-3′; and VCAM-1 sense 5′-TGG AAA GAC ATG
GCT GCC TAT-3′ and antisense, 5′-ACA CCA CCC CAG TCA CCA TAT-3′. Assays
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were run using the Applied Biosystems 7300 Real time PCR System (Life Technologies,
Carlsbad, CA) using absolute quantification. The raw data were quantified using a
standard curve and analyzed with a manual CT threshold of 0.200. Sample data were
normalized to individual β-actin values.
3.B.3.7 Measurement of CYP1A1, MCP-1 and VCAM-1 protein
CYP1A1 and VCAM-1 protein levels were assessed by Western blotting, as
described previously240. After semi-dry transfer, nitrocellulose membranes were
incubated for 2 h in blocking buffer (5% non-fat milk in Tris-buffered saline containing
0.05% Tween 20). Rabbit polyclonal CYP1A1 (H-70) and VCAM1 (C-19)-R (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) primary antibodies were diluted 1:1000 in blocking
buffer and incubated overnight at 4 °C, and the secondary antibody was diluted 1:4000.
β-actin primary and secondary antibodies were diluted 1:10,00023. MCP-1 protein levels
were measured in cell culture media diluted 1:7 using an OptEIA Human MCP-1 ELISA
Kit (BD Biosciences, San Diego, CA) according to manufacturer guidelines.
3.B.3.8 Statistical analysis
Values are reported as means ± SEM obtained from a representative sample set
of a minimum of three independent experiments, unless otherwise stated. Comparisons
were made by one-way analysis of variance (ANOVA) with Tukeys test for post-hoc
analysis, using SigmaPlot 12.0 software (Systat Software, San Jose, CA). Statistical
probability of pvalue < 0.05 was considered significant. Similar statistical marker letters
between treatments indicate no statistical difference.
3.B.4 Results
3.B.4.1 Dechlorination alters cellular oxidative stress and viability
PCB-induced cellular dysfunction is characterized by increased oxidative stress
and subsequent activation of inflammatory pathways including NFкB. The uncoupling of
CYP1A1 leads to the generation of reactive oxygen species (ROS), such as superoxide.
Endothelial cell monolayers were exposed to representative dechlorination product
mixtures (Table 3.B.1) for 4 h before ROS were visualized with DHE fluorescence
(Figure 3.B.1.A). Strong staining was observed in cells exposed to 0 h (pure PCB 77)
and 10 h dechlorination products, whereas mixtures representing longer periods of
dechlorination showed decreased superoxide production. When DHE fluorescence was
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quantified and normalized to DAPI nuclear staining, fluorescence from initial
dechlorination mixtures (0 and 10 h of dechlorination) indicated higher ROS production
which decreased to control levels with further dechlorination (differences between
groups approached significance, p=0.052; See Figure 3.B.1.B). A similar trend was
observed with regard to viability, where no changes were observed in cells treated with
PCB vehicle (DMSO) and the 48 h dechlorination product, although cell viability was
decreased in 0 h (parent compound, PCB 77), 10 h and 24 h dechlorination product
treatments to 69±1%, 61±3%, 87±2% of control, respectively.
3.B.4.2 NFкB activation is attenuated by dechlorination
Data from an NFкB EMSA showed that cells treated for 4 h with the
dechlorination products exhibited a prominent increase in NFкB activation when treated
with the 0 h product, or pure PCB 77. Intermediate activation by the 10 and 24 h
products was observed; NFĸB:DNA binding for these treatments was significantly
decreased compared to exposure to the 0 h product but remained increased relative to
the vehicle control and biphenyl (48 h product; see Figure 3.B.2). Biphenyl was
consistently within control expression levels for superoxide fluorescence, viability, and
NFкB:DNA binding. The 10 and 24 h dechlorination products were increased from
control but did not exhibit a consistent linear change from parent PCB 77, 0 h of
dechlorination, expression levels. We, therefore, tested a series of treatment mixtures to
delineate between the effects of the dechlorination products and the residual PCB 77.
3.B.4.3 Dechlorination products alter CYP1A1, MCP-1 and VCAM-1 mRNA
expression
CYP1A1, VCAM-1 and MCP-1 levels were assessed in mRNA using treatment
groups 1-10 (Figure 3.B.3, Table 3.B.2). CYP1A1 expression is a sensitive marker of
coplanar PCB-mediated cellular activation and toxicity. Thus, significant response from
all treatments containing PCB 77 was expected (Figure 3.B.3.A). Indeed, all treatments
that contained pure or some PCB 77 (treatments 2, 3, 5, 7, 9 and 10) exhibited almost
maximal CYP1A1 expression. There was no difference in CYP1A1 expression among
the pure PCB 77 (treatment 2) and both 10 h (treatment 3) and 24 h (treatment 5)
dechlorination mixtures. Interestingly, when 10 h and 24 h dechlorination treatments
lacked PCB 77 (treatments 4 and 6, respectively), induction of CYP1A1 was reduced
linearly. Both MCP-1 and VCAM-1 mRNA expression patterns (Figures 3.B.3.B and
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3.B.3.C, respectively) followed approximately the CYP1A1 treatment patterns,
suggesting some correlation between CYP1A1 induction and inflammatory markers in
these dechlorination experiments. As with CYP1A1 expression, MCP-1 and VCAM-1
expression exhibited a linear decrease to control levels when treated with mixtures
representing 10, 24 and 48 h dechlorination products without PCB 77 (treatments 4, 6
and 8), indicating that any byproduct contribution to the inflammatory response was
eliminated by further dechlorination. Total dechlorination to biphenyl (48 h product)
showed no statistical difference from control, indicating that it was relatively benign in
our EC model. The presence of residual parent PCB dominated the inflammatory
response in product mixtures, but mRNA expression levels of PCB 77 alone were
moderately attenuated at the lower concentrations.
3.B.4.4 Degree of dechlorination affects CYP1A1, MCP-1 and VCAM-1 protein
expression
Endothelial cells were treated with the dechlorination mixtures mentioned above
(Table 3.B.2) in order to determine the effects of PCB 77 dechlorination on endothelial
cell inflammatory response expressed in protein markers (Figure 3.B.4). Treatments
containing the parent compound showed strong correlations in both mRNA and protein.
Similar to the mRNA expression levels, CYP1A1 protein levels were highest for
treatments containing PCB 77 (Figure 3.B.4.A). However, treatments that did not
contain PCB 77 showed a marked decrease in CYP1A1 and MCP-1 protein expression,
correlated to the degree of dechlorination. Significant increases in MCP-1 expression
were observed with the 0 h product (PCB 77, treatment 2) and, to a lesser degree, with
dechlorination products containing decreasing concentrations of PCB 77 (treatments 3,
5, and 8). VCAM-1 protein expression of dechlorination product mixtures without PCB 77
(treatments 4 and 6) and biphenyl (treatment 8) were not significantly different from
control. The presence of PCB 77 in all treatment groups corresponded to significant
increases in VCAM-1 protein expression above control levels. These data suggest a
complicated interplay between inflammatory parameters in response to PCB 77
dechlorination product exposure. Nevertheless, the presence of PCB 77 in the individual
treatments markedly induced vascular inflammation.
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3.B.5 Discussion
PCBs are man-made chemicals that were used in hundreds of industrial and
commercial applications244 and are byproducts of certain industries today232. Even
though their mass production has been banned, PCBs are chemically stable, persistent
environmental toxicants that can cause harmful health effects. Remediation or
detoxification of contaminated sites is difficult and expensive, and it is not clear to what
extent these remediation processes have to occur before their disease potential is
mitigated. The present study was designed to test the hypothesis that dechlorination of
coplanar PCB 77 diminishes its pro-inflammatory potential in vascular endothelial cells.
This is an important issue because PCBs can damage vascular tissues and thus
contribute to cardiovascular diseases such as atherosclerosis. In fact, a recent study
reported increased hospitalization rates for acute myocardial infarction and diabetes
mellitus in populations residing near areas contaminated with persistent organic
pollutants245; 246. Furthermore, the administration of PCB 77 to male apolipoprotein E
(ApoE) -/- mice has been shown to promote atherosclerosis247.
The lining of blood vessels is protected by the endothelium, and endothelial cells
play an active role in physiological processes such as regulation of vessel tone, blood
coagulation, and vascular permeability. Dysfunction of endothelial cells is a critical
underlying cause of the initiation of cardiovascular diseases such as atherosclerosis.
Coplanar PCBs are initiators of endothelial dysfunction and exert their toxicity through
binding to the AhR. AhR target genes, including CYP1A1, are considered a source of
oxidative stress in endothelial cells and subsequent vascular dysfunction248; 249. We
confirmed in the present study the oxidative stress potential of coplanar PCBs. In fact,
CYP1A1 induction was maximal in cells exposed to pure PCB 77 and remained elevated
in all dechlorination mixtures that contained PCB 77, independent of its relative
concentration. When residual amounts of PCB 77 were excluded from the
dechlorination mixtures, CYP1A1 induction was markedly reduced, suggesting that the
presence of the parent coplanar PCB is necessary for maximal CYP1A1 expression.
Furthermore, we have previously shown that coplanar PCBs 77, 126 and 169 increased
expression of the CYP1A1 gene, oxidative stress (DCF fluorescence), and the DNAbinding activity of NFкB20. In the current study, oxidative stress and DNA-binding of
NFкB decreased with increasing dechlorination. In fact, when PCB 77 was completely
dechlorinated to biphenyl, oxidative stress and NFкB levels approached control levels.
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This suggests that effective dechlorination should be as complete as possible to avoid
oxidative stress-mediated tissue toxicity.
Oxidative stress-induced transcription factors such as NFкB, which regulate
inflammatory cytokine and adhesion molecule production, play critical roles in the
induction of inflammatory responses and subsequent atherosclerotic lesion formation.
We have demonstrated previously that coplanar PCBs can cause endothelial cell
dysfunction as determined by inflammatory markers, such as expression of inflammatory
cytokines and adhesion molecules, i.e. MCP-1 and VCAM-1, respectively23; 56; 77. In our
analysis of the dechlorination product mixtures, we found that inflammatory patterns of
MCP-1 and VCAM-1 were similar to CYP1A1 patterns induced by pure PCB 77 and the
dechlorination mixtures that contained residual PCB 77, suggesting that the parent
compound is necessary for an endothelial inflammatory response. The 10 h
dechlorination byproducts also induced an MCP-1 and VCAM-1 response that was
alleviated by further dechlorination. Again, as was found with CYP1A1, total
dechlorination to biphenyl did not induce MCP-1 and VCAM-1 inflammatory parameters
in our endothelial cell model system.
The dechlorination process decreased the parent PCB 77 but contributed to
various lower-chlorinated PCBs. Furthermore, the ratio and proportion of these lowerchlorinated PCBs changes with degree of dechlorination. Even though their level of
interaction with the AhR is not well characterized, lower-chlorinated PCBs may
contribute to cellular dysfunction. For example, PCB 15, which was found in relatively
high concentrations in the dechlorination mixtures, can contribute to liver
carcinogenesis250. PCB 11, another common PCB in our dechlorination mixtures,
recently has been discovered in relatively large amounts in commercial paint
pigments232. Furthermore, other lower chlorinated PCBs generated during
dechlorination have been shown to be metabolically activated by electrophilic quinoid
species, which can bind to DNA251. Our data suggest that the temporary formation of
lower chlorinated PCBs during dechlorination can contribute in part to induction of
inflammatory parameters.
In addition, the lipophilic nature of PCBs enables them to perturb membrane
structures. We have evidence that membrane domains like caveolae are critically
involved in endothelial inflammation induced by exposure to PCBs. For example, PCB
77 can accumulate in caveolae-rich fractions of endothelial cells83, and up-regulation of
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endothelial MCP-1 by PCB 77 is caveolin-1-dependent23. Evidence from our laboratory
implicates caveolae as a regulatory platform involved in endothelial activation and
inflammation by environmental contaminants (Figure 3.B.5). As a regulatory platform,
caveolae facilitate the interaction of PCBs with the AhR, which in turn promotes the upregulation of CYP1A1, a phase I detoxifying enzyme. CYP1A1 metabolism of coplanar
PCBs, like PCB 77, is inefficient, leading to protein uncoupling and release of
superoxide, which promotes the formation of reactive oxygen species (ROS) in the cell18.
The cell responds to this change in redox status by activating the transcription factor
NFкB, which regulates enzymes and inflammatory parameters associated with
endothelial dysfunction and cell injury such as MCP1 and VCAM1252. Further studies
are needed to understand whether caveolae have differential selectivity for various PCB
species such as those present in dechlorination mixtures and to determine if the
interaction of these congeners with caveolae has potential to induce endothelial cell
dysfunction.
In summary, our study provides evidence that dechlorination of highly chlorinated
PCBs is beneficial for protecting the vasculature from oxidative stress-induced
inflammation and subsequent pathologies like atherosclerosis. Highly chlorinated PCBs
are persistent and cytotoxic and a significant risk factor to endothelial injury and
associated vasculature pathologies. The pro-inflammatory potential of the dechlorination
mixtures that we observed appears to depend largely on the presence of the parent
compound (e.g., PCB 77). Clearly, cytotoxicity decreased relative to degree of
dechlorination, and the final dechlorination product, biphenyl, was nontoxic in our
endothelial cell model system. More studies are needed to understand threshold
concentrations of dechlorination mixtures that are required to prevent or mitigate
compromised health associated with exposure to environmentally toxic chlorinated
biphenyls. (The data presented in Chapter 3.B were published21.)

Copyright © Bradley J. Newsome 2014
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PCB 77
PCB 37
PCB 35
PCB 15
PCB 13
PCB 12
PCB 11
PCB 03
PCB 02
Biphenyl
Total

Mixture
components

DMSO
(vehicle)
100% (5)
0%
0%
0%
0%
0%
0%
0%
0%
0%
100% (5)

0h
(5 µM PCB 77)
wt% (µM)
20% (0.7)
4% (0.2)
4% (0.2)
11% (0.5)
8% (0.3)
8% (0.3)
11% (0.5)
3% (0.1)
3% (0.1)
30% (1.9)
100% (5)

10 h
(5 µM dechlor. product)
wt% (µM)
7% (0.2)
2% (0.1)
2% (0.1)
9% (0.4)
7% (0.3)
7% (0.3)
9% (0.4)
3% (0.1)
3% (0.1)
50% (3.1)
100% (5)

24 h
(5 µM dechlor. product)
wt% (µM)
0%
0%
0%
0%
0%
0%
0%
0%
0%
100% (5)
100% (5)

48 h
(5 µM biphenyl)
wt% (µM)

Table 3.B.1
Treatment mixtures representing PCB 77 dechlorination byproducts at various time points during dechlorination.
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a

0.7 (0.200)
0.2 (0.042)
0.2 (0.042)
0.5 (0.110)
0.3 (0.076)
0.3 (0.076)
0.5 (0.110)
0.1 (0.028)
0.1 (0.028)
1.9 (0.300)
5 (1.01)

10 h [µM
(ppm)]

3

—
0.2 (0.042)
0.2 (0.042)
0.5 (0.110)
0.3 (0.076)
0.3 (0.076)
0.5 (0.110)
0.1 (0.028)
0.1 (0.028)
1.9 (0.300)
4.3 (0.810)

10 h without
PCB 77b [µM
(ppm)]

4
a

0.2 (0.064)
0.1 (0.020)
0.1 (0.020)
0.4 (0.090)
0.3 (0.070)
0.3 (0.070)
0.4 (0.090)
0.1 (0.024)
0.1 (0.024)
3.1 (0.480)
5 (0.954)

24 h [µM
(ppm)]

5

—
0.1 (0.020)
0.1 (0.020)
0.4 (0.090)
0.3 (0.070)
0.3 (0.070)
0.4 (0.090)
0.1 (0.024)
0.1 (0.024)
3.1 (0.480)
4.8 (0.890)

24 h without
PCB 77b [µM
(ppm)]

6

8
a

9

10

0.7 (0.200)
0.1 (0.020)
0.1 (0.020)
0.4 (0.090)
0.3 (0.070)
0.3 (0.070)
0.4 (0.090)
0.1 (0.024)
0.1 (0.024)
3.1 (0.480)
5.5 (1.09)

—
—
—
—
—
—
—
—
—
5 (0.771)
5 (0.771)

0.7 (0.200)
—
—
—
—
—
—
—
—
—
0.7 (0.200)

0.2 (0.064)
—
—
—
—
—
—
—
—
—
0.2 (0.064)

24 h with addition of 48 h
10 h Concentration 24 h Concentration
10 h PCB 77 c [µM
[µM (ppm)]
of PCB 77d [µM
of PCB 77d [µM
(ppm)]
(ppm)]
(ppm)]

7

a

Concentrations listed represent final PCB concentrations in cell culture media
Treatment compositions representing different products at various points in the dechlorination process (see also Table 3.B.1)
b
Treatment compositions representing dechlorination products at 10 and 24 h of dechlorination without the parent compound, PCB 77
c
Treatment composition representing the dechlorination products of 24 h dechlorination with the increased concentration of PCB 77 present at 10 h of dechlorination
d
Treatment composition representing the concentrations of PCB 77 present at 10 and 24 h of dechlorination

5 (1.46)
—
—
—
—
—
—
—
—
—
5 (1.46)

—
—
—
—
—
—
—
—
—
—
—

a

PCB 77
PCB 37
PCB 35
PCB 15
PCB 13
PCB 12
PCB 11
PCB 03
PCB 02
Biphenyl
Total
Concentration

2

DMSO
0 h [µM
(0.1 %v/v vehicle)
(ppm)]

a

Mixture
components

1

Table 3.B.2
Original and modified treatment conditions based on PCB 77 dechlorination byproduct

Figure 3.B.1. Dechlorination of PCB 77 alters cellular oxidative stress. Cells grown on
chamber slides were treated with DMSO (vehicle control) or dechlorination products with
a total concentration of 5 µM total concentrations and were incubated for 4 h. Cells were
then treated with N,N'-(1,2-dihydroxyethylene) bisacrylamide, (DHE, in red) for
superoxide detection. Slides were fixed with DAPI (in blue) for nuclear staining, (A)
fluorescent images were recorded at 40X and (B) DHE fluorescence was quantified and
normalized to DAPI.
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Figure 3.B.2. Dechlorination of PCB 77 attenuates NFкB activation. Cells were treated
with vehicle control (DMSO), 0 h (PCB 77, 5 µM) 10 h, 24 h and 48 h dechlorination
mixtures (5 µM), and incubated for 4 h. Both PCB 77 and dechlorination products (10
and 24 h product treatments) significantly increased DNA binding of NFкB over DMSO
and biphenyl (48 h treatment). Results are given as mean±SEM. Different statistical
marker letters represent significant differences among treatment groups (determined by
Pvalue≤0.05).
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Figure 3.B.3. Dechlorination products alter CYP1A1 (A), MCP-1 (B) and VCAM-1 (C)
mRNA expression. The presence of PCB 77 significantly up-regulated mRNA
inflammatory markers in ECs; inflammation decreased with further dechlorination of the
parent compound. Please see Table 3.B.2 for detailed treatment descriptions. The
vehicle, DMSO (treatment 1), was applied at 0.1%v/v for all treatments. Treatments
representing the dechlorination products at 0 h (treatment 2), 10 h (treatment 3), 24 h
(treatment 5), and 48 h (treatment 8) are the same as those tested previously for NFкB,
superoxide production and viability. Treatments 4 and 6 excluded PCB 77 while
maintaining the representative concentrations of the dechlorination products found at 10
h and 24 h, respectively. In contrast, treatments 9 and 10 contained only PCB 77 at the
concentrations found in the 10 h and 24 h mixtures, respectively. Treatment 7 consisted
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of the 24 h dechlorination mixture with the level of PCB 77 found in the 10 h mixture.
Different statistical marker letters represent significant differences among treatment
groups (determined by Pvalue≤0.05). For example, in CYP1A1, treatment 2 (statistical
marker “b”) is significantly different from treatment 1 (“a”) and treatment 4 (“c”).
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Figure 3.B.4. Dechlorination mixtures alter CYP1A1 (A), MCP-1 (B) and VCAM-1 (C)
protein expression. The presence of PCB 77 significantly up-regulated protein
inflammatory markers in ECs; inflammation decreased with further dechlorination of the
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parent compound. Treatments are the same as described in Figure 3.B.3 (please see
Table 3.B.2 for detailed treatment descriptions). Statistical differences among treatment
groups (determined by Pvalue≤0.05) are represented by marker letters, as stated
previously.
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Figure 3.B.5. PCB 77 increases ROS production and downstream cellular dysfunction.
PCB 77 interacts with caveolae in the plasma membrane, is endocytosed into the cell,
and interacts with the AhR and its chaperone ARNT (aryl hydrocarbon receptor nuclear
translocater), leading to nuclear translocation, XRE (xenobiotic response element)
binding and CYP1A1 up-regulation. CYP1A1 protein uncoupling occurs during PCB 77
metabolism and leads to an increase in cellular ROS. NFкB is activated in response to
the change in cellular redox status and translocates to the nucleus where it acts as a
transcription factor to up-regulate adhesion molecules and cytokines.
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Chapter 4. Nutritional modulation of environmental pollutant in vivo toxicity
4.1 Synopsis
Superfund chemicals such as polychlorinated biphenyls pose a serious human
health risk due to their environmental persistence and link to multiple diseases. Selective
bioactive food components such as flavonoids have been shown to ameliorate PCB
toxicity, but primarily in an in vitro setting. Here, we show that mice fed a green teaenriched diet and subsequently exposed to environmentally relevant doses of coplanar
PCB exhibit decreased overall oxidative stress primarily due to the up-regulation of a
battery of antioxidant enzymes. C57BL/6 mice were fed a low fat diet supplemented with
green tea extract (GTE) for 12 weeks and exposed to 5 µmol PCB 126/kg mouse weight
(1.63 mg/kg-day) on weeks 10, 11 and 12 (total body burden: 4.9 mg/kg). F2-Isoprostane
and its metabolites, established markers of in vivo oxidative stress, measured in plasma
via HPLC-MS/MS exhibited five-fold decreased levels in mice supplemented with GTE
and subsequently exposed to PCB compared to animals on a control diet exposed to
PCB. Livers were collected and harvested for both mRNA and protein analyses, and it
was determined that many genes transcriptionally controlled by AhR and Nrf2 proteins
were up-regulated in PCB-exposed mice fed the green tea supplemented diet. An
increased induction of genes such as SOD1, GSR, NQO1 and GST, key antioxidant
enzymes, in these mice (green tea plus PCB) may explain the observed decrease in
overall oxidative stress. A diet supplemented with green tea allows for an efficient
antioxidant response in the presence of PCB 126 which supports the emerging paradigm
that healthful nutrition may be able to bolster and buffer a physiological system against
the toxicities of environmental pollutants.
4.2 Introduction
The contamination of soil and groundwater aquifers by toxic chlorinated organic
compounds at Superfund sites, e.g., polychlorinated biphenyls (PCBs) and
trichloroethylene (TCE), is a pervasive environmental problem with serious public health
consequences253. PCBs are persistent organic pollutants found in soil, air, and water,
and a major source of human exposure to PCBs is dietary intake of contaminated
foods254. Because PCBs are lipid soluble, they readily accumulate in human tissues, thus
increasing human health concerns15. For example, the recent Aniston Community Health
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Survey reported a significant correlation between PCB levels and risk of developing
diabetes25, and circulating levels of PCBs have also been associated with cardiovascular
disease risk255. Prenatal exposure to PCBs also may be associated with increased
weight in children256. The liver is particularly vulnerable to PCB-induced toxicity because
it is the primary organ associated with detoxification, and there is strong evidence from
NHANES data that exposure to PCBs is associated with liver disease in humans257.
There is evidence from cell culture and animal models that nutrition can modulate
the toxicity of environmental pollutants258 and thus affect vulnerability to environmental
insults and compromised health. For example, PCBs can act as diet-dependent
obesogens when administered with a high-fat diet, and thus worsen nonalcoholic fatty
liver disease259. We have previously shown that PCB exposure can modify lipid
metabolism while dietary fat supplementation can ameliorate these negative effects260.
For example, we have shown that PCB exposure increases neutral lipid staining in LDLR−/− mice fed a corn oil-enriched diet (i.e., a diet rich in omega-6 fatty acids), which
could indicate increased inflammation, while inflammation was decreased in mice fed an
olive oil-enriched diet. Omega-3 fatty acids derived from fish oil are protective and
reduce PCB-induced toxicity in endothelial cells48; 70. Similarly, antioxidant nutrients such
as dietary flavonoids can protect against endothelial cell damage mediated by these
persistent organic pollutants60; 67. This is important since coplanar PCBs (e.g., PCB 126)
exert their toxicity primarily through activation of the aryl hydrocarbon receptor (AhR)
and subsequent uncoupling of cytochrome P450 1A1 (CYP1A1), which can be a source
of oxidative stress261; 262.
Mammalian cells are constantly exposed to endogenous and exogenous sources
of free radicals which tip the cellular balance towards an overall oxidative stress
condition. To counteract the ubiquitous nature of reactive oxygen species (ROS),
mammalian cells have evolved intricate and interrelated protein defenses that can work
efficiently to limit the detrimental effects of these toxic molecules. PCBs have been
shown to cause oxidative stress primarily through a CYP1A1 uncoupling mediated
mechanism3. Production of superoxide and related ROS triggers an up-regulation of a
battery of antioxidant enzymes such as superoxide dismutase (SOD), catalase,
glutathione reductase (GSR), glutathione transferases (GST), thioredoxins (Trx) and
thioredoxin reductases (TrxR)263; 264. These proteins work in concert to either catalyze
the transformation of ROS to benign molecules such as water and molecular oxygen or
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to reactivate enzymes, usually by catalytic reductions (e.g. TrxR reduces oxidized Trx to
its active form265). Such an interconnected system requires the crosstalk of multiple
regulatory pathways including the aryl hydrocarbon receptor (AhR) and nuclear factor
(erythroid-derived 2)-like 2 (Nrf2) transcription factors, which work together to detoxify
xenobiotics and to up-regulate the antioxidant response (see Figure 4.1).
Upon activation via endogenous ligands, such as arachidonic acid metabolites,
or xenobiotics, such as dioxin (TCDD) or coplanar PCB 126, the AhR translocates to the
nucleus, binds consensus cis-acting sequences known as dioxin or xenobiotic response
elements (DRE or XRE) and facilitates the up-regulation of multiple genes, especially
those related to phase I detoxification (e.g. CYP1A1 and UDP-glucuronosyl Stransferases)266. Certain environmental toxicants with relatively long half-lives, such as
TCDD and PCB 126, can promote sustained AhR activation resulting in chronic low
levels of oxidative stress and inflammation248. The Nrf2 pathway shares many target
genes with AhR, but is generally regarded as a redox sensor, because its dissociation
with inhibitory proteins (e.g. Keap1) and subsequent transactivation is promoted by ROS
and electrophiles90. Binding of Nrf2 to consensus antioxidant response elements (ARE)
up-regulates a battery of protective genes including cytochrome P450s, GSTs and
NAD(P)H dehydrogenase [quinone] 1 (NQO1)84. Nrf2 is a critical mediator of oxidative
stress and xenobiotic toxicity as evidenced by multiple studies involving Nrf2 KO mice267;
268

. It appears that the interrelatedness of Nrf2 and AhR pathways is not a coincidental

occurrence as recently intimate cross-talk between the two xenobiotic related proteins
has been illustrated91. In fact, AhR and Nrf2 promoter gene sequences contain binding
sites for one another and in instances where either is absent (e.g., KO) a decreased
protective response occurs92. Importantly, bioactive nutrients such as tea catechins may
work through both Nrf2- and AhR-mediated mechanisms to prevent toxicant-induced
global inflammation60.
We have demonstrated previously that the tea catechin epigallocatechin-3gallate (EGCG) can protect against vascular endothelial cell activation by coplanar
PCBs60; 126, and that EGCG can inhibit expression of AhR-regulated genes and induce
Nrf2-regulated antioxidant enzymes, thus providing protection against PCB-induced
inflammatory responses in cultured endothelial cells60. EGCG also can inhibit oxidative
damage and attenuate carbon tetrachloride-induced hepatic fibrosis269. Mechanisms
responsible for EGCG-induced protection against environmental pollutants are not fully
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understood. In the current study we provide evidence that green tea extract, composed
primarily of EGCG (Supplementary Table 4.1), can decrease oxidative stress in livers of
mice exposed to PCB 126 by a mechanism that, at least in part, is due to induction of
antioxidant genes. Thus, diet supplementation with green tea may allow for an efficient
antioxidant response to buffer against toxicities of environmental pollutants in humans
and protect against PCB-induced liver damage257.
4.3 Materials and Methods
4.3.1 Animals, diets, and dosing treatments
Forty C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, ME)
at 2 months of age and evenly assigned to the following experimental groups: control
diet (10% kcal as fat) + vehicle, control+1% green tea extract (GTE) + vehicle, control +
PCB 126, control+1% GTE + PCB 126. The control diet was purchased from Research
Diets, Inc. (New Brunswick, NJ, catalog number D12450B). Sunphenon 30S-O organic
green tea extract (lot number: 105131, containing 37.4% total polyphenols, 32.0% total
catechins, and 5.3% caffeine) was obtained from Taiyo International Inc. (Minneapolis,
MN) and incorporated into the control diet formulation, as described in Supplementary
Table 4.1. Green tea extract treatment amounts per body weight coincide with
approximately 4 cups of tea (~200 ml/cup) per day in humans270. Mice were fed the
control and GTE-supplemented diets for 12 weeks and were gavaged with PCB 126 (5
µmol/kg mouse) or vehicle (stripped safflower oil; Acros Chemical Company, Pittsburgh,
PA) in weeks 10, 11, and 12. The PCB 126 gavage concentration was chosen based on
observations in preliminary studies where gavage of 5 µmol PCB 126/kg mouse weight
(1.63 mg/kg-day, total body burden: 4.9 mg/kg) showed pro-inflammatory responses in
C57/BL6 mice but not wasting syndrome.
4.3.2 Blood and tissue harvesting
In this study, we examined the role that green tea extract catechins play in
altering oxidative stress and inflammation following insult with environmental pollutants
(i.e., PCB 126). 24 h after week 12 treatment, mice were euthanized with CO2 and
quickly exsanguinated. Ethylenediaminetetraacetic acid (EDTA) was added to collected
blood samples, briefly mixed, and centrifuged at 5000 g for 5 min at 4 °C to separate
blood plasma. Plasma samples were frozen in liquid nitrogen and stored at -80 °C until
processing. Livers were harvested, weighed, divided in half, and frozen in liquid nitrogen
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for protein studies or stored in RNAlater solution (Life Technologies, Grand Island, NY)
at 4 °C for 24 h then -80 °C prior to mRNA analysis.
4.3.3 Plasma PCB and isoprostane analysis
PCB 126 and its metabolites were extracted from plasma samples to determine
systemic PCB and metabolite concentrations and correlate these findings to potential
PCB-induced oxidative stress as well as the role of green tea extract in mitigating these
effects. PCB 126 and its hydroxy metabolites were isolated from plasma samples (plus
10 µM 13C12-labeled PCB 126 internal standard (IS), Cambridge Isotope Laboratories,
Tewksbury, MA) through extraction with acetonitrile and subsequent sonication and
centrifugation at 15,000 rpm for 5 min to pellet plasma debris. Supernatants were dried
under N2 and reconstituted in 99:1 methanol:dI H2O solvent mixture with 0.5% formic
acid and 0.1% 5 M ammonium formate.
Measurement of F2-Isoprostanes (F2-IsoPs) provides one of the most reliable
assessment methods for oxidative stress in vivo271. For F2-IsoP analysis, plasma
samples were added to 5:1 ethyl acetate: methanol + 0.5% acetic acid (v/v) + 10 µM 8iso-PGF2α-D4 (internal standard, Cayman Chemical, Ann Arbor, MI), vortexed briefly,
and centrifuged to pellet plasma debris. Supernatants were transferred and dried under
N2 prior to reconstitution in methanol and addition of acetic acid for subsequent solid
phase extraction (SPE).
Reconstituted F2-IsoP samples were loaded onto pre-conditioned Supel-Select
HLB SPE columns (Sigma-Aldrich, St. Louis, MO) and washed with 0.5% acetic acid
followed by washing with 0.5% acetic acid containing 20% methanol. Columns were
eluted with methanol, eluent was evaporated to dryness with N2, and samples were
reconstituted with 50:50 methanol:dI H2O.
Plasma PCB 126 and a hydroxy metabolite as well as extracted plasma F2-IsoPs
were analyzed using a Shimadzu ultra fast liquid chromatography (UFLC) system
coupled with an AB Sciex 4000-Qtrap hybrid linear ion trap quadrupole mass
spectrometer in multiple reaction monitoring (MRM) mode. MRM transitions monitored:
325.9/256.1, 325.9/254.1, and 325.9/184 for PCB 126; 338/268.1, 338/196.1, and
338/265.7 for 13C12 PCB126. In the MRM ion transition, the precursor ion represents
the M+· and the product ion represents either [M-Cl]+ or [M-2Cl]+. MRM transitions
monitored with regard to hydroxy PCB metabolites: 340.8/340.9 for hydroxy PCB126
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and 386.8/340.9 for dihydroxy PCB126. The precursor ion of the ion transition is a formic
acid adduct: [M+FA-H]- and product ion is [M-H]-. F2-IsoP were analyzed by integrating
peak area (area under the curve, AUC) with regard to known internal standard
concentrations (AUC/IS). All values were subsequently normalized for sample volume
and compared to ion transitions of internal standard (13C12 PCB 126) with known
concentration to determine PCB parent and metabolite concentrations (pmol/µL plasma).
4.3.4 RNA isolation and polymerase chain reaction (PCR) amplification
Liver samples used to analyze oxidative stress and inflammatory mRNA markers
were homogenized and mRNA was isolated with TRIzol reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. mRNA concentrations were then
determined using a NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham,
MA). Reverse transcription was performed using the AMV reverse transcription system
(Promega, Madison, MI). mRNA levels were determined by quantitative real-time PCR
using a 7300 Real-Time PCR system (Applied Biosystems, Foster City, CA) and SYBR
Green master mix (Applied Biosystems) as compared to constitutively expressed β-actin
(forward primer: 5’-TGTCCACCTTCCAGCAGATGT-3’; reverse primer: 5’GCTCAGTAACAGTCCGCCTAGAA-3’) using the relative quantification method (ΔΔCt).
Primer sequences (see Table 4.1) for SYBR Green reactions were designed using the
Primer Express Software 3.0 for real-time PCR (Applied Biosystems) and synthesized by
Integrated DNA Technologies, Inc. (Coralville, IA).
4.3.5 Immunoblotting
Liver samples used for protein analysis were homogenized in extraction RIPA
buffer containing protease inhibitors (Pierce, Rockford, IL). Lysed tissue was centrifuged
at 10,000 g for 30 min at 4 ºC followed by Bradford protein assay (Pierce). Protein
samples were separated using 10% SDS-PAGE and subsequently were transferred onto
nitrocellulose membranes. Membranes were blocked with 5% non-fat milk buffer and
incubated overnight at 4 ºC with the following primary antibodies: β-actin (product
#A2066, ~42 kD, Sigma, St. Louis, MO), GAPDH (product #sc-20357, ~37 kD, Santa
Cruz Biotechnology, Dallas, TX), GSR (product #ab16801, ~58 kD, Abcam, Cambridge,
MA), and NQO1 (product #ab34173, ~31 kD, Abcam). After washing, membranes were
incubated with secondary antibodies conjugated with horseradish peroxidase and
visualized using ECL detection reagents (Thermo, Waltham, MA).
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Liver samples used for nuclear translocation assays were prepared and
cytoplasmic and nuclear proteins were extracted according to manufacturer protocol
(NE-PER® Nuclear and Cytoplasmic Extraction Method, Thermo). Translocation
samples subsequently were processed for Western blotting as described above, and
probed with the following primary antibodies: lamin (product #sc-7292, ~69 kD, Santa
Cruz Biotechnology) and Nrf2 (product #sc-722, ~59 kD, Santa Cruz Biotechnology).
4.3.6 Data analyses
Data were analyzed using SigmaStat software (Systat Software, Point Richmond,
CA). Comparisons between treatments were made by one-way or two-way ANOVA with
post-hoc comparisons of the means. Overall, few statistical differences were exhibited
between vehicle control diet groups, thus in most cases Student’s t-test was used to
analyze differences between PCB treatment groups. qRT-PCR mRNA analysis (n=8-10),
Western blot protein analysis (n=8), and nuclear translocation analysis (n=4) represent
three experimental replicates. A probability value of p≤0.05 was considered statistically
significant.
4.4 Results
4.4.1 Systemic toxicity associated with PCBs
PCB 126 levels in mouse plasma were examined as a measure of systemic PCB
body burden and to determine the possible effect of green tea extract (GTE) diet
supplementation on PCB metabolism/excretion. As seen in Figure 4.2, plasma PCB 126
was found almost completely as its hydroxylated metabolite, OH-PCB 126, with
concentrations of approx. 0.04 pmol PCB 126/µL plasma versus approx. 30 pmol OHPCB 126/µL, respectively. GTE diet supplementation did not modulate PCB metabolism
or plasma concentrations 24 h following PCB exposure, indicating that it plays a minimal
role in pollutant clearance from the body. Additionally, Supplementary Figure 4.1 shows
that while PCB treatment led to a significant increase in liver/body weight ratio
(hepatosomatic index, p<0.001), in both control and GTE-supplemented diets, GTE
supplementation did not significantly mitigate this PCB-induced increase.
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4.4.2 F2-isoprostane levels are significantly reduced in green tea extractsupplemented, PCB-exposed mice
Analysis of F2-isoprostanes (F2-IsoPs), prostaglandin-like eicosanoids formed
during fatty acid peroxidation, has emerged as the most reliable method for assessing in
vivo oxidative stress271. Plasma samples from mice fed control and GTE-supplemented
diets and subsequently treated with vehicle or PCB 126 (n=8-10) were analyzed to
determine GTE’s role in modulating environmental toxicant-induced oxidative stress.
Plasma F2-IsoP (including PGF2α, 8-iso-PGF2α, iPF2α-III, 8-epiPGF2α, 8-isoprostane,
and 15-F2t isoprostanes) and F2-IsoP metabolite (13,14-dihydro-15-ketoPGF2α)
concentrations were determined. As seen in Figure 4.3, GTE diet supplementation led to
drastically decreased F2-IsoP levels (approximately a five-fold reduction, p<0.05) in mice
treated with PCB 126, indicating that GTE acts as a strong antioxidant to modulate
against environmental toxicant insult. Additionally, GTE drastically decreased PCBinduced F2-IsoP metabolite production (greater than a five-fold reduction, p<0.05); F2IsoP metabolite analysis is developing as an even more sensitive measure of in vivo
oxidative stress because the metabolites do not undergo autoxidation and artificial
production as has been seen with parent F2-IsoP272. Interestingly, GTE supplementation
led to no significant modulation of F2-IsoP parent or metabolite levels under control
situations, indicating that antioxidant modulation occurs primarily when a system is
under a secondary stressor.
4.4.3 Green tea extract increases antioxidant gene expression
Antioxidant enzyme levels were measured in mouse liver to further develop the
role of GTE diet supplementation in modulating environmental insults in vivo. Table 4.2
highlights antioxidant mRNA markers tested and overall results. qRT-PCR analysis (n=810) shows a significant up-regulation in catalase, glutathione peroxidase (Gpx3),
glutaredoxin (Grx2), glutathione reductase (GSR), glutathione S-transferases (GSTa1,
GSTa4, GSTm1, GSTm2, and GSTm3), NAD(P)H dehydrogenase [quinone] 1 (NQO1),
superoxide dismutase 1 (SOD1), thioredoxin 2 (Trx2), and thioredoxin reductase 1
(TrxR1) during the concomitant treatment of PCB 126 and GTE diet supplementation.
As before, in most cases GTE supplementation did not significantly modulate antioxidant
response in the absence of PCBs. NQO1 and GSTm3, enzymes associated with
detoxification, exhibited significantly increased mRNA levels above vehicle control diet
levels in the presence of PCB 126, while GTE diet supplementation drastically induced
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antioxidant mRNA expression following PCB insult. mRNA levels of SOD1, critical for
modulating harmful superoxide radicals produced during toxicant insult, were
significantly decreased following PCB gavage, while GTE supplementation returned
mRNA expression to vehicle control diet levels. While PCB administration did not
modulate GSR (an important cellular antioxidant) mRNA levels in mice fed vehicle
control diets, GTE diet supplementation led to a significantly increased antioxidant
response (see Figure 4.4, p<0.01). Additional data shown in Supplementary Figure 4.2
is also consistent with these trends observed in response to GTE supplementation. For
example, thioredoxin 2 (Trx2, an important redox protein) mRNA levels are significantly
up-regulated in the concomitant presence of GTE and PCB 126 although GTE does not
induce increased antioxidant activity without the addition of secondary external insult.
4.4.4 Green tea extract increases NQO1 and GSR antioxidant protein response
against PCB 126
Antioxidant marker protein analysis was performed in order to better understand
the role that GTE diet supplementation plays in increasing the body’s defensive
mechanisms against toxicant insult. Proteins of interest were normalized to multiple
housekeeping genes, β-actin and GAPDH. In PCB 126-treated mouse liver samples,
NQO1 protein was significantly up-regulated when fed a GTE supplemented diet, as
shown in Figure 4.5 when quantified against GAPDH (p<0.01). The associated
representative blot continues trends seen in mRNA with a large increase in antioxidant
protein activity in GTE supplemented mice exposed to PCB insult. GSR protein
expression was also statistically increased in response to diet supplementation and
continues the trend seen in mRNA analysis in which neither GTE supplementation nor
PCB treatment led to modulation of antioxidant response while their concomitant
treatment led to significant up-regulation (p≤0.05).
4.4.5 Green tea extract drives Nrf2 nuclear translocation in the presence of PCB
126
Nuclear translocation assays are commonly used techniques that serve as a
representation of cellular transcriptional activation. Nuclear factor (erythroid-derived 2)like 2 (Nrf2) nuclear translocation was analyzed in comparison to lamin, a nuclear
fraction housekeeping gene; liver samples from GTE-supplemented mice exposed to
PCB 126 showed a trend toward increased nuclear abundance of Nrf2 (p=0.1, n=4). As
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in antioxidant mRNA and protein studies, GTE without a concomitant insult from PCB did
not modulate Nrf2 activity and translocation. The Nrf2 antioxidant pathway plays a
pivotal role in modulating oxidative stress, and therefore its up-regulation by GTE diet
supplementation, as seen in Figure 4.6, is an important indicator of GTE’s ability to
increase the body’s responsiveness toward environmental stressors.
4.4.6 Green tea extract modulates inflammatory and xenobiotic-related markers in
the presence of PCB 126
Cytochrome P450 (e.g., CYP1A1 and CYP1B1), a family of enzymes controlled
by the aryl hydrocarbon receptor (AhR) and Nrf2 proteins that are vital for the
metabolism of xenobiotic substances, including toxicants, was analyzed from liver
samples to determine potential modulation of its activity in response to GTE diet
supplementation. Substantial CYP up-regulation was seen in the presence of PCB insult,
as has been shown previously67, while concurrent GTE supplementation causes a
significant up-regulation in CYP1B1 mRNA analysis (as seen in Figure 4.7). In mice fed
GTE-supplemented diets and exposed to PCB, major indicators of inflammation
including monocyte chemoattractant protein-1 (MCP-1, also referred to as chemokine
(C-C motif) ligand 2, CCL2) and CCL3 (also referred to as macrophage inflammatory
protein-1α, MIP-1α) were significantly decreased back to vehicle control levels.
Interestingly, GTE supplementation alone led to significant increases in inflammatory
marker mRNA levels, although these levels returned to vehicle control levels with
concomitant treatment (p<0.05).
4.4.7 The AhR is implicated as a control mechanism both in PCB 126 toxicity and
antioxidant response
As seen in Figure 4.8, GTE diet supplementation led to significant up-regulation
of AhR mRNA levels in liver in the presence of PCB 126, a dioxin-like AhR ligand. PCB
126 insult did not induce AhR mRNA in vehicle control, vehicle + GTE control, and PCB
control settings, but, interestingly, concomitant treatment led to a two-fold up-regulation,
similarly to that seen in mRNA and protein antioxidant and inflammatory markers, thus
allowing for increased in vivo toxicant clearance (p<0.01). Nrf2 mRNA levels were also
significantly increased during PCB 126 insult, although GTE supplementation did not
cause significant modulation of PCB toxicity. AhR and Nrf2 signaling pathways control
both xenobiotic responses and inflammatory cascades, therefore their modulation by
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GTE diet supplementation implicates further GTE’s role in strengthening antioxidant
response toward insult by environmental pollutants.
4.5 Discussion
Healthy nutrition can positively influence, or lessen, the human health risks
associated with exposure to mixtures of environmental chemicals273. The liver is one
tissue particularly vulnerable to environmental pollutants, and especially PCB-induced
toxicity257. One type of liver disease that affects more than 20% of Americans is
nonalcoholic fatty liver disease, which can lead to nonalcoholic steatohepatitis274.
Industrial toxicants also have been linked to secondary insults that can lead to
steatohepatitis274. Our laboratory and others have shown that PCB exposure increases
liver/body weight ratio (hepatosomatic index, HSI; see Supplementary Figure 4.1), which
is generally accepted as indicative of an adverse hepatic response to chemical
exposure275. Mechanisms defining the involvement of environmental pollutants in the
pathology of liver diseases may include a compromised redox status or toxicant-induced
increase in oxidative stress.
Lifestyle modifications that include healthful nutrition have been suggested as a
powerful means of reducing the vulnerability to environmental insults273 and in reducing
the risk to environmental toxicant-induced liver disease274. For example, green tea
extract has been shown to protect against hepatic steatosis in obese mice by reducing
oxidative stress and enhancing hepatic antioxidant defenses276; 277. In the present study
we observed significant protection against PCB 126-induced oxidative stress by dietary
supplementation with green tea extract. In fact, mice supplemented with green tea
extract and subsequently exposed to PCB displayed a decrease in overall F2isoprostane and metabolite levels compared to animals on a control diet exposed to
PCB. We did not see a large increase in oxidative stress as evidenced by an increase in
F2-isoprostane levels in mice fed a control diet and subsequently gavaged with PCB.
This may have been due to the fact that the amount of administered PCB 126 reflects
more relevant environmental PCB exposure concentrations in humans than previous
studies using high concentrations of PCB congeners (e.g., 150 µmol/kg in previous
studies versus 5 µmol/kg used herein)278; 279. We hypothesize that levels of PCBs
encountered by humans today initiate low levels of chronic oxidative stress and
inflammation that, together with multiple other factors including poor diet and exposures
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to other environmental stressors, leads to augmented or exacerbated human disease.
The protective properties of green tea have been studied extensively, and recent human
studies suggest that consumption of green tea may protect against cardiovascular
disease and some forms of cancer, have anti-hypertensive and anti-obesity effects, and
contribute to antibacterial and antiviral activity280.
Certain environmental pollutants, and in particular ligands for the AhR, induce
oxidative stress, in part via induction and uncoupling of cytochrome P450 enzymes18.
Hepatic changes in lipid composition, altered membrane structure and membrane
functions are well-described phenomena of PCB-induced liver damage281-284. The
protective properties of green tea extracts against PCB-induced pathologies, and in
particular liver damage, may be numerous. For example, green tea may normalize the
formation of lipid peroxide products induced by exposure to toxicants to prevent hepatic
fibrosis269, or green tea may favorably regulate intestinal tight junction proteins or overall
intestinal barrier function285. It has been proposed that green tea can inhibit the intestinal
absorption of lipids and highly lipophilic organic compounds99; 100. Induction of antioxidant
enzymes by green tea also may contribute to its tissue protective properties286. Our
current study supports this concept, and we observed an increased induction of
antioxidant genes such as SOD1, GSR, NQO1 and GST in mice that were fed a green
tea-supplemented diet and subsequently challenged with PCB, compared to animals
exposed to the control diet plus PCB. This may explain in part the observed decrease in
overall oxidative stress due to green tea supplementation. Of particular interest is our
observed induction of NQO1, a Nrf2 target gene, which suggests that green tea protects
in part by modulation of the Nrf2/ARE pathway. In fact, it has been shown that food
polyphenols, including the green tea polyphenol EGCG, the primary component of GTE
tested herein, can modulate Nrf2-mediated antioxidant and detoxifying enzyme
induction287; 288. Our own work with vascular endothelial cells further suggests that
multiple pathways including lipid raft caveolae and the antioxidant defense controller
Nrf2 play a role in nutritional modulation of PCB-induced vascular toxicity3 and that
cross-talk between caveolae-related proteins and cellular Nrf2 may be required for
optimal cytoprotection by green tea catechins and other diet-derived polyphenols.
Many groups, including ours, have shown that green tea catechins such as
EGCG can up-regulate basal levels of antioxidant enzymes in vitro71; 280; 289. Interestingly,
our overall results show that green tea extract supplemented in the diet acts as an
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antioxidant only in the presence of a secondary stressor, in this case, the proinflammatory coplanar PCB 126. The inconsistencies between in vitro and in vivo studies
may be explained by the relatively high doses of tea catechins usually employed in cell
culture or the fact that most tea catechins are quickly biotransformed in vivo to
metabolites that exhibit differential physiological effects286. There are many other
examples of instances where supplementation with GTE or specific catechins is
protective in in vivo models of inflammation and oxidative stress. For many of our
investigated antioxidant enzymes we saw decreased expression in the presence of PCB
when fed a control diet, but levels were up-regulated, many returning to control vehicle
levels in PCB groups fed a GTE-rich diet (e.g., SOD1 in Figure 4.4). These observations
are in line with other groups who investigated GTE effects on other stressors including
ethanol toxicity and bacterial infection290; 291.
Our past work in cell culture points to the antioxidant controller Nrf2 as a major
player in nutritional modulation of PCB toxicity. Many nutrients other than green tea
catechins, including resveratrol, found in the skins of grapes, and sulforaphane, which is
found in broccoli, have been shown to activate Nrf274; 87; 88; 290; 291. Nrf2 can become
transcriptionally active through multiple mechanisms including direct phosphorylation by
PKC delta and loss of contact between Nrf2 and inhibitory kelch-like ECH-associated
protein 1 (Keap1)89. Upon activation, Nrf2 is able to evade ubiquitination, enter the
nucleus, and bind cis-acting antioxidant response elements in target genes such as
NQO190. Nrf2 activation leads to decreased overall oxidative stress and inflammation,
which is a hallmark of PCB toxicity86. In this work we observed a relatively significant
trend toward increased NRF2 translocation to the nucleus in animals supplemented with
GTE and subsequently exposed to PCB (Figure 4.6). More interestingly and novel, we
also saw a drastic increase in AhR mRNA expression in this same treatment group
(Figure 4.8). This up-regulation was mirrored in increases in both CYP1A1 and CYP1B1
mRNA levels in mice fed a GTE rich diet and subsequently exposed to PCB. An
increase in AhR may help to detoxify the acute exposure to PCB by increasing
metabolism-assisted excretion. Although a consistent, steady up-regulation of AhR may
create a negatively imbalanced redox situation, the GTE’s ability to up-regulate AhR only
in the presence of a toxicant may in some cases be a protective and positive
mechanism. Other groups have shown that different catechins within GTE display either
antagonistic or agonist activities against CYP1A1292, but to our knowledge no group has
reported the mRNA up-regulation as seen in Figure 4.7. In our analysis of PCB
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concentrations in plasma we observed a very slight trend towards decreased levels of
parent PCB 126 in the plasma of mice supplemented with GTE (Figure 4.2). Although
plasma levels may be a good overall picture of body-burden of PCBs, in the future,
collecting urine and feces may paint a clearer picture of GTE’s involvement with
detoxification and excretion. Also, we may have been able to see a more significant
decrease in PCB levels and or a modulation of PCB hydroxy metabolite in mice
supplemented with GTE if we sacrificed the mice more than 24 hours after the final PCB
dose99.
PCBs can induce vascular inflammation by up-regulating pro-inflammatory
mediators such as MCP-1 and CCL3. We hypothesized that GTE would down-regulate
basal levels of these inflammatory markers in vehicle treated mice as well as decrease
PCB-mediated up-regulation in PCB 126 treated mice. Interestingly however, for both of
our inflammatory markers we saw a significant increase in mRNA levels in vehicle
treated mice supplemented with GTE (Figure 4.7). This observation would suggest that
the dose of GTE used in this study may not be optimal, and perhaps toxic to some
degree, in basal levels of oxidative stress and inflammation. Other groups have shown
GTE toxicities at certain doses in vivo293; 294, and interestingly, data illustrating protection
seems to be more conclusive in animal models of oxidative stress and inflammation.
Importantly, for our study, both MCP-1 and CCL3 mRNA levels return to vehicle treated
control diet levels in mice fed GTE and subsequently exposed to PCB. This may point to
GTE as exhibiting possible hormetic activity by inducing a slight response by the
organism that ultimately primes the protective antioxidant system for a future stressor,
i.e., Superfund pollutant exposure. Understanding hormesis and the role that nutrients
can play is an extremely interesting scientific discipline and demands much more future
investigation295.
In summary, our current study supports our in vitro data that green tea catechins
can protect against PCB 126-induced cytotoxicity by reducing oxidative stress60. Our
current in vivo data contributes to the overall hypothesis that nutrition can modulate
environmental insults. More studies are needed to further understand detailed
mechanisms of protective benefits to consume diets high in protective and healthful
nutrients such as plant-derived polyphenols and other bioactive compounds. (The data
presented in Chapter 4 were published98.)
Copyright © Bradley J. Newsome 2014
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Table 4.1
Primers used for qRT-PCR
Gene name Forward primer 5'-3'
Inflammatory and xenobiotic-related markers
AhR
GACCAAACACAAGCTAGACTTCACACC
CCL3
CACCCTCTGTCACCTGCTCAA
CYP1A1
TGGAGCTTCCCCGATCCT
CYP1B1
TGCATCGGTGAGGAACTGTCT
MCP-1
GCAGTTAACGCCCCACTCA
Nrf2
GAGTCGCTTGCCCTGGATATC
Antioxidant markers
Catalase
CAGAGAGCGGATTCCTGAGAGA
Gpx2
GTGGCGTCACTCTGAGGAACA
Gpx3
CATACCGGTTATGCGCTGGTA
Grx2
CATCCTGCTCTTACTGTTCCATGGCCAA
GSR
TCGGAATTCATGCACGATCA
GSTa1
AAGCCCGTGCTTCACTACTTC
GSTa4
TACCTCGCTGCCAAGTACAAC
GSTm1
ATACTGGGATACTGGAACGTCC
GSTm2
ACACCCGCATACAGTTGGC
GSTm3
CCCCAACTTTGACCGAAGC
NQO1
GGCATCCAGTCCTCCATCAA
SOD1
GAAACAAGATGACTTGGGCAAAG
Trx2
GCTAGAGAAGATGGTCGCCAAGCAGCA
TrxR1
GGCCAAAATCGGTGAACACATGGAAG

Reverse primer 5'-3'

Fragment size

CAAGAAGCCGGAAAACTGTCATGC
TGGCGCTGAGAAGACTTGGT
CATACATGGAAGGCATGATCTAGGT
CTCATGTTTGAGGACTCATTTTGG
CCTACTCATTGGGATCATCTTGCT
TCATGGCTGCCTCCAGAGAA

200 bp
100 bp
100 bp
104 bp
63 bp
100 bp

CTTTGCCTTGGAGTATCTGGTGAT
CAGTTCTCCTGATGTCCGAACTG
CCTGCCGCCTCATGTAAGAC
TCATCTTGTGAAGCGCATCTTGAAACTGG
GGCTCACATAGGCATCCCTTT
GGGCACTTGGTCAAACATCAAA
GAGCCACGGCAATCATCATCA
AGTCAGGGTTGTAACAGAGCAT
TGCTTGCCCAGAAACTCAGAG
GGTGTCCATAACTTGGTTCTCCA
GTTAGTCCCTCGGCCATTGTT
TTACTGCGCAATCCCAATCA
TCCTCGTCCTTGATCCCCACAAACTTG
CGCCAGCAACACTGTGTTAAATTCGCCCT

100 bp
125 bp
80 bp
123 bp
100 bp
159 bp
109 bp
349 bp
118 bp
208 bp
100 bp
100 bp
168 bp
175 bp
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Table 4.2
The effect of green tea extract (GTE) diet supplementation on
PCB 126-induced mRNA Inflammatory, xenobiotic-related and
antioxidant markers
Gene name

5 µmol PCB 126/kg mouse (fold change)
Control diet
Control + 1% GTE

Inflammatory and xenobiotic-related markers
AhR
0.771±0.096
1.506±0.131
CCL3
2.051±0.224
0.945±0.116
CYP1A1
915.208±136.510
1169.338±78.900
CYP1B1
87.504±7.694
146.998±12.329
MCP-1
1.909±0.478
0.745±0.235
Nrf2
3.088±0.307
3.212±0.234
Antioxidant markers
Catalase
0.495±0.057
0.817±0.071
Gpx2
0.339±0.161
0.682±0.098
Gpx3
0.925±0.167
1.411±0.159
Grx2
0.213±0.015
0.486±0.078
GSR
0.702±0.074
1.245±0.097
GSTa1
14.771±2.911
22.955±3.975
GSTa4
0.896±0.117
2.222±0.245
GSTm1
2.306±0.450
4.024±0.301
GSTm2
0.868±0.097
1.366±0.114
GSTm3
4.469±0.664
18.596±1.819
NQO1
1.980±0.051
6.138±0.031
SOD1
0.311±0.041
0.684±0.063
Trx2
0.731±0.050
1.556±0.152
TrxR1
1.522±0.143
2.673±0.276
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p-value
<0.001
<0.001
N.S.
<0.001
0.012
N.S.
0.003
0.08
0.004
0.003
0.001
0.034
<0.001
0.006
0.004
<0.001
0.006
<0.001
<0.001
0.002
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Figure 4.1. Proposed signaling pathway for PCB detoxification in vivo. PCB 126, an
AHR ligand and activator of NRF2, causes CYP1A1 up-regulation, which leads to
superoxide production. Green tea extract (GTE) diet supplementation effectively upregulates redox-related enzymes in the presence of PCB 126 which allows for a more
efficient antioxidant response to environmental insult.

97

40
35

0.05

30
0.04

25

0.03

20
15

0.02

10
0.01

5

0

Plasma OH-PCB 126 level (pmol/µL)

Plasma PCB 126 level (pmol/µL)

0.06

0

PCB126
126
PCB

OH-PCB
OH-PCB126
126

Figure 4.2. The effect of green tea extract (GTE) diet supplementation on systemic PCB
126 concentration and metabolism. PCB 126 and its hydroxy metabolites were
measured in mouse plasma by UFLC/MS MS and normalized to sample volume and
internal standard recovery. PCB 126 is heavily metabolized in vivo, as seen by very low
levels of parent PCB 126 remaining in plasma samples while its hydroxylated
metabolites predominate. GTE supplementation did not significantly modulate systemic
PCB or metabolite concentrations. Data are presented as mean±S.E.M (n=5).
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Figure 4.3. PCB 126-induced oxidative stress is modulated by green tea extract (GTE)
diet supplementation. Plasma F2-isoprostane (A) and metabolite (B) levels were
measured by HPLC/MS MS to assess in vivo oxidative stress induced by PCB 126 that
is potentially mitigated by GTE supplementation. Relative levels of combined F-2 IsoPs,
including PGF2α, 8-iso-PGF2α, iPF2α-III, 8-epiPGF2α, 8-isoprostane, and 15-F2t
isoprostanes, were determined by averaging the AUC integration values from retention
times of 8 and 11.3 minutes (Q1 = 353.144, Q2 =193.1). Additionally, the level of 13,14dihydro-15-ketoPGF2α, an F-2 IsoP metabolite, was determined by integrating its peak
at 11.3 minutes (Q1 = 355.2, Q2 = 311.4). Data are presented as mean±S.E.M. (n=810). GTE supplementation significantly decreased oxidative stress induced by PCB 126
treatment (*p<0.05).
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Figure 4.4. Relative mRNA levels of representative antioxidant enzyme markers, NQO1
(A), GSTm3 (B), SOD1 (C) and GSR (D) in mouse liver samples. Overall GTE
supplementation did not significantly increase antioxidant mRNA levels in control diets,
but, in the presence of environmental perturbation (i.e. PCB 126 gavage), significantly
higher antioxidant levels were seen in mouse liver above non-supplemented diet. All
values were determined using the relative quantification method (ΔΔCt) as a fold change
from control. Data are presented as mean±S.E.M (*p<0.01, n=8-10). See Table 4.2 and
Supplementary Figure 4.1 for more information concerning all antioxidant markers
tested.
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Figure 4.5. GTE supplementation leads to increased antioxidant protein expression in
the presence of PCB 126. Protein expression of NQO1 (A) and GSR (B) in mouse liver
samples was assessed by Western blot analysis. Protein samples were separated
through gel electrophoresis and probed with NQO1 and GSR primary antioxidant-related
antibodies. Statistically significant increases in antioxidant protein activity were seen in
PCB 126-treated mice that were fed a GTE-supplemented diet. In addition to visualized
Western blot comparison to β-actin housekeeping gene, samples were compared to
GAPDH housekeeping gene for densitometry quantification to further substantiate
findings. GTE supplemented mice exposed to PCB showed a significant increase in
protein expression, indicating a strengthened antioxidant response due to GTE
supplementation (*p<0.01,**p≤0.05, N=8).
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Figure 4.6. Nuclear translocation of Nrf2 in mouse liver samples. Mice fed a 1% GTEsupplemented diet and subsequently exposed to PCB 126 displayed increased Nrf2
activation, as evidenced by increased Nrf2 translocation to the nucleus, compared to
mice fed 10% fat control diet and exposed to PCB. Lamin was used as a nuclear fraction
housekeeping gene for densitometry quantifications. GTE supplemented mice exposed
to PCB showed a trend toward increased nuclear abundance of Nrf2 (*p=0.1, n=4).
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Figure 4.7. Relative mRNA levels of inflammatory and xenobiotic-related markers,
Cyp1A1 (A), Cyp1B1 (B), MCP-1 (C) and CCL3 (D) in mouse liver samples. GTE
supplementation led to increased cytochrome P450 (CYP1A1 and CYP1B1) mRNA
expression in the presence of both GTE and environmental toxicant (i.e., PCB 126),
indicating increased activity for toxicant degradation and/or excretion. MCP-1 and CCL3
inflammatory markers were statistically increased in GTE-supplemented mice liver
samples but toxicant-induced inflammatory markers returned to control levels due to
GTE supplementation. All values were determined using the relative quantification
method (ΔΔCt) as a fold change from control. Data are presented as mean±S.E.M.
(*p<0.01, **p<0.05, n=8-10).
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Figure 4.8. mRNA expression for AhR (A) and Nrf2 (B) genes in mouse liver samples.
GTE diet supplementation leads to significant up-regulation of AhR mRNA levels in the
presence of PCB 126, thus increasing in vivo toxicant clearance. Nrf2 mRNA levels are
significantly increased during PCB 126 insult, although GTE supplementation does not
cause statistically significant modulation of PCB toxicity. All values were determined
using the relative quantification method (ΔΔCt) as a fold change from control. Data are
presented as mean±S.E.M (n=8-10). GTE supplementation significantly increased AhR
in the presence of PCB 126 treatment (*p<0.01).
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Chapter 5. Conclusions
5.1 Overall outcomes
In conclusion, we have demonstrated that aluminum oxide nanoparticles can be
effectively stabilized under biologically relevant conditions by optimizing charge
stabilization based on buffer characteristics and pH, and by tailoring ultrasonic sheer to
initially disperse aggregated particles as single nanoparticles or small agglomerates.
Citrate buffer, pH 6.0, with high sheer probe ultrasonication produces alumina
nanoparticle suspensions in the nanosize regime (below 100 nm) that are stable for
extended periods of time in buffer or when added to relevant biological media for
eventual in vitro toxicity studies.
Nanotoxicology studies were performed to study potential concerns associated
with increased nanoparticle usage in industrial and biomedical settings. Titanium
dioxide nanoparticles, another highly relevant metal oxide particle system used heavily
in industrial and commercial applications, were tested to determine overall in vitro effects
in vascular endothelial cells and to further understand the cellular signaling pathways
involved in TiO2-linked oxidative stress and inflammation. TiO2 NP exposure was shown
to increase cellular oxidative stress and DNA binding of NFκB, significantly increase
induction of mRNA and protein levels of VCAM-1 and MCP-1 inflammatory markers, and
increase phosphorylation of key signaling pathways linked to NFκB activation and
subsequent inflammation. These data indicate that TiO2 NPs can induce endothelial
inflammatory responses via redox-sensitive cellular signaling pathways.
The toxicity of PCB 77, a coplanar persistent environmental pollutant that exhibits
dioxin-like toxicity, was studied at various stages of iron/palladium nanoparticle-induced
dechlorination to determine the effectiveness of PCB degradation for decreasing
associated public health risk. Although complete PCB 77 degradation to biphenyl was
shown to eliminate PCB-induced endothelial dysfunction, degradation product mixtures
showed significant in vitro toxicity in vascular endothelial cell systems in the presence of
any concentration of parent PCB 77. As the concentration of parent PCB 77 decreased
with increased remediation duration, though, cellular viability improved and superoxide
production decreased, as did NFκB activation and mRNA and protein inflammatory
marker expression. These data implicate PCB dechlorination as a beneficial tool for
decreasing biological toxicity to the vascular endothelium.
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Nutrient polyphenol-functionalized nanomaterials were developed to address the
need for efficient, environmentally friendly POP remediation. Capitalizing on the
previously determined binding affinity of PCBs to aromatic polyphenols, quercetin and
curcumin multiacrylates were synthesized and were both surface functionalized onto
magnetic iron oxide nanoparticles and incorporated into magnetic nanocomposite
microparticle systems. Preliminary results show rapid PCB binding in both MNP and
MNM systems, with increased binding contingent on higher polyphenolic polymer
content, as seen primarily in MNM binding systems. Additionally, curcumin-based
systems exhibited higher PCB binding affinity and higher binding capacity when
incorporated into MNM systems. Future work will further substantiate the use of these
polyphenolic systems for fluorescence-based, concentration-dependent pollutant
sensing.
Finally, green tea extract, comprised primarily of the potent antioxidant
polyphenol EGCG, was tested as a nutritional intervention mechanism for PCB-induced
in vivo toxicity. Mice fed a green tea-enriched diet and subsequently exposed to
environmentally relevant doses of coplanar PCB 126 exhibited decreased overall
oxidative stress primarily due to the up-regulation of a battery of antioxidant enzymes.
F2-isoprostane and its metabolites, established markers of in vivo oxidative stress,
exhibited fivefold decreased levels in mice fed green tea-supplemented diets. In addition
to data indicating increased induction of key antioxidant enzymes, liver mRNA and
protein analysis showed that many genes transcriptionally controlled by the aryl
hydrocarbon receptor and nuclear factor (erythroid-derived 2)-like 2 proteins were upregulated in PCB-exposed mice fed the green tea-supplemented diet, which indicates
both higher pollutant degradation/excretion and a more efficient antioxidant response to
environmental insult. These data support the emerging paradigm that healthful nutrition
may be able to bolster and buffer a physiological system against the toxicities of
environmental pollutants.

5.2 Broad approach to addressing a public health concern
Overall, this research has sought to address the significant public health risks
and enduring remediation challenges posed by PCBs, as well as to further understand
potential concerns and opportunities associated with nanomaterial usage. Nutrition is
being further substantiated as an important modulator of inflammatory and antioxidant
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pathways, especially associated with environmental insult, and is also emerging as a
tool to address exposure toxicity of persistent organic pollutants as both a sensing and
remediation platform. Evidence now shows that a person’s nutritional status can play a
key role in determining the severity of environmental toxicant-induced pathologies such
as diabetes and cardiovascular diseases. People with subprime nutrition may be more
susceptible to the toxicity of environmentally persistent pollutants, whereas individuals
that make healthy nutritional decisions and emphasize the importance of foods high in
bioactive nutrients such as flavonoids may be less vulnerable to environmental insults by
being able to buffer against the toxicity of pro-inflammatory pollutants. This research
has highlighted that while PCBs have been shown to cause vascular toxicity through
ROS-initiated inflammation, the detrimental effects can be counteracted by nutritional
modulation via bioactive food components, such as EGCG found in green tea, that have
potent antioxidant and anti-inflammatory properties. Thus, the use of healthy nutrition as
a tool against the toxicity of environmental pollutants may be an economically and
socially viable alternative to expensive and logistically challenging ecological
remediation.
Although augmenting the nutritional profiles of at-risk populations may prove to
be an effective modulator of toxicant-induced disease in the long term, it is critical to
discover and design novel sensing and remediation technologies that are effective,
sustainable and environmentally friendly to address immediate needs. To this end,
nanoparticle-based remediation systems have been studied to determine new methods
for binding and removing organic pollutants from contaminated water sources,
biologically-relevant nanoparticle suspension methods have been optimized, and
nanotoxicological tests have been performed to understand potential causes of concern.
Novel and emerging evidence indicates that bioactive nutrients may be incorporated into
nanomaterial-based sensing and remediation platforms for the development of viable
technologies that circumvent many of the issues concerning current-day
decontamination systems. Ultimately, further research into nutrient polyphenols, such as
EGCG, quercetin, and curcumin, will highlight their potential as sustainable, inexpensive
components that can both decrease health concerns associated with environmental
pollutants in the short term and remediate these concerns in the long term.

Copyright © Bradley J. Newsome 2014
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Appendices
Appendix A. Biomimetic nanocomposite-mediated removal of chlorinated organic
pollutants from contaminated water sources
A.1 Synopsis
Polychlorinated biphenyls (PCBs), organic pollutants prevalent in multiple
Superfund sites, have proven difficult to remediate due to their high structural stability
and their broad environmental presence. Endothelial dysfunction attributed to exposure
to PCB contamination may lead to atherosclerosis and steatohepatitis. There is a need
to not only address toxicological implications of PCB contamination, but also to detect
and remediate contamination sites. Currently, though, there remains an unmet need in
the ability to rapidly detect and remove PCBs from a variety of environmental water
sources. Ongoing research indicates that polyphenol-functionalized magnetic
nanomaterials can serve as a platform for rapid binding of PCBs from contaminated
water sources, with eventual use as a combined detection and remediation platform.
Quercetin and curcumin antioxidant polyphenols with binding affinities for PCBs were
acrylated (producing quercetin multiacrylate (QMA) and curcumin diacrylate (CDA)) and
either surface-functionalized onto or polymerized with magnetic iron oxide nanoparticles
using PEG200DMA as a co-macromer crosslinker. Polyphenol-functionalized magnetic
nanoparticles (MNPs) and magnetic nanocomposite microparticles (MNMs) were
characterized for proper functional groups using FTIR (addition of C=O peak at 1740 cm1

), for size using TEM/SEM and DLS (MNPs: approx. 15nm individual particles, 200-

400nm aggregates; MNMs: approx. 10µm individual particles, 20 µm aggregates), and
for overall composition using TGA (MNPs: approx. 10 wt% polymer; MNMs: approx. 90
wt% polymer). CDA- and QMA-functionalized MNP and MNM PCB binding affinities and
capacities were analyzed in 50:50 ethanol:DI H2O or contaminated groundwater and
quantified using LC-MS/MS. PCB binding to materials as a function of binding material
concentration, binding time, and as a ratio of polyphenolic polymer mass to bound PCB
indicated that MNMs, containing higher percentages of polyphenolic polymer, exhibit
higher PCB binding capacities (approx. 80% of initial PCB (5 ppm initial concentration)
bound to CDA-MNMs (5 mg/mL)), while optimal PCB binding for all systems occurs
within minutes of addition to contaminated water samples. Studies in complex
groundwater samples showed that polyphenol-functionalized materials have increased

108

affinity in comparison to suspended particulate matter (QMA-MNPs captured 87% of
PCBs). Initial pollutant release studies indicate a release of 12% bound PCB 126
following AMF heating, which indicates the potential for material regeneration following
binding. Overall, quercetin and curcumin incorporation into biomimetic pollutant binding
systems significantly increased PCB 126 binding from contaminated water samples and
may serve as an effective fluorescence-based pollutant detection system.
A.2 Introduction
More than 30 years after passage of the initial Superfund legislation, risk
managers continue to confront high concentrations of persistent chlorinated organic
compounds at Superfund sites296 despite decades of remediation effort297. Soil and
groundwater aquifer contamination by toxic chlorinated organic compounds at Superfund
sites across the country and throughout the world is a pervasive environmental problem
which has been studied extensively to further understand associated health
consequences as well as to develop effective means of pollutant decontamination and
mitigation of negative health effects296; 298. For instance, polychlorinated biphenyls
(PCBs), persistent organic chemicals heavily used as dielectric and heat transfer fluids
prior to their production ban in 1979, have been shown to play a contributory role in a
wide variety of chronic diseases such as atherosclerosis, diabetes and obesity. A recent
population study by Silverstone et al. identified PCB exposure as a risk factor for
development of type 2 diabetes independent of other risk factors25, while other studies
have shown that circulating levels of PCBs are associated with atherosclerotic plaque
formation247; 255. PCBs, particularly dioxin-like congeners that are ligands of the aryl
hydrocarbon receptor (AhR)(i.e., PCB 77 and 126), have been shown to promote
expression of proinflammatory cytokines and to effect changes in redox status, events
which act as precursors to these disorders21. In addition to highly toxic dioxin-like
congeners and despite a total production ban, though, studies have shown that many
lesser-known PCBs continue to be produced as unintentional byproducts of pigment
manufacturing processes, further increasing exposure risk299. The result is that
environmentally persistent chlorinated organics present a 21st century challenge.
Biomedical intervention strategies and environmental remediation techniques
both have been employed to address environmental pollutant-induced public health
concerns. For example, a recently published case study of the residents of Anniston, AL,
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a community affected by 30 years of PCB contamination, showed that nutritional
intervention with the fat substitute olestra effectively decreased body burden of PCBs300.
Additionally, green tea extract, primarily composed of the antioxidant polyphenol
epigallocatechin gallate (EGCG), has been shown to significantly decrease PCB-induced
proinflammatory protein and mRNA markers in vivo by up-regulating a battery of
antioxidant enzymes as well as the AhR and nuclear factor (erythroid-derived 2)-like 2
(Nrf2) pollutant clearance and antioxidant response mechanisms (see Chapter 5)98.
Other antioxidant polyphenols, i.e., quercetin and curcumin, also have been shown to
protect against in vivo and in vitro PCB-induced oxidative stress126; 301 and have been
studied extensively for their use as overall free radical scavengers and as the basis for
biodegradable antioxidant polymer systems128. While environmental remediation
provides a more long-term answer to pollutant-induced public health concerns, this large
goal has proven difficult and costly. Traditional treatment strategies, e.g., dredging/soil
removal, reactive barriers, six phase heating, microbial transformation, carbon
adsorption, etc. for remediation/reclamation of contaminated areas require extensive use
of chemicals and/or energy or post-treatment due to formation of undesirable
byproducts302-307. Thus, complete remediation has been technically unattainable and
economically impractical.
Affinity-based methods (i.e., antibody-based detection systems) are emerging as
effective binding and detection platforms for pollutant remediation due to their refined
specificity and reduced need for sample purity308-310. Although antibody affinity in the
form of enzyme-linked immunoassays currently serves as the most commonly applied
immunoassay for environmental PCB detection, antibodies are prone to long-term
stability concerns and are expensive to produce118; 309; 311. Instead, biomimetic polymeric
systems can be tailored that exploit the binding domains of pollutant-specific antibodies
while addressing these stability and cost concerns. Studies have shown that binding
domains of PCB-specific antibodies (e.g., S2B1) form sterically constrained, highly
aromatic pockets that allow for pi-pi bond stacking interactions312. This binding
relationship is also seen in tests of PCB soil distribution (e.g., humic containing matter)
and biodistribution (e.g., lipid rafts, PCB-binding proteins)312-316. We hypothesize that
synthetic, biomimetic PCB binding domains can be synthesized by incorporating
phenolic moieties into polymeric coatings for high PCB binding affinity and capacity as
an effective means of pollutant removal from contaminated sites. As with biomedical
intervention strategies, polyphenols (e.g., plant derived flavonoids) offer an intriguing
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mechanism to address PCB-related public health concerns through their use as
precursors for creating biomimetic affinity domains. Similar to the ability of antibodies
and natural humic matter to bind PCBs, we hypothesize that nutrient polyphenols (i.e.,
curcumin and quercetin) can be used as monomeric starting materials to mimic PCB
binding microdomains, allowing for the synthesis of PCB binding pockets that enable
environmentally-benign pollutant capture/removal systems.
Additionally, the development of magnetic iron-based nanomaterials has brought
important and promising new opportunities to the field of contaminant detection and
environmental remediation in addition to its wide use for biomedical applications (i.e.,
magnetic resonance imaging, targeted drug delivery, and hyperthermia)40-43. Beyond
their growing use as a platform for PCB dechlorination/remediation21; 237; 240; 302; 317-320,
magnetic nanoscale iron particles have attracted growing attention for their easy
manipulation with a magnetic field (e.g. for magnetic separation of captured molecules or
transport and immobilization at target sites) and response to an alternating magnetic
field (AMF) for targeted heating to modify properties (e.g. binding/release properties,
reaction rates, etc.). By tailoring nanoparticle surface characteristics through
functionalization it is possible to combine the pollutant binding capabilities of biomimetic
polymer systems with the separation and heating characteristics of magnetic
nanoparticles for effective and environmentally benign pollutant capture/removal from
contaminated sites41; 42.
This research employs plant polyphenol-derived polymers incorporated into
magnetic nanocomposite platforms that allows for the selective capture and removal of
PCB congeners from contaminated water samples (see Figure A.1). This work provides
a potential means of environmentally sound pollutant remediation by combining
biomedical treatment strategies with materials-based remediation platforms for the
creation of biomimetic binding systems with the potential for future use not only in
pollutant capture but also detection and release for material reuse.
A.3 Materials and Methods
A.3.1 Materials
Quercetin, curcumin, acryloyl chloride, 2-bromo2-methylpropionic acid (BMPA),
iron(II) chloride tetrahydrate, iron(III) chloride hexahydrate, dimethyl sulfoxide (DMSO),
2,2’-bipyridine (BPY), ammonium persulfate (APS), and tetramethylethylenediamine
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(TEMED) were purchased from Sigma-Aldrich (St. Louis, MO). Triethylamine (TEA),
tetrahydrofuran (anhydrous) (THF), acetonitrile (ACN), dichloromethane (DCM), and
potassium carbonate (K2CO3) were purchased from Thermo Fisher Scientific (Waltham,
MA). Poly(ethylene glycol) (200) dimethacrylate (PEG200DMA) was purchased from
Polysciences (Warrington, PA). 3,3’,4,4’,5-pentachlorobiphenyl (PCB 126) was
purchased from Accustandard (New Haven, CT). All other organic solvents, acids, and
salts were obtained from Sigma-Aldrich or Thermo Fisher Scientific and used as
received.
A.3.2 Synthesis of magnetic iron oxide nanoparticles
Magnetic iron oxide nanoparticles were synthesized by a coprecipitation method
as previously reported by our laboratory40; 321. Briefly, Fe(II) and Fe(III) salts were
dissolved in deionized water via sonication at a 1:2 molar ratio, respectively, stirred
under N2, and heated to 85 °C. Ammonium hydroxide was added dropwise when the
reaction mixture reached 85 °C and was stirred for 1 h to precipitate the nanoparticles.
Subsequently, magnetic iron oxide nanoparticles were washed and dialyzed for 24 h in
deionized (DI) water. Nanoparticles were characterized for size and suspension stability
using dynamic light scattering (DLS, Zetasizer Nano ZS90, Malvern, Worcestershire,
United Kingdom) (See Table A.1). Particles were stored in DI water until further use.
A.3.3 Synthesis and purification of quercetin multiacrylate and curcumin
diacrylate
Acrylated antioxidant polyphenols were synthesized by reacting the polyphenols
quercetin and curcumin with acryloyl chloride in tetrahydrofuran (THF) and potassium
carbonate (K2CO3) or triethylamine (TEA), similar to work previously reported by our
laboratory128, to enable their subsequent polymerization (See Supplementary Figure A.1
for synthesis overview). Quercetin and curcumin polyphenols were dissolved in THF at a
concentration of 100 mg/mL. K2CO3 was added to the quercetin solution at a 6:1
K2CO3:quercetin molar ratio while TEA was added to the curcumin solution at a 3:1
TEA:curcumin molar ratio, followed by purging with N2. Acryloyl chloride was added
dropwise to the reaction mixtures with stirring on an ice bath at initial molar ratios
(acryloyl chloride:antioxidant) of 6:1 and 3:1 for quercetin and curcumin, respectively.
The reactions were allowed to proceed for 18 h at room temperature, protected from
light.
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Subsequently, THF was removed from acrylated products by vacuum distillation
using a liquid N2 trap, and precipitated salts and potassium bicarbonate were separated
by vacuum filtration. In order to remove unreacted acryloyl chloride from the products,
dried quercetin multiacrylate (QMA) and curcumin diacrylate (CDA) powders were then
redissolved in dichloromethane (DCM) (80 mL) and QMA and CDA were extracted using
0.1 M K2CO3 (3 x 150 mL) and DI water (3 x 120 mL) with centrifugation at 10,000 rpm
for 5 min. Residual water was then removed using anhydrous MgSO4, solutions were
filtered using vacuum filtration, and DCM solvent was removed from purified products
under vacuum using a roto-evaporator (Rotovapor R II, Buchi, Switzerland). Synthesized
polyphenol multiacrylates were then characterized using high performance liquid
chromatography (HPLC, Shimadzu, Kyoto, Japan). Products were stored at -20 °C until
further use.
A.3.4 Synthesis of polyphenol-functionalized magnetic nanoparticles (MNPs)
Polyphenol-functionalized magnetic iron oxide nanoparticles (QMA- and CDAMNPs) were synthesized using atom transfer radical polymerization (ATRP) to
functionalize acrylates (PEG200DMA and antioxidant multiacrylates) onto BMPA-surface
initiated nanoparticles, similar to that reported previously322. Uncoated MNPs were
mixed with BMPA initiator at a 1:4 molar ratio in 75:25 water:ethanol (v/v) and stirred for
24 h at RT. The particles were then washed 3x with ethanol, retrieved by magnetic
decanting, and suspended at 10 mg/mL in ethanol. Surface initiated magnetic
nanoparticles (5 mL in ethanol) were then combined with BPY and CuBr catalysts, along
with 2-3 Cu0 crystals, at 1:0.01 and 1:0.04 PEG200DMA:catalyst molar ratios,
respectively. PEG200DMA was used herein as the primary macromer and QMA/CDA as
secondary functional monomer. Catalyst solution was stirred and heated to 50 °C with
N2 bubbling. At 50 °C, 8 mmol macromer (99:1, 95:5, and 90:10 molar ratios of
PEG200DMA to QMA or CDA) was injected into the catalyzed mixture and allowed to
react for 24 h, protected from light. Functionalized nanoparticles were then magnetically
decanted, washed 3x with ethanol to remove excess catalyst, and further washed with
50:50 ACN/DCN, followed by DI water to determine potential macromer leaching.
Functionalized MNPs were characterized to determine accurate synthesis characteristics
using Fourier transform infrared spectroscopy (FTIR, 7000e, Varian, Palo Alto, CA), for
size using DLS and transmission electron microscopy (TEM, 2010F, Jeol, Tokyo,
Japan), for polymer weight loss using thermogravimetric analysis (TGA), and for

113

potential macromer leaching rates using UV-vis spectrophotometry (50 Bio, Varian).
Nanoparticles were stored at 4 °C in DI water until further use.
A.3.5 Synthesis of polyphenolic magnetic nanocomposite microparticles (MNMs)
Polyphenolic magnetic nanocomposite microparticles (QMA- and CDA-MNMs)
were synthesized by polymerizing primary and secondary macromers in the presence of
suspended uncoated magnetic nanoparticles, followed by gel cryomilling to produce
particles in micron size regime. PEG200DMA and QMA or CDA were mixed at 99:1,
95:5, and 90:10 molar ratios and polymerized in the presence of 1 wt% magnetic
nanoparticles via free radical polymerization with 3 wt% APS and 1.5 wt% TEMED.
Following polymer formation in glass templates, gels were cut into small pieces, washed
5x with 50/50 anhydrous ACN/DCN with stirring for 30 min each wash. Solvent was then
removed, microparticles were frozen at -20 °C overnight, and subsequently lyophilized
overnight. Dried gels were then cryomilled for 10 min using a SPEX 6770 Freezer/Mill
(Metuchen, NJ). Polyphenolic MNMs were characterized for size using laser diffraction
particle size analysis (SALD-7101, Shimadzu) and scanning electron microscopy (SEM,
S-4300, Hitachi, Houston, TX), for polymer weight loss using TGA, and for potential
macromer leaching using UV-vis spectrophotometry. Dry MNM powders were stored at 20 °C until further use.
A.3.6 Polyphenol MNP- and MNM-mediated binding of polychlorinated biphenyls
from contaminated water samples
PCB 126 was added to 50:50 ethanol:water at 5 ppm to mimic an aqueous
environment while the addition of ethanol increases the overall solubility of PCB to
enable higher test concentrations. QMA/CDA-MNPs and MNMs were added to PCBcontaminated samples at varying particle concentrations (0.5, 1, and 5 mg/mL) and
incubated with shaking at RT for times ranging from 1 min to 2 h to optimize binding
conditions. Uncoated magnetic nanoparticles and PEG200DMA-coated MNPs/MNMs
served as pollutant binding controls. MNPs/MNMs with bound PCB were magnetically
separated and supernatants were removed. Pollutant binding ability and efficiency of the
materials were analyzed by measuring remaining PCB in supernatants using a
Shimadzu ultra fast liquid chromatography system coupled with an AB Sciex 4000-Qtrap
hybrid linear ion trap quadrupole mass spectrometer (LC-MS/MS) in multiple reaction
monitoring (MRM) mode using atmospheric pressure chemical ionization (APCI). MRM
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transitions monitored: 325.9/256.1, 325.9/254.1, and 325.9/184 for PCB 126. Unbound
PCB 126 was analyzed by integrating peak area (area under the curve, AUC) and
comparing to that of a concentration curve of known PCB 126 values.
A.3.7 AMF heating for PCB removal from particles
The efficiency of PCB 126 release from particle systems following PCB binding
was tested to determine the viability of material reuse. An alternating magnetic field
(AMF) was applied to heat the polyphenolic MNPs and MNMs for controlled
destabilization of the polymer matrix and subsequent release from the particles back in
to 50:50 ethanol:water. LC-MS/MS was used as reported in Section A.3.6 to determine
PCB leachate concentrations following heating and PCB release.
A.4 Results and Discussion
A.4.1 Material development and characterization
Polyphenol-functionalized magnetic nanoparticle (MNP) and nanocomposite
microparticle (MNM) binding systems were successfully synthesized with quercetin and
curcumin multiacrylate polymers (QMA and CDA, respectively) to create biomimetic
binding systems for chlorinated organic pollutants (i.e., PCBs). First, magnetic iron oxide
nanoparticles were produced through a one-pot coprecipitation method as the core
material to impart controlled heating and separation functionality. QMA and CDA were
then synthesized by incorporating acrylate groups onto the native quercetin and
curcumin structures to enable polymerization with poly(ethylene glycol) (PEG), while
maintaining original monomer functionality (see reaction scheme, Supplementary Figure
A.1). Magnetic nanoparticles were surface-functionalized with QMA and CDA polymers
using atom transfer radical polymerization or incorporated within the polyphenolic
polymer matrix at 1 wt% and cryomilled to the micron size regime.
In these studies, PEG was used as a crosslinker and co-macromer along with
QMA and CDA functional monomers in order to tune the polymer network structure of
the polymer coating for tailored PCB binding affinities and matrix porosity. PEG-based
systems were selected due to their low non-specific interactions with hydrophobic
systems and wide variety of commercially available systems with various molecular
weights, allowing for the tuning of polymeric network structures. Following
polymerization of CDA or QMA with PEG200DMA to form MNPs and MNMs, FTIR
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analysis was used to confirm successful incorporation of desired polyphenolic functional
groups, as indicated by the C=O peak observed at 1740 cm-1 (see Figure A.2).
Size analysis of both polyphenolic binding systems (i.e., MNPs and MNMs) was
performed using light scattering and electron microscopy methods, as seen in Table A.1
and Figure A.3. TEM analysis of MNPs showed individual particle sizes of 10-20 nm
(CDA-MNPs: 11 nm; QMA-MNPs: 15 nm) while DLS showed MNP aggregate
hydrodynamic diameters ranging from 240 (CDA-MNPs) to 400 nm (QMA-MNPs). This
large increase in particle size is primarily due to the slightly hydrophobic nature of the
particles that enables both a higher affinity binding environment for lipophilic PCBs and
faster magnetic decantation from contaminated water. Size analysis of cryomilled MNMs
showed much larger particle sizes (approx. 10 µm particle sizes via SEM), as expected,
and less particle aggregation (aggregate particle diameters of approx. 20 µm via laser
diffraction particle sizing).
While nanoparticles exhibit much higher overall surface area than microparticles,
with increasing surface area potentially leading to increased total pollutant binding,
microparticles are composed of a higher percentage of functional polymer in comparison
to the magnetic nanoparticle core material. TGA was used to analyze overall particle
composition based on particle mass loss at increased temperatures. As seen in Figure
A.4, MNP system mass was attributed primarily to the magnetic nanoparticle core (90
wt% NP core, 10 wt% polymer) while polymeric material predominated in MNM systems
(10 wt% NPs, 90 wt% polymer). Leaching studies were also performed to further clarify
overall material composition and determine QMA and CDA incorporation rates into the
polymeric matrix. MNPs and MNMs were washed following synthesis to remove
uncrosslinked macromer and washes were analyzed via UV-vis spectroscopy.
Absorbance measured at 370 nm (QMA) or 380 nm (CDA) indicated that CDA was
incorporated into both MNP and MNM systems at approx. 90% of initial macromer
content while QMA was incorporated at approx. 60-70%.
A.4.2 Preliminary studies of fluorescence modulation for pollutant detection
Curcumin and quercetin nutrient polyphenols are of interest not only due to their
wide use as natural antioxidant supplements and expected affinity for chlorinated
organics, but also due to their inherent fluorescence characteristics that form the basis
for future pollutant detection systems and are a key functionality to be exploited with
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future experimentation. Preliminary solution phased fluorescence interaction studies
were performed to evaluate the potential of quercetin and curcumin esters as
fluorescence indicators for PCB interaction. Heterocyclic rings under high concentrations
can exhibit pi-pi bond stacking. When the ringed molecules also have fluorescence
activity, pi-bond stacking can lead to resonance energy transfer, which shifts the
emission spectra into the red323; 324. Initially, QMA was tested for potential fluorescence
modulation in the presence of PCB 126; when excited at 350 nm, QMA exhibited a
fluorescence peak at 390 nm. However, as the concentration of PCB 126 increased from
0.04 to 20 ppm, a second peak emerged at 535 nm, with the ratio between these peaks
increasing proportionally over the observed range (see preliminary data in Figure A.5A).
Additionally, by characterizing both Kd and potential fluorescence shifts, it is possible to
develop a calibration curve for identification of PCB concentration. A Langmuir binding
interaction model was used to approximate QMA/PCB binding affinities, indicating a
preliminary Kd of the interaction of 2.2 ppm.
While QMA was found to exhibit a PCB-induced fluorescence shift, it was not
clear if this capability would remain following incorporation into magnetic nanocomposite
binding platforms. Further studies involving QMA-functionalized MNPs were then
performed to substantiate the viability of this platform. Surface functionalized MNPs
containing 20% QMA were incubated with and without PCB 126 and fluorescence
analysis indicated that 6 ppm of PCB resulted in an intense fluorescent peak at 535 nm.
This fluorescence shift corresponds directly to that of QMA alone in solution and
indicates that QMA incorporation into nanocomposite binding systems does not inhibit
binding/sensing activity (see Figure A.5B).
A.4.3 PCB 126 binding to polyphenol-functionalized nanomaterials
Capture materials are designed for high affinity of the analyte (i.e., PCB) to the
material, the number of available binding sites (binding capacity), and selectivity of the
material for the analyte of interest. These binding interactions are the result of multiple
weak molecular forces (e.g., pi-pi stacking, electrostatics, hydrogen bonding), which are
dictated by the localized environment of the binding pocket. Following substantiation of
CDA and QMA affinity for PCBs, CDA- and QMA-functionalized MNPs and MNMs were
optimized for binding capacity using a variety of polyphenolic polymer compositions and
binding conditions. The magnetic core material of these binding systems enables
manipulation with both static and alternating magnetic fields (AMF) for decantation or
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remote heating, respectively. As seen in Figure A.6A, MNPs and MNMs well dispersed
in medium of interest were completely collected within 5 min following exposure to a
static magnetic field. Although the primary purpose of the magnetic core material is to
enable simple separation of bound pollutant from contaminated samples, its ability to be
manipulated (i.e., remotely heated) with an AMF is key for polymer destabilization for
pollutant release. Initial studies performed with magnetic iron oxide nanoparticles at 5
mg/mL showed that temperature increased from 23 °C to 65 °C within 10 min when
exposed to an AMF at 300 kHz and 30 kA/m (Figure 4.6B).
Pollutant binding studies were conducted to determine PCB 126 affinity for CDAand QMA-functionalized MNPs and MNMs as a function of binding material
concentration, PCB binding time, and as a ratio of polyphenolic polymer mass to bound
PCB. MNPs and MNMs (1 or 5 mg/mL) were added to 50:50 ethanol:water (v/v)
containing 5 ppm PCB 126 and incubated with shaking for a variety of time points from 1
min to 2 h. LC-MS/MS analysis was then performed using supernatants following
magnetic separation of PCB-bound materials. As seen in Figure A.7A, a five-fold
increase in polyphenolic material concentration led to increased PCB binding, although
total PCB binding only increased by approx. 20% at higher material concentrations. This
indicates that the availability of binding sites plays some role in increased pollutant
binding, although equilibrium effects with the 50:50 ethanol:water medium also play
some role in incomplete PCB binding. When normalized for polymeric content instead of
total particle mass (Figure A.7B), MNPs were shown to bind PCB 126 at much lower
rates over the entire study time span. This is both indicative of the primary role that the
polyphenolic polymer plays in PCB binding (much increased polymer content in the
MNMs yielded significantly higher pollutant binding rates) as well as the role of increased
NP surface area in compensating for decreased polymeric content (when comparing
PCB binding as a function of total particle mass as opposed to polymeric content).
Equilibrium time studies indicated that high pollutant binding is seen within minutes of
exposure to functionalized nanomaterials while decreasing pollutant binding, primarily
seen with CDA-functionalized MNMs, may be due to excessive vortex-based sheer force
during pollutant binding.
When transitioning to real-world settings dealing with contaminated groundwater
sources, soluble humic acid components (found in sediment and soil samples) have
been found to negatively impact PCB sorbent performance. Both competitive binding for
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sites on the sorbent material and preferential PCB-humic acid interactions, which may
favor the suspension of PCB in the aqueous environment, can lead to decreased binding
efficiencies for capture platforms325-327. Herein, preliminary studies were performed to
test the viability of polyphenol-functionalized nanomaterials as PCB binding systems in
complex media. Groundwater from the Paducah Gaseous Diffusion Plant, Kentucky’s
largest Superfund site and the sight of initially significant PCB contamination, (a 50:50
mixture of ethanol to groundwater) was spiked with 5 ppm PCB 126, 1 mg/mL QMAMNPs were introduced and allowed to bind PCB for 1 h, and bound PCB was
magnetically decanted, followed by removal of supernatant. LC-MS/MS analysis
indicated that QMA-MNPs captured 87% of PCB 126 in complex media samples,
indicating that these polyphenolic functionalities may have higher affinity for PCBs than
humic containing matter suspended in water samples (see Figure A.8). This suggests
that further development of this system is warranted.

A.4.4 Reversible capture of PCBs using controlled heating
Currently, capture materials used for PCB extraction and detection require
extensive post processing with large amounts of organic solvents and complex
extraction methods. Materials that exhibit switchable affinities for PCBs and other
pollutants, though, could provide a means for material reuse without extensive
processing with chemicals that also pose health hazards, thus forming a low energy,
“greener” approach to pollutant remediation. As highlighted in section A.4.3, magnetic
nanomaterials can be heated remotely by applying an AMF to destabilize the polymeric
coating material and release PCBs back into the medium of interest. As seen in Figure
A.9, QMA-MNPs were used to remove PCB 126 from contaminated water samples,
which, following magnetic separation, were resuspended and exposed to an AMF
(amplitude of 60 kA/m and frequency of 293 kHz). AMF heating for 10 min led to a 12%
PCB 126 release back in to the medium (M±SE, n=3) from the MNPs. While it is
necessary to further optimize this release system, this ability to remotely impact affinity
substantiates further studies for the development of capture/release systems that can
easily cycle from low to high affinity binding states.
A.5 Conclusions
This research provides a framework for continued experimentation in the
development of environmentally benign, biomimetic PCB capture systems. Polyphenolic
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macromers based on quercetin and curcumin antioxidant polyphenols with notable
affinity for persistent organic pollutants were surface-polymerized onto or polymerized in
the presence of magnetic iron oxide nanoparticles to create nanocomposite materials
that can be manipulated with a magnetic field. The potential of these systems for
fluorescence-based detection of PCBs and as a capture/release platform for material
reuse was substantiated. Further, QMA- and CDA-functionalized MNPs and MNMs
were shown to bind PCB 126 in both control and real-world contaminated groundwater
settings (see Figure A.10 for overall schematic of PCB capture/release platform).
Ongoing experimentation is focused on optimizing material affinities and binding
characteristics for a wide variety of PCB congeners, as well as PCB release and material
reuse. Future experimentation is needed to further substantiate the use of these
materials in fluorescence-based pollutant detection, especially in complex mixtures of
organic pollutants, and in higher throughput settings for rapid pollutant binding and
contaminated material separation. Overall, this work highlights the use of novel
biologically inspired materials for pollutant removal from contaminated water sources
and its potential use as a capture/detection/release platform for addressing public health
concerns associated with PCBs.

Copyright © Bradley J. Newsome 2014
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Table A.1
Particle system size analysis
Particle system

Analyzed hydrodynamic
aggregate size

Analyzed TEM
average size (nm)

Analyzed SEM
average size (µm)

Uncoated MNPs
PEG-coated MNPs
CDA-coated MNPs
QMA-coated MNPs
PEG MNMs
CDA MNMs
QMA MNMs

162±4 nm a
203±3 nm a
241±11 nm a
401±6 nm a
16.2±0.5 µmb
19.6±0.3 µmb
22.1±0.3 µmb

--11
15
----

----8
10
11

a

Size analysis performed using dynamic light scattering to determine nanoparticle
aggregate hydrodynamic diameters
b

Size analysis performed using laser diffraction particle analysis to determine
microparticle hydrodynamic diameters
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Figure A.1. Overall illustration of composite magnetic nanomaterial platforms for the
capture, sensing, and release of chlorinated organic pollutants from contaminated water
sources.
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1
)

Iron oxide NPs

2
)

Surface activated NPs

3

Polyphenol-functionalized MNPs

Figure A.2. FTIR transmittance showing steps of MNP synthesis. 1) Core magnetic
particles are 2) surface initiated by coating with BMPA and 3) functionalized with
polyphenolic polymers (i.e., CDA and QMA crosslinked with PEG200DMA). FTIR
analysis confirms successful functionalization with the desired polyphenolic polymers via
the C=O peak observed at 1740 cm-1, which confirms in this case the presence of
quercetin functionality in the polymer coating.
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Figure A.3. Electron microscopy particle size determination. SEM analysis of MNMs
indicates average particle sizes of A) QMA MNMs, B) CDA MNMs, and C) PEG MNMs
as 11, 10, and 8 µm, respectively. TEM analysis of MNPs indicates average particle
sizes of D) QMA MNPs and E) CDA MNPs as 11 and 15 nm, respectively.
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Figure A.4. Thermogravimetric analysis of functionalized nanomaterial systems. Weightloss profiles were analyzed to determine average polymer content of MNP and MNM
binding systems, indicating that MNMs were composed of approximately 90% polymeric
material and 10% magnetic nanoparticles. Conversely, approximately 90% of the mass
of MNPs is due to the core magnetic nanoparticles while polyphenolic polymer surface
coating comprises 10% overall particle mass.
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A

B

Figure A.5. Fluorescence-based sensing of PCB 126. QMA and PCB demonstrate a
concentration dependent fluorescence shift. A) When excited at 350 nm, QMA exhibits a
fluorescence peak at 390 nm. As PCB 126 increased from 0.04 to 20 ppm, a second
peak emerged at 535 nm, with the ratio between these peaks increasing proportionally
over the observed range. Using a Langmuir binding interaction model to approximate
QMA/PCB binding affinities it was found the Kd of this interaction as 2.2 ppm. B) Studies
involving QMA-functionalized MNPs also showed a concentration specific fluorescence
peak at 535 nm upon QMA-MNP/PCB binding.
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B

Figure A.6. Material response to static and alternating magnetic fields. A) MNPs and
MNMs can be completely separated from PCB-contaminated water samples within 5 min
after exposure to a static magnetic field. B) Illustration of the heating of Blank MNPs in
an alternating magnetic field (Amp = 60 kA/m, Freq = 293 kHz)(M±SE, n=3).
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A) Material concentration-dependent PCB 126 binding
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B) PCB 126 binding normalized to polyphenolic polymer content
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Figure A.7. PCB 126 capture by polyphenolic MNPs and MNMs. CDA- and QMAfunctionalized MNP and MNM binding affinities for PCB 126 (5 ppm) were analyzed as a
function of binding material concentration, PCB binding time, and as a ratio of
polyphenolic polymer mass to bound PCB. A) a five-fold increase in polyphenolic
material concentration leads to increased PCB binding, although total PCB binding only
increased by approx. 20% at higher material concentrations. B) When normalized for
polymeric content instead of total particle mass, MNPs were shown to bind PCB 126 at
much lower rates over the entire study time span (M±SE, n=3). This is both indicative of
the primary role that the polyphenolic polymer plays in PCB binding (increased polymer
content yields higher pollutant binding) as well as the role of increased NP surface area
in compensating for decreased polymeric content. Equilibrium time studies indicate that
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high pollutant binding is seen within minutes of exposure to functionalized nanomaterials
while decreasing pollutant binding, primarily seen with CDA-functionalized MNMs, may
be due to excessive vortex-based sheer force during pollutant binding.
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capture (ppm)
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Figure A.8. QMA-MNP capture of PCB 126 from contaminated groundwater samples.
Contaminated water samples from the Paducah Gaseous Diffusion Plant were spiked
with 5 ppm PCB 126, 1 mg/mL QMA-MNPs with varying QMA content was introduced
into samples, and remaining PCB 126 in supernatant following magnetic separation was
analyzed with LC-MS/MS. Functionalized particles capture 87% of PCB in complex
media samples, indicating that material binding affinities are higher than that of the
particulate matter suspended in the water samples (M±SE, n=3).
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PCB 126 Bound (% of Control)

90%

85%

80%

75%

70%

65%
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No AMF

Figure A.9. Temperature-induced PCB 126 release from MNPs. QMA-MNPs were
heated with AMF (amplitude of 60 kA/m and frequency of 293 kHz), which led to a 12%
PCB 126 release back in to supernatant (M±SE, n=3).
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Biomimetic
binding pockets

Magnetic Separation
Thermal
destabilization

PCBs released
and stored.

PCBs in solution
Composite regeneration

Figure A.10. Overall schematic of PCB capture and material regeneration. Polyphenolfunctionalized materials (MNPs or MNMs) can be introduced into PCB-contaminated
water sources within a closed system where PCBs bind within biomimetic binding
pockets. The application of a static magnetic field can then be used to magnetically
decant PCB-bound MNPs and MNMs, leaving decontaminated groundwater, while
exposure to an alternating magnetic field can serve to destabilize the polymer matrix,
releasing bound PCB to be further remediated while also regenerating the polyphenolic
material for reuse.
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Appendix B. Additional data

D

E

Supplementary Figure 2.1. Transmission electron microscopy images of characteristic
alumina aggregates under various conditions. (A) Alumina dispersed in citrate buffer,
pH 6.0, with 10 min sonication using a probe sonicator showed mean aggregate
diameter of ~72 nm, while alumina suspended using ultrasonic bath with (B) 24-h
sonication and (C) 6-h sonication resulted in aggregate diameters of ~84 nm and 113
nm, respectively. Average aggregate sizes of citrate-stabilized alumina suspended in
(D) DMEM/High Glucose medium and (E) F-12K medium remain relatively the same,
with average particle diameters of ~93 nm and ~79 nm, respectively. Although primarily
suspended at sizes below 100 nm, some alumina particle agglomeration was seen when
suspended in media that resulted in particle diameters of ~150 nm. Mean aggregate
diameter represents n≥5 TEM data.
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Supplementary Table 4.1
Experimental diets
1% GTE-supplemented diet
g/kg
kcal

Control diet
g/kg
kcal

Protein

19 (20%)

19 (20%)

Carbohydrate

67 (70%)

67 (70%)

Fat

4 (10%)

Casein
L-Cystine
Corn Starch
Maltodextrin 10
Sucrose
Cellulose, BW200
Soybean Oil
Lard

190
3
299
33
332
47
24
19

800
12
1260
140
1400
0
225
180

190
3
299
33
332
47
24
19

800
12
1260
140
1400
0
225
180

Mineral Mix S10026

9

0

9

0

Vitamin Mix V10001
Green Tea Extract

9
10

40
!!

9
0

40
!!

Total

1065

4057

1055

4057

4 (10%)
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0.09

*

*

Liver/Body Weight (HSI)

0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0

Vehicle

PCB 126

Supplementary Figure 4.1. PCB 126 exposure leads to a significant increase in
liver/body weight ratio (hepatosomatic index, HSI) in both control and GTEsupplemented diets, although GTE supplementation did not significantly mitigate this
PCB-induced increase. Statistical analysis was performed using two-way ANOVA
followed by Tukey test with *p<0.001. A trend toward a statistically significant interaction
between diet and PCB 126 treatment (p=0.06) was also seen.
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Trx2 mRNA level
(Fold change)
2

5

2

0.6

0.4

0.2

Vehicle

1.5

*

1

0.5

30

Vehicle

25

**

20

15

10

5

Vehicle

4

*

3

2

1

Vehicle

*

1.5

1

0.5

Vehicle

Gpx2 mRNA level
(Fold change)

*

Grx2 mRNA levels
(Fold change)

Catalase mRNA level
(Fold change)
1

GSTa4 mRNA level
(Fold change)

Gpx3 mRNA level
(Fold change)
0.8

GSTm2 mRNA level
(Fold change)

GSTa1 mRNA level
(Fold change)

1.2

TrxR1 mRNA level
(Fold change)

GSTm1 mRNA level
(Fold change)

1.4
3.5

0

PCB 126

0

0

PCB 126

0

PCB 126

0

PCB 126
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3

1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0

PCB 126

2

3.5

*

2.5
2

1.5
1

0.5
0

Vehicle
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Supplementary Figure 4.2. Relative mRNA levels of antioxidant enzyme markers.
Overall, GTE supplementation did not significantly increase antioxidant mRNA levels in
control diets, but, in the presence of environmental perturbation (i.e., PCB 126 gavage),
significantly higher antioxidant levels were seen in mouse liver above non-supplemented
diet. All values were determined using the relative quantification method (ΔΔCt) as a fold
change from control. Vehicle and PCB 126-treated mice with 10% fat control and GTEsupplemented diets: n=8-10. Data are presented as mean±S.E.M (*p<0.01, **p<0.05).
See Table 5.2 and Figure 5.3 for more information concerning antioxidant markers
tested.
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Supplementary Figure A.1. Curcumin diacrylate (CDA) and quercetin multiacrylate
(QMA) synthesis schemes. To enable crosslinking with PEG200DMA, A) curcumin and
B) quercetin were first acrylated to form CDA and QMA, respectively, as seen in the
above reaction mechanisms. These polyphenols were reacted with acryloyl chloride to
form ester bonds between the acid chloride (–OCl) of acryloyl chloride and the
polyphenol hydroxyls (–OH), with the release of HCl byproduct that is neutralized with
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